data_1zub_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zub _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.614 -0.194 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.425 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.406 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.404 ' CE ' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.519 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.204 0.05 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.421 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 81.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.412 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.463 ' CZ2' HG22 ' A' ' 690' ' ' ILE . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.434 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.432 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.566 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.432 HD13 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 687' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.566 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.519 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.776 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.449 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 701' ' ' ILE . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.443 HD13 ' CB ' ' A' ' 658' ' ' ALA . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.418 ' HB3' HD23 ' A' ' 630' ' ' LEU . 13.7 ptmm? . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.503 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 119.87 -0.109 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.439 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.4 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 73.8 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.424 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 660' ' ' VAL . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 657' ' ' LEU . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 662' ' ' GLY . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.407 ' CG2' HG11 ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.428 ' CE2' HG12 ' A' ' 690' ' ' ILE . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.447 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.44 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.466 ' HA ' HD12 ' B' ' 946' ' ' ILE . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.448 ' CD1' HD13 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 701' ' ' ILE . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 687' ' ' TYR . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.503 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.78 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 658' ' ' ALA . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.412 ' CE ' ' HA ' ' A' ' 694' ' ' LYS . 2.6 mtpp . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.483 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 65.9 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.828 0.346 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.428 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 616' ' ' LEU . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.431 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.411 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.455 ' O ' HD11 ' A' ' 689' ' ' ILE . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.454 ' HA ' HD11 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.445 ' HD1' HD11 ' B' ' 946' ' ' ILE . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.494 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 694' ' ' LYS . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 701' ' ' ILE . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 670' ' ' VAL . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.483 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.795 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . 0.401 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.416 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.438 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.586 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.566 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.417 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.528 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 22.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.405 ' CG1' HD22 ' A' ' 616' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.421 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.513 ' CE2' HD11 ' A' ' 690' ' ' ILE . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.439 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.42 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.527 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.418 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 689' ' ' ILE . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.472 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 686' ' ' VAL . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.547 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.409 ' CA ' HG23 ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.547 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.432 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.586 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.446 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 699' ' ' VAL . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . 0.419 ' O ' HD12 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.692 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.431 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.432 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 31.1 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 617' ' ' ASN . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.465 ' CD1' HG12 ' A' ' 690' ' ' ILE . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CD1' HD12 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.489 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.513 ' CD1' HD13 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 616' ' ' LEU . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.513 HD13 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.492 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.692 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 120.906 0.17 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 701' ' ' ILE . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . 0.417 HG23 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 661' ' ' VAL . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.51 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.844 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.429 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.343 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.415 HG12 ' CD1' ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.416 ' HA ' HG23 ' A' ' 660' ' ' VAL . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 657' ' ' LEU . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . 0.403 ' N ' HD12 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 690' ' ' ILE . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.408 HG11 HD12 ' B' ' 946' ' ' ILE . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 676' ' ' LYS . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . 0.417 ' NE2' HG23 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 701' ' ' ILE . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.402 HG12 ' CG2' ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.473 HD11 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.51 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.844 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.457 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 701' ' ' ILE . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 699' ' ' VAL . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.437 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.636 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.561 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 635' ' ' VAL . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 632' ' ' LEU . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 616' ' ' LEU . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 662' ' ' GLY . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.442 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.433 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 649' ' ' ILE . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.415 ' CG2' HG12 ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.42 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.457 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.424 HG13 HD11 ' B' ' 946' ' ' ILE . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.469 ' CD1' HD12 ' B' ' 946' ' ' ILE . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.401 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.457 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.835 -0.106 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 687' ' ' TYR . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.433 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.636 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.798 0.11 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.452 ' HB3' ' CD2' ' A' ' 630' ' ' LEU . 6.9 ptmt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.612 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.573 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.436 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 81.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.791 0.329 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 634' ' ' VAL . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.407 HG12 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.458 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 662' ' ' GLY . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.436 ' CZ2' HD12 ' A' ' 690' ' ' ILE . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.436 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.436 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.414 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.414 ' CB ' ' CB ' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.492 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.456 ' CD1' HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.442 HD13 HG23 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.451 -0.083 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.492 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.436 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.612 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.432 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 701' ' ' ILE . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.411 HD23 ' CG1' ' A' ' 661' ' ' VAL . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.455 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.662 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.535 ' N ' HD13 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.437 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 635' ' ' VAL . 17.5 mmtp . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 27.0 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.805 0.336 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.419 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.406 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 662' ' ' GLY . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.401 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.481 ' CE2' HD12 ' A' ' 690' ' ' ILE . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.765 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.594 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.765 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 673' ' ' TRP . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.428 HG13 ' HB ' ' A' ' 614' ' ' VAL . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.455 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.662 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.452 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.573 0.225 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.628 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 656' ' ' SER . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.546 HD11 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.459 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 682' ' ' THR . 24.2 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.418 ' HB3' ' CA ' ' A' ' 631' ' ' GLY . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.455 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 658' ' ' ALA . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.482 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.488 ' CD1' HG23 ' A' ' 689' ' ' ILE . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.436 ' CE ' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.436 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.588 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.48 ' HA ' HD11 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 673' ' ' TRP . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.559 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 701' ' ' ILE . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.401 HG11 ' CG2' ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.559 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.459 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.628 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.447 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.407 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 661' ' ' VAL . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.412 ' CA ' ' OG ' ' A' ' 656' ' ' SER . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . 0.427 ' HE3' HG11 ' A' ' 635' ' ' VAL . 28.3 mmtp . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 73.6 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.421 HG12 ' CD1' ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.412 ' OG ' ' CA ' ' A' ' 631' ' ' GLY . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 664' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 662' ' ' GLY . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.419 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.547 ' CE2' HD12 ' A' ' 690' ' ' ILE . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.432 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.78 ' N ' ' HD2' ' A' ' 679' ' ' PRO . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.78 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.451 ' HA ' HD11 ' A' ' 689' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' A' ' 686' ' ' VAL . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.557 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 52.9 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.557 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.49 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.805 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.432 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 701' ' ' ILE . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.52 0.2 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.65 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.435 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 41.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.425 ' O ' HG11 ' A' ' 661' ' ' VAL . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 657' ' ' LEU . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 661' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.418 ' CH2' HD13 ' A' ' 690' ' ' ILE . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.425 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.534 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.471 ' HA ' HD13 ' B' ' 946' ' ' ILE . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 690' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.438 HG13 ' HB ' ' A' ' 614' ' ' VAL . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.45 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.65 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.734 -0.146 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 657' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . 0.415 ' O ' ' CD2' ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.688 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 68.4 mt . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 631' ' ' GLY . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 616' ' ' LEU . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 657' ' ' LEU . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 662' ' ' GLY . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.464 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.464 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.538 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.412 HG11 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.462 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.414 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.688 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.448 ' HB ' HG13 ' A' ' 701' ' ' ILE . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 629' ' ' LEU . 2.5 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.645 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.417 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 58.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.728 0.299 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.405 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 662' ' ' GLY . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.445 ' CE2' HD13 ' A' ' 690' ' ' ILE . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.424 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.424 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.563 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.543 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.405 HG12 ' CD ' ' A' ' 676' ' ' LYS . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.481 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 614' ' ' VAL . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.407 HG13 ' CG2' ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.487 0.155 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.543 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.48 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.645 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.417 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.664 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.67 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.446 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.462 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 13.5 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.413 ' HA ' HG21 ' A' ' 660' ' ' VAL . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 616' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 657' ' ' LEU . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.416 HG11 ' N ' ' A' ' 662' ' ' GLY . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.416 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.401 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.453 ' CD1' HG12 ' A' ' 690' ' ' ILE . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.445 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.445 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.47 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.522 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.436 HG12 ' CD ' ' A' ' 676' ' ' LYS . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.484 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 701' ' ' ILE . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.56 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.67 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 613' ' ' ARG . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 701' ' ' ILE . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 701' ' ' ILE . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 694' ' ' LYS . 1.6 mttp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.464 0.173 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.706 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 635' ' ' VAL . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.424 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.379 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.445 ' CD1' ' HD2' ' A' ' 638' ' ' LYS . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.414 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 662' ' ' GLY . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.429 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.436 ' CE2' HD12 ' A' ' 690' ' ' ILE . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.433 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.548 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.478 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.7 p30 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.545 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.433 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.505 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 694' ' ' LYS . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 618' ' ' LYS . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-O 120.214 -0.215 . . . . 0.0 113.508 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.545 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.523 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.706 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.422 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.41 HD21 HG13 ' A' ' 661' ' ' VAL . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.511 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.247 0.07 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.423 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.488 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 62.8 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.795 0.331 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.434 HG13 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.4 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.41 HG13 HD21 ' A' ' 616' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 690' ' ' ILE . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.597 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 681' ' ' ALA . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.575 ' CD1' HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 694' ' ' LYS . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 701' ' ' ILE . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.452 -0.082 . . . . 0.0 113.089 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.575 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.511 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.797 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.402 HD13 ' CB ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.561 ' HB2' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.451 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.5 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.409 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 47.9 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . 0.404 ' HA ' ' HB1' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.401 ' CB ' ' CD2' ' A' ' 616' ' ' LEU . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.402 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.408 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 648' ' ' PHE . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.471 ' CE2' HD11 ' A' ' 690' ' ' ILE . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.551 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.404 ' HA ' HD12 ' A' ' 689' ' ' ILE . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.517 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.409 HG12 ' CD ' ' A' ' 676' ' ' LYS . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.514 ' CD1' HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 701' ' ' ILE . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 15.5 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.517 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.495 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.707 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.651 0.262 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.614 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.522 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.417 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 682' ' ' THR . 80.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.834 0.349 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' SER . . . . . 0.4 ' HB2' ' CA ' ' A' ' 631' ' ' GLY . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.46 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 662' ' ' GLY . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.431 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.539 ' CE2' HG13 ' A' ' 690' ' ' ILE . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.404 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.4 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.559 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.477 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.588 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.416 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.402 HG12 ' CG2' ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 687' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 120.552 -0.027 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.588 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.614 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ARG . . . . . 0.404 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 1.5 mtpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' LEU . . . . . 0.449 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' LEU . . . . . 0.615 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.582 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' ILE . . . . . 0.428 HG12 ' CD1' ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 616' ' ' LEU . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 662' ' ' GLY . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' ARG . . . . . 0.405 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' TRP . . . . . 0.512 ' CZ2' HD11 ' A' ' 690' ' ' ILE . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' LYS . . . . . 0.487 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' GLU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' TYR . . . . . 0.544 ' HD1' HD11 ' B' ' 946' ' ' ILE . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' ILE . . . . . 0.487 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.512 HD11 ' CZ2' ' A' ' 673' ' ' TRP . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 946' ' ' ILE . . . . . 0.544 HD11 ' HD1' ' A' ' 687' ' ' TYR . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 947' ' ' TRP . . . . . 0.449 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 948' ' ' ALA . . . . . 0.615 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.579 0.228 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.28 171.61 13.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.445 2.097 . . . . 0.0 112.26 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.021 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -123.44 155.35 37.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.3 119.28 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.23 156.4 41.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.801 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 134.14 42.59 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.836 2.357 . . . . 0.0 112.338 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 31.0 t -64.87 -175.48 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -79.61 -11.53 59.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.92 -9.06 21.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.647 0.261 . . . . 0.0 111.375 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 73.26 5.4 66.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.039 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -121.09 7.62 10.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.808 0.304 . . . . 0.0 111.332 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.44 167.64 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.24 114.51 21.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.653 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 17.4 mm -109.58 107.25 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.34 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -96.86 162.95 22.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.614 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.425 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.406 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.404 ' CE ' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER -83.85 55.33 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.05 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.062 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 13.9 p 55.44 68.09 0.92 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.4 t -163.54 31.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.521 ' HB2' ' HD2' ' A' ' 623' ' ' PRO . 1.0 OUTLIER -60.87 159.47 26.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.827 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' A' ' 622' ' ' MET . 8.5 Cg_endo -50.09 -24.82 11.67 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.794 2.33 . . . . 0.0 112.183 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -65.6 -58.24 6.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.16 -92.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 3.0 m -128.41 -30.9 2.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.032 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . 0.418 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 76.41 -126.78 8.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.45 ' CB ' HD21 ' A' ' 629' ' ' LEU . . . -169.12 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.337 . . . . 0.0 111.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.519 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.05 -89.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -91.85 85.53 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 46.5 tpp -58.47 114.7 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 81.4 p -86.77 -176.11 5.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -8.47 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.386 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -82.46 -34.26 28.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.834 0.35 . . . . 0.0 110.949 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.41 17.9 6.9 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.7 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -130.29 153.91 48.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.421 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 81.3 mt -94.54 154.52 17.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.05 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.412 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.438 ' HA ' HG23 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.463 ' CZ2' HG22 ' A' ' 690' ' ' ILE . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.434 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.432 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.566 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.432 HD13 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.2 m -141.56 111.55 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.752 0.311 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -129.87 177.19 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.4 ' O ' ' CE1' ' A' ' 687' ' ' TYR . . . -147.77 -65.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.692 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.566 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.519 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.776 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.739 0.305 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.59 171.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.603 2.202 . . . . 0.0 112.384 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.9 t -96.86 152.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.039 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -126.74 155.23 43.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.037 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.418 ' HA ' ' HA2' ' A' ' 612' ' ' GLY . 13.0 m95 -129.11 128.09 42.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.967 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 603' ' ' PRO . 9.6 pt20 -118.53 160.13 41.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 602' ' ' GLN . 80.7 Cg_exo -44.88 124.56 5.84 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.258 . . . . 0.0 112.505 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' SER . . . . . 0.433 ' CB ' HG12 ' A' ' 611' ' ' ILE . 48.2 t -68.64 158.56 33.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.222 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -21.05 66.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.909 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.05 -27.53 57.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 99.13 -31.83 7.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.959 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -113.34 23.02 13.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 167.65 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.102 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -122.11 129.47 52.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.727 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . 0.433 HG12 ' CB ' ' A' ' 604' ' ' SER . 12.3 mm -119.97 104.67 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 601' ' ' TRP . . . -93.96 162.68 25.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.416 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.449 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 701' ' ' ILE . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.443 HD13 ' CB ' ' A' ' 658' ' ' ALA . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.418 ' HB3' HD23 ' A' ' 630' ' ' LEU . 13.7 ptmm? -117.04 37.55 3.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.73 -32.25 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.237 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 3.3 t -114.71 155.37 26.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.32 179.98 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.65 155.03 38.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.24 -28.0 5.03 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.011 2.474 . . . . 0.0 112.311 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.8 -37.71 74.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.186 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.76 -80.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 16.8 m -115.67 173.19 6.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -133.07 121.19 2.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.439 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.426 ' CB ' HD22 ' A' ' 629' ' ' LEU . . . -97.1 -80.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.636 0.255 . . . . 0.0 111.242 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.503 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -117.88 -95.11 0.49 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.938 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.439 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -100.17 91.45 4.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.47 113.94 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.2 p -93.63 -177.37 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -11.74 60.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.1 -26.14 62.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.943 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 105.55 11.14 29.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.791 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -136.37 168.4 19.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.4 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 73.8 mt -94.4 157.31 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.424 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 660' ' ' VAL . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.455 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 657' ' ' LEU . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 662' ' ' GLY . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.424 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.407 ' CG2' HG11 ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.428 ' CE2' HG12 ' A' ' 690' ' ' ILE . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.447 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.44 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.466 ' HA ' HD12 ' B' ' 946' ' ' ILE . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . . . . . . . . . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.448 ' CD1' HD13 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 701' ' ' ILE . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.407 HG11 ' CG2' ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.64 107.44 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.994 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.77 160.87 43.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -116.19 -62.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 687' ' ' TYR . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.503 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.78 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.707 0.289 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.13 171.69 15.44 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.539 2.159 . . . . 0.0 112.21 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.54 147.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.026 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.8 151.17 51.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.435 ' CZ3' HG22 ' A' ' 703' ' ' VAL . 44.1 m95 -126.82 118.39 24.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -115.28 159.27 38.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 142.97 22.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.925 2.417 . . . . 0.0 112.262 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.4 t -80.62 -175.46 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -9.57 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.324 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -101.31 -20.29 15.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 92.87 -43.14 2.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.665 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.01 7.12 22.45 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 155.83 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.772 0.32 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.63 121.63 40.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.28 146.52 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.996 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.69 160.69 25.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.568 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 658' ' ' ALA . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.412 ' CE ' ' HA ' ' A' ' 694' ' ' LYS . 2.6 mtpp -73.83 62.28 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -37.06 85.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 7.5 p 57.61 19.09 5.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 28.4 p -157.89 65.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 110.373 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.37 133.22 87.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.053 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.75 -18.52 41.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.405 2.07 . . . . 0.0 112.107 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -32.61 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -82.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.7 m 178.17 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 57.75 165.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.493 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.457 ' CB ' HD22 ' A' ' 629' ' ' LEU . . . -118.2 -43.5 2.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.483 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -126.55 -91.32 0.52 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.238 179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.518 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -127.22 93.17 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.54 104.53 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 71.1 p -80.48 180.0 7.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.36 -18.22 65.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.99 -29.76 65.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 108.49 15.4 13.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.657 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -131.72 168.73 17.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 65.9 mt -93.36 149.61 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.428 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.414 ' HB2' HD21 ' A' ' 616' ' ' LEU . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.494 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.431 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.411 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.455 ' O ' HD11 ' A' ' 689' ' ' ILE . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.454 ' HA ' HD11 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.445 ' HD1' HD11 ' B' ' 946' ' ' ILE . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.494 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 694' ' ' LYS . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 701' ' ' ILE . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.435 HG22 ' CZ3' ' A' ' 601' ' ' TRP . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 37.2 p -142.74 115.87 8.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -59.83 -177.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -145.06 -50.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.846 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.483 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.795 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.594 0.235 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.58 171.73 12.64 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.349 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.28 148.28 43.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.104 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.403 ' CE3' ' HA3' ' A' ' 612' ' ' GLY . 30.5 m95 -128.99 126.71 40.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 162.57 33.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.57 127.64 26.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.721 2.28 . . . . 0.0 112.079 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 21.6 t -60.79 171.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -73.53 -9.35 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.77 -19.98 20.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 84.35 -2.54 87.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.933 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.08 4.56 7.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.779 0.29 . . . . 0.0 111.397 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -129.22 157.94 40.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.24 126.09 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.1 141.73 29.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.403 ' HA3' ' CE3' ' A' ' 601' ' ' TRP . . . -137.74 160.64 25.29 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.558 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.438 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -116.11 35.97 4.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -26.86 14.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 1.2 p -108.28 -176.77 3.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 60.2 m -96.48 148.95 22.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.833 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.75 153.59 75.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.5 -15.37 24.78 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.558 2.172 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -56.11 -58.4 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.779 0.324 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 178.72 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.948 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.6 m -122.42 -175.98 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.792 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -144.22 72.34 0.36 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.597 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.4 -84.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.579 0.228 . . . . 0.0 110.836 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.84 -89.58 0.58 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.584 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.586 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.566 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.417 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.528 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -108.2 92.57 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.38 111.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 20.4 p -82.91 179.01 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.12 -16.32 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.231 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -74.45 -27.01 60.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.773 0.32 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.61 31.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.796 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -124.05 158.0 33.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 22.1 mt -90.55 146.16 24.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.421 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.405 ' CG1' HD22 ' A' ' 616' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.421 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.513 ' CE2' HD11 ' A' ' 690' ' ' ILE . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.439 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.42 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.527 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.418 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 689' ' ' ILE . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.472 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 686' ' ' VAL . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.547 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 14.9 t -143.97 115.45 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.91 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.847 0.356 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 635' ' ' VAL . 2.0 mp0 -82.31 -170.92 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.409 ' CA ' HG23 ' A' ' 635' ' ' VAL . . . -128.8 -64.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.092 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.547 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.432 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.586 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.584 0.231 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.33 171.62 13.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.4 151.93 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.09 150.77 42.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.073 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -129.78 127.13 39.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.925 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -118.82 156.71 51.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.06 139.32 42.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.914 2.409 . . . . 0.0 112.229 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 609' ' ' ARG . 39.3 t -65.38 -175.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -22.62 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.481 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.92 -25.33 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 102.29 -33.54 6.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.487 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.44 -10.16 41.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . 0.41 ' HB2' ' CB ' ' A' ' 604' ' ' SER . 13.2 mtm180 -124.13 160.56 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.49 118.13 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.155 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 21.4 mm -106.74 142.35 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.68 162.45 25.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.446 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 699' ' ' VAL . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . 0.419 ' O ' HD12 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -34.15 7.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -29.05 69.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 9.0 t -74.1 -39.34 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.761 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.86 -169.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.076 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.23 149.19 54.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -25.68 8.6 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 112.6 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -34.1 30.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.133 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 178.03 151.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.78 129.17 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -95.25 -67.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -174.29 -71.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -120.35 -85.4 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.692 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.502 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.431 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -88.97 91.55 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 2.1 tpt -58.29 116.63 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -95.72 -177.65 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -72.09 -9.98 59.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 642' ' ' LEU . 2.2 mm? -92.22 11.23 26.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.407 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.93 36.61 81.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.692 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -139.55 139.9 36.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.432 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 31.1 mt -88.2 144.18 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.978 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 617' ' ' ASN . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.4 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.465 ' CD1' HG12 ' A' ' 690' ' ' ILE . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.541 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.432 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.41 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CD1' HD12 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.489 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.513 ' CD1' HD13 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 616' ' ' LEU . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.1 p -147.55 136.85 22.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.882 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.39 168.9 13.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -121.78 -64.19 0.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.513 HD13 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.492 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.692 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.703 0.287 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 171.64 11.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.562 2.175 . . . . 0.0 112.277 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.63 152.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.89 151.67 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.026 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -132.26 138.0 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.68 154.25 73.04 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.38 129.04 14.33 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.798 2.332 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.3 p -101.91 146.77 27.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 607' ' ' GLY . 0.0 OUTLIER -81.8 -8.5 59.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.483 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.75 17.58 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 605' ' ' LYS . . . 125.9 25.81 1.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.92 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.67 74.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.98 167.69 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.459 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.34 114.56 26.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 16.6 mm -104.86 137.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.51 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.74 162.94 25.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 701' ' ' ILE . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . 0.417 HG23 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 661' ' ' VAL . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.29 55.13 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.71 -21.4 52.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 4.9 p 57.5 32.56 22.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.019 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.6 t -118.0 49.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -60.6 145.97 86.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.36 -14.39 43.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.411 2.074 . . . . 0.0 112.333 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -54.55 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 -81.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.77 -43.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 96.53 -142.56 16.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.618 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.407 ' CB ' HD23 ' A' ' 629' ' ' LEU . . . -154.59 -60.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.51 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -116.59 -91.9 0.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.844 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.429 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -106.05 89.6 3.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 47.3 tpp -58.87 115.89 3.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 68.4 p -90.12 -174.71 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.9 -10.72 59.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.439 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.48 -34.46 41.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.94 6.27 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -132.26 157.27 44.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.05 152.17 20.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.415 HG12 ' CD1' ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.416 ' HA ' HG23 ' A' ' 660' ' ' VAL . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 657' ' ' LEU . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . 0.403 ' N ' HD12 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 690' ' ' ILE . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.442 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.442 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.408 HG11 HD12 ' B' ' 946' ' ' ILE . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.403 HG12 ' CD ' ' A' ' 676' ' ' LYS . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.473 ' CD1' HD11 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . 0.417 ' NE2' HG23 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 701' ' ' ILE . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.402 HG12 ' CG2' ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 12.6 m -143.89 104.64 4.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -120.09 178.75 4.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -133.36 -54.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.473 HD11 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.51 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.844 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.648 0.261 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.08 171.67 7.26 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.57 2.18 . . . . 0.0 112.228 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.29 149.96 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.238 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.3 p -133.62 154.74 50.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.22 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 18.8 m95 -129.95 123.94 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.24 156.29 47.26 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.99 130.73 39.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 0.0 112.238 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -177.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.089 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -9.22 59.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.463 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -98.93 -13.13 20.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 111.248 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 76.39 4.12 79.03 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.826 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.23 2.98 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.798 0.299 . . . . 0.0 111.371 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.83 160.47 31.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.75 115.43 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.77 146.43 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . -137.7 162.51 25.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.444 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.457 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 701' ' ' ILE . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 699' ' ' VAL . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.437 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER -92.79 -35.72 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -30.4 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.367 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 50.0 p -83.95 -59.75 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.066 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.41 156.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.574 ' HB2' ' HD3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -73.63 123.8 89.72 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 110.694 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.53 -1.27 11.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 113.473 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.574 ' HD3' ' HB2' ' A' ' 622' ' ' MET . 0.0 OUTLIER -88.87 -35.0 16.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 111.309 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.85 -79.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.23 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 133.74 61.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.432 ' HB2' HD21 ' A' ' 629' ' ' LEU . . . -69.45 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -122.83 -77.46 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.636 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.561 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 635' ' ' VAL . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -131.71 94.34 3.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.55 104.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.759 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 27.9 p -81.77 -178.57 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.49 -23.43 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.228 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.82 -27.45 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.5 13.93 25.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.843 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -128.63 166.5 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 20.9 mt -90.62 148.24 22.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.429 HG12 ' CD1' ' A' ' 632' ' ' LEU . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.413 ' N ' HD22 ' A' ' 616' ' ' LEU . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 662' ' ' GLY . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.442 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.433 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 649' ' ' ILE . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.415 ' CG2' HG12 ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.42 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.457 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.424 HG13 HD11 ' B' ' 946' ' ' ILE . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.469 ' CD1' HD12 ' B' ' 946' ' ' ILE . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.401 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.457 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t -149.41 138.82 21.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.783 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -86.71 179.12 6.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -130.26 -60.35 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.835 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 687' ' ' TYR . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.433 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.636 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . 0.428 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 4.8 t60 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 6.0 Cg_exo -77.72 165.43 26.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.7 2.267 . . . . 0.0 112.154 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.07 144.43 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -130.68 152.05 50.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.295 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -130.23 128.1 40.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -116.27 128.11 26.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.81 148.62 91.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.171 . . . . 0.0 112.142 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' SER . . . . . 0.401 ' HB3' ' CG ' ' A' ' 609' ' ' ARG . 9.7 t -119.81 146.34 45.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.319 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 607' ' ' GLY . 0.5 OUTLIER -81.62 -8.71 59.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.612 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.08 17.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 605' ' ' LYS . . . 137.66 5.92 1.64 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.193 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.8 64.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 110.46 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . 0.401 ' CG ' ' HB3' ' A' ' 604' ' ' SER . 11.8 ptt180 -124.78 159.63 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.223 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.86 114.47 27.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 9.0 mm -103.7 140.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.485 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.71 162.68 25.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.965 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.452 ' HB3' ' CD2' ' A' ' 630' ' ' LEU . 6.9 ptmt -116.0 33.8 5.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -57.99 2.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 5.1 t -84.41 167.74 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.98 167.75 11.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.798 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 2.7 tpp -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.99 -25.29 52.93 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.412 2.075 . . . . 0.0 112.203 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -36.15 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -81.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.047 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.4 p -172.83 -176.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -161.64 148.88 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.436 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 629' ' ' LEU . . . -74.56 -58.89 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -118.94 -84.61 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.362 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.612 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.573 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.436 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -119.82 86.93 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 48.0 tpp -59.36 115.72 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 4.6 p -102.92 -177.1 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.12 -16.03 60.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.51 -26.14 65.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 98.94 9.61 51.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.791 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.56 168.83 17.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 81.2 mt -94.01 151.46 19.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 634' ' ' VAL . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.407 HG12 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.458 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 662' ' ' GLY . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.436 ' CZ2' HD12 ' A' ' 690' ' ' ILE . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.436 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.436 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.414 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.414 ' CB ' ' CB ' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.492 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.412 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.456 ' CD1' HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.442 HD13 HG23 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.6 t -146.78 109.87 4.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.873 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.735 0.302 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -100.64 -177.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -149.19 -41.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.976 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.492 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.436 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.612 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.561 0.22 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.66 167.5 14.87 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.95 148.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.825 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.83 151.21 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.292 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 59.6 m95 -132.65 135.21 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.886 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.43 151.38 78.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.969 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 120.01 7.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.242 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 6.7 t -81.03 164.94 22.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -8.31 59.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.79 -16.22 57.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.576 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 128.4 -33.71 3.09 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.86 30.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.85 136.57 37.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 110.6 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.88 114.46 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.79 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 7.4 mm -99.61 140.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.98 160.12 25.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.717 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.432 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.428 ' HB ' HG13 ' A' ' 701' ' ' ILE . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.411 HD23 ' CG1' ' A' ' 661' ' ' VAL . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -103.84 36.32 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -98.99 -46.24 5.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.329 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 17.5 p -96.41 176.17 6.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.718 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.98 144.72 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 3.0 ptp -59.39 153.28 49.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.38 -3.94 13.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.821 2.347 . . . . 0.0 113.236 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -24.75 14.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.666 0.269 . . . . 0.0 111.163 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.89 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 2.1 m 178.62 -43.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.032 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 88.41 -160.46 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.378 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -128.46 -52.35 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.106 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.455 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -125.7 -80.72 0.62 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.662 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.535 ' N ' HD13 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.437 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 635' ' ' VAL . 17.5 mmtp -103.57 90.49 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.11 126.08 26.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 77.5 p -92.31 -176.36 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -75.42 -7.23 53.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.469 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.74 -33.8 24.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.67 21.54 6.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -132.36 150.73 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 27.0 mt -88.57 144.71 26.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 633' ' ' LYS . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.419 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.406 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 662' ' ' GLY . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.401 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.481 ' CE2' HD12 ' A' ' 690' ' ' ILE . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.765 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.594 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.436 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.765 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 673' ' ' TRP . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.428 HG13 ' HB ' ' A' ' 614' ' ' VAL . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t -151.75 112.06 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.918 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -127.75 169.74 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -124.36 -72.17 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.602 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.468 HD11 HD11 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.455 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.662 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.654 0.264 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 171.57 17.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.565 2.177 . . . . 0.0 112.206 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.14 151.52 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.5 p -134.92 154.8 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.221 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -129.03 121.56 28.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.746 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -118.23 144.02 34.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.03 141.2 93.57 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.705 2.27 . . . . 0.0 112.143 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 76.8 p -60.63 178.96 0.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.746 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -62.56 -54.55 38.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.03 -27.68 69.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.348 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.17 32.59 11.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.082 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -125.63 -24.29 3.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.55 0.214 . . . . 0.0 111.222 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.3 152.68 33.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.14 123.72 49.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.765 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 22.5 mm -114.43 140.85 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.265 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . -137.78 159.01 24.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.423 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.452 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -102.15 -36.48 8.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -29.25 17.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 41.2 p -87.46 135.21 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.011 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 27.7 m -80.72 146.17 31.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 623' ' ' PRO . 1.6 mpp? -66.27 140.15 96.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.928 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 622' ' ' MET . 2.9 Cg_exo -75.26 -29.12 8.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.764 2.309 . . . . 0.0 112.496 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -30.48 13.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.223 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -145.39 -163.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.0 m -95.67 -77.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.028 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.54 165.2 25.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.408 ' CB ' HD23 ' A' ' 629' ' ' LEU . . . -98.82 -60.58 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -127.9 -80.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.612 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.628 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 656' ' ' SER . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.546 HD11 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.459 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -115.37 91.85 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.37 119.07 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 24.8 p -92.23 -178.9 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -10.64 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.363 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.11 -31.87 25.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 107.61 22.69 7.24 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.614 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -129.77 144.35 51.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 682' ' ' THR . 24.2 mt -86.83 143.88 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.418 ' HB3' ' CA ' ' A' ' 631' ' ' GLY . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.455 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 662' ' ' GLY . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 658' ' ' ALA . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.482 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.488 ' CD1' HG23 ' A' ' 689' ' ' ILE . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.436 ' CE ' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.436 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.588 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.441 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.48 ' HA ' HD11 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 673' ' ' TRP . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.559 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 701' ' ' ILE . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.401 HG11 ' CG2' ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 65.4 m -146.35 113.27 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . 0.446 ' HA ' ' CG2' ' A' ' 635' ' ' VAL . 65.5 mt-10 61.22 166.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -146.0 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.559 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.459 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.628 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.3 171.58 17.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.554 2.169 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.86 151.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.4 p -134.33 154.08 51.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.373 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -131.89 130.06 41.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -123.19 163.62 32.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.84 134.06 60.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.69 2.26 . . . . 0.0 112.193 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.4 t -60.69 -176.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.061 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -81.52 -9.17 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -103.88 -17.37 15.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.63 0.252 . . . . 0.0 111.194 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 82.67 11.81 81.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.808 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.8 -3.11 7.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 0.218 . . . . 0.0 111.487 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.97 40.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.74 114.46 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 32.2 mm -100.83 144.45 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.9 161.38 25.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.594 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.447 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.407 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.411 HD21 HG11 ' A' ' 661' ' ' VAL . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -104.73 -36.63 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -61.35 -25.89 67.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.002 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 80.9 p -84.6 134.35 34.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.741 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.86 142.7 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.11 167.46 30.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.14 -29.74 87.66 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 0.0 111.825 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -35.89 10.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.917 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.8 66.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.7 t -137.08 -19.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -62.56 -128.75 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.718 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -171.61 -39.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.824 0.345 . . . . 0.0 111.588 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -121.23 -89.64 0.6 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.827 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.412 ' CA ' ' OG ' ' A' ' 656' ' ' SER . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.517 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . 0.427 ' HE3' HG11 ' A' ' 635' ' ' VAL . 28.3 mmtp -106.15 94.44 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.33 112.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.4 p -88.65 -177.68 5.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -16.28 64.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.88 -28.73 63.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 110.923 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 106.1 13.11 24.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.742 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.39 167.62 18.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.42 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 73.6 mt -93.62 150.2 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.421 HG12 ' CD1' ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.412 ' OG ' ' CA ' ' A' ' 631' ' ' GLY . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 664' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 662' ' ' GLY . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.419 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.547 ' CE2' HD12 ' A' ' 690' ' ' ILE . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.432 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.432 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.78 ' N ' ' HD2' ' A' ' 679' ' ' PRO . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.78 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.451 ' HA ' HD11 ' A' ' 689' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' A' ' 686' ' ' VAL . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.557 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.402 HG11 ' CG2' ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 52.9 p -144.21 104.18 4.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.922 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.84 0.353 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -106.35 168.29 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -130.34 -69.14 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.557 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.49 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.805 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.568 0.223 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.75 171.71 12.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.453 2.102 . . . . 0.0 112.198 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.06 150.55 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.987 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 2.0 p -138.46 157.21 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.223 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.446 ' CE3' ' HA3' ' A' ' 612' ' ' GLY . 73.0 m95 -130.74 129.01 41.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.88 142.35 45.24 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.86 156.15 45.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.186 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -65.8 -179.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.653 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -65.26 -50.36 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -63.19 -27.6 69.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.37 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 89.89 33.01 9.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.191 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -24.99 3.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.683 0.278 . . . . 0.0 111.265 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.95 167.61 10.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.86 117.82 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 14.3 mm -115.73 142.2 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.446 ' HA3' ' CE3' ' A' ' 601' ' ' TRP . . . -137.93 162.52 25.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.432 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 701' ' ' ILE . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.2 OUTLIER -101.56 -31.67 10.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -73.58 -28.73 62.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 60.5 p -59.26 -20.87 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.95 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.66 161.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.775 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.403 ' CE ' ' HA3' ' A' ' 627' ' ' GLY . 2.3 mpp? -102.77 164.97 14.53 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.141 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.79 -21.15 14.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.991 2.461 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -41.64 47.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.411 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.58 -61.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.764 0.316 . . . . 0.0 111.301 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.4 p -175.37 -35.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . 0.403 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 79.41 -97.64 1.59 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.413 ' CB ' HD21 ' A' ' 629' ' ' LEU . . . -168.79 -67.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.791 0.329 . . . . 0.0 111.629 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -118.3 -82.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.65 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.435 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -122.23 100.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.43 106.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.797 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 80.8 p -74.47 174.04 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.259 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.56 -21.16 62.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.271 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.67 -40.08 19.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.04 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 121.56 17.22 3.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.874 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -115.82 141.73 47.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.412 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 41.2 mt -87.02 147.27 25.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.761 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.425 ' O ' HG11 ' A' ' 661' ' ' VAL . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 657' ' ' LEU . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.411 ' N ' ' CG1' ' A' ' 661' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.418 ' CH2' HD13 ' A' ' 690' ' ' ILE . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.425 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.534 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.471 ' HA ' HD13 ' B' ' 946' ' ' ILE . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 690' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.438 HG13 ' HB ' ' A' ' 614' ' ' VAL . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.405 HG12 ' CG2' ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.3 p -141.71 113.93 8.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -98.85 172.43 7.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -118.74 -64.66 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.682 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.45 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.65 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.56 166.74 17.53 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.561 2.174 . . . . 0.0 112.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.17 151.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -132.84 152.9 51.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.291 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -131.62 131.86 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.934 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -122.07 157.96 56.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.92 128.91 9.5 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.787 2.325 . . . . 0.0 112.394 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.55 144.17 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.348 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 607' ' ' GLY . 14.1 mtpt -81.65 -8.48 59.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.76 17.71 0.09 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 605' ' ' LYS . . . 128.36 21.56 1.45 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.98 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 t0 69.55 72.72 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -126.04 167.63 15.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -115.73 114.37 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.888 0.375 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.34 139.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.775 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 702' ' ' ILE . . . -137.79 162.69 25.56 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.734 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.465 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 657' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . 0.415 ' O ' ' CD2' ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.29 -29.89 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.95 -31.03 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.591 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' THR . . . . . 0.539 ' O ' ' HB ' ' A' ' 621' ' ' THR . 7.1 t -112.24 172.07 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.169 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 620' ' ' THR . 17.5 m 74.75 -7.45 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.057 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 625' ' ' GLU . 47.9 tpp -104.65 122.69 42.7 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.708 0.29 . . . . 0.0 111.255 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.36 -45.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.695 2.263 . . . . 0.0 112.729 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -56.66 3.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.945 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 622' ' ' MET . 6.0 mt-10 73.9 100.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.346 . . . . 0.0 110.878 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.2 m -68.72 -47.04 67.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 123.66 37.54 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 629' ' ' LEU . . . -136.91 -103.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.929 -0.16 . . . . 0.0 110.789 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -126.79 -146.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.688 ' HG ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.409 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -112.06 97.76 6.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 2.0 ttm -59.03 107.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.1 p -74.54 -177.53 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -19.14 62.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.15 -29.07 60.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 111.28 15.18 10.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.736 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -125.13 160.59 28.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.41 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 68.4 mt -91.39 149.26 21.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.409 ' CB ' ' HA3' ' A' ' 631' ' ' GLY . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.56 ' HB2' ' CD2' ' A' ' 616' ' ' LEU . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 657' ' ' LEU . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 662' ' ' GLY . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 690' ' ' ILE . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.464 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.464 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.538 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.412 HG11 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.462 HD13 ' CZ2' ' A' ' 673' ' ' TRP . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 701' ' ' ILE . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t -147.77 126.61 12.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.912 0.387 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.71 178.82 7.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -127.97 -62.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.633 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.43 ' CD1' ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.414 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.688 ' C ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . 0.422 ' N ' ' HD2' ' A' ' 598' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 597' ' ' HIS . 77.0 Cg_endo -79.16 170.49 17.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.403 2.069 . . . . 0.0 112.275 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.18 146.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.6 p -135.8 155.66 50.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.401 ' CZ3' HG22 ' A' ' 703' ' ' VAL . 47.8 m95 -129.49 123.64 32.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -122.57 159.32 53.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.73 138.19 41.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.821 2.347 . . . . 0.0 112.338 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 611' ' ' ILE . 9.0 p -81.12 -177.45 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.081 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -9.44 59.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.395 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 -25.09 29.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.733 0.302 . . . . 0.0 110.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 95.1 -25.29 24.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.738 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.89 16.06 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -128.19 157.23 41.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.878 0.37 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.15 126.75 52.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 604' ' ' SER . 12.6 mm -110.37 146.65 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.23 159.14 24.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.408 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.448 ' HB ' HG13 ' A' ' 701' ' ' ILE . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 629' ' ' LEU . 2.5 ptpt -112.23 39.73 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 620' ' ' THR . 0.0 OUTLIER -73.71 -35.39 65.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.521 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' THR . . . . . 0.421 ' N ' ' HG2' ' A' ' 619' ' ' ARG . 11.4 t -138.64 -170.65 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.258 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m -58.3 151.59 19.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.049 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.87 158.68 31.51 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.025 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.49 -17.93 43.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.61 2.207 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 3.28 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.06 -176.96 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.818 0.342 . . . . 0.0 110.993 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.69 -64.46 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.32 42.7 3.64 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.388 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -55.69 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.454 0.168 . . . . 0.0 110.92 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -130.44 -78.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.645 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -103.54 88.14 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.37 116.23 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 25.3 p -97.22 -177.61 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -73.97 -7.89 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.424 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 642' ' ' LEU . 2.3 mm? -90.5 11.51 21.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.627 0.251 . . . . 0.0 111.45 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.83 29.62 70.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.658 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 145.09 38.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.417 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 58.8 mt -90.73 154.25 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.405 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 662' ' ' GLY . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 661' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.445 ' CE2' HD13 ' A' ' 690' ' ' ILE . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.424 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.424 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.563 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.543 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.405 HG12 ' CD ' ' A' ' 676' ' ' LYS . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.481 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.448 HG13 ' HB ' ' A' ' 614' ' ' VAL . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.407 HG13 ' CG2' ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 83.5 p -146.28 117.27 7.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.855 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.71 -175.02 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -145.2 -47.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.487 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.543 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.48 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.645 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.714 0.292 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.4 171.58 17.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.93 152.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.032 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.2 152.78 42.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.433 ' CZ3' HG21 ' A' ' 703' ' ' VAL . 24.6 m95 -131.3 131.9 44.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -119.83 142.06 32.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.68 139.58 86.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.154 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.6 t -60.65 176.06 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -54.49 42.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.92 -27.66 69.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.318 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.0 10.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.159 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.38 -22.41 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.585 0.231 . . . . 0.0 111.217 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 152.78 30.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.854 0.359 . . . . 0.0 110.917 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.52 114.47 25.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.589 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 12.5 mm -105.63 143.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.265 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.69 159.06 24.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.417 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER -106.27 -28.53 10.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.28 70.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 9.0 t -59.54 135.49 57.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.711 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 3.6 m -67.59 148.75 51.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 111.256 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.453 ' HG2' ' HA ' ' A' ' 625' ' ' GLU . 0.0 OUTLIER -104.98 167.53 9.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.898 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 -46.93 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.815 2.344 . . . . 0.0 112.686 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.41 62.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.514 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 622' ' ' MET . 0.7 OUTLIER 62.34 126.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.533 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -46.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 97.19 73.48 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.702 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 629' ' ' LEU . . . -155.9 -97.96 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 0.186 . . . . 0.0 111.325 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.664 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.81 -132.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.431 -0.107 . . . . 0.0 110.816 -179.384 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.67 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.574 ' N ' HD13 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.446 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.462 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -121.26 95.2 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.12 111.59 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.44 179.65 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.284 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.28 -20.58 66.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 5.9 mt -83.25 -41.62 18.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.057 0.456 . . . . 0.0 110.947 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 123.25 17.12 3.35 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.804 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -113.71 141.87 46.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 110.77 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.47 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 13.5 mt -86.78 146.0 26.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.413 ' HA ' HG21 ' A' ' 660' ' ' VAL . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 616' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' A' ' 657' ' ' LEU . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.416 HG11 ' N ' ' A' ' 662' ' ' GLY . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.416 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.401 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.453 ' CD1' HG12 ' A' ' 690' ' ' ILE . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.445 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.445 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.47 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.522 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.436 HG12 ' CD ' ' A' ' 676' ' ' LYS . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.484 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 701' ' ' ILE . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.433 HG21 ' CZ3' ' A' ' 601' ' ' TRP . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 4.5 t -144.1 119.87 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 177.77 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -150.16 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.674 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.56 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.67 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 2.6 t60 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 93.9 Cg_endo -80.64 168.52 17.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.456 2.104 . . . . 0.0 112.404 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -92.94 151.92 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 151.22 41.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -129.96 126.69 38.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -119.3 155.66 53.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.45 132.27 34.58 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.784 2.323 . . . . 0.0 112.257 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.2 t -60.79 -175.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -9.31 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.17 -10.16 15.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.271 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.45 82.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.817 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.64 -0.14 8.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.566 0.222 . . . . 0.0 111.459 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -133.05 167.54 20.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.773 0.321 . . . . 0.0 110.841 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.71 114.48 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.749 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.82 141.03 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.8 162.66 25.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.396 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 613' ' ' ARG . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 701' ' ' ILE . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 701' ' ' ILE . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 694' ' ' LYS . 1.6 mttp -94.35 -29.23 15.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -81.22 -28.03 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 10.9 t -57.85 -22.66 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.092 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.44 170.99 0.3 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.4 ' CE ' ' HA ' ' A' ' 626' ' ' SER . 0.0 OUTLIER -104.58 165.63 12.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 -20.4 14.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -84.51 -56.03 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.151 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -173.01 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 622' ' ' MET . 0.3 OUTLIER 75.44 163.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 167.22 -29.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.696 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 629' ' ' LEU . . . -84.18 -105.53 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.626 0.213 . . . . 0.0 111.133 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -137.14 -83.46 0.34 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.377 -0.202 . . . . 0.0 111.03 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.706 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 656' ' ' SER . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 635' ' ' VAL . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.424 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt -123.49 117.53 25.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.97 104.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.246 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.09 -173.89 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.39 -22.15 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.284 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.99 -26.92 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 102.99 11.26 34.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -128.86 170.3 13.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 29.3 mt -96.43 149.17 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.445 ' CD1' ' HD2' ' A' ' 638' ' ' LYS . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' B' ' 944' ' ' GLU . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.414 ' CB ' ' HA2' ' A' ' 631' ' ' GLY . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 662' ' ' GLY . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.429 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.415 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.436 ' CE2' HD12 ' A' ' 690' ' ' ILE . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.433 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.548 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.478 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.7 p30 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 689' ' ' ILE . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.545 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.433 HG12 ' CD ' ' A' ' 676' ' ' LYS . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.505 ' CD1' HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 694' ' ' LYS . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 618' ' ' LYS . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 701' ' ' ILE . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 80.9 p -141.52 122.49 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.86 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 635' ' ' VAL . 1.9 pt-20 -158.54 177.32 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -162.45 -43.67 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.508 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.545 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.523 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.706 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.57 0.224 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.06 171.59 13.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.537 2.158 . . . . 0.0 112.315 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.52 152.14 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.39 158.28 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.038 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -132.2 121.82 24.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 611' ' ' ILE . 3.4 pm0 -109.66 156.18 40.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.9 127.24 22.45 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.679 2.253 . . . . 0.0 112.222 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 16.0 t -60.83 -175.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -80.87 -9.36 59.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.68 -14.26 22.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 78.54 0.15 78.27 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.14 8.26 8.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.798 0.299 . . . . 0.0 111.349 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.76 164.76 26.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.796 0.332 . . . . 0.0 110.84 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.97 114.45 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 602' ' ' GLN . 31.9 mm -102.49 141.14 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -132.68 160.0 23.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.567 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.422 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.41 HD21 HG13 ' A' ' 661' ' ' VAL . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER -88.92 -31.1 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -32.41 72.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 75.6 p -94.82 96.93 9.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -56.92 177.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.467 ' HG3' ' HG2' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -98.81 165.52 14.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.76 -45.63 6.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.119 2.546 . . . . 0.0 113.468 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.467 ' HG2' ' HG3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -53.39 -40.25 64.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 6.0 pt-20 178.02 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.566 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 3.6 m -94.9 134.26 37.74 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.626 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -99.14 177.23 29.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.66 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.447 ' CB ' HD23 ' A' ' 629' ' ' LEU . . . -86.79 -63.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.511 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.64 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.52 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.423 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.488 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -112.1 90.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 1.3 ttm -58.58 113.42 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.3 p -84.68 178.57 7.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.79 -13.6 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.298 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -32.28 49.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.0 16.39 9.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.653 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.14 155.76 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.952 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 62.8 mt -90.41 150.12 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.434 HG13 ' CD2' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.4 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.41 HG13 HD21 ' A' ' 616' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 690' ' ' ILE . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.422 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.597 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 681' ' ' ALA . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.575 ' CD1' HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.419 ' O ' ' CG ' ' A' ' 694' ' ' LYS . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 701' ' ' ILE . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t -151.84 144.67 24.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.015 0.436 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . 0.414 ' HA ' HG23 ' A' ' 635' ' ' VAL . 4.8 mp0 60.72 177.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -155.68 -58.1 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.575 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.511 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.797 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . 0.477 ' HB3' ' HD3' ' A' ' 598' ' ' PRO . 41.8 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 597' ' ' HIS . 85.5 Cg_endo -82.88 128.03 5.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.344 2.03 . . . . 0.0 112.322 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.46 151.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -123.19 151.69 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -130.01 131.28 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.4 161.55 44.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.4 125.71 7.66 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.729 2.286 . . . . 0.0 112.569 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 46.6 t -66.33 175.67 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.287 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -20.52 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.269 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -88.42 -16.9 31.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 93.38 -43.32 2.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -95.03 14.68 21.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.465 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -122.6 158.65 29.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.753 0.311 . . . . 0.0 110.597 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.08 116.36 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 26.4 mm -105.85 146.32 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.75 162.35 25.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.55 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.402 HD13 ' CB ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -101.29 -31.05 11.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.13 12.13 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 621' ' ' THR . 9.6 t -167.16 -177.2 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 0.0 111.539 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 621' ' ' THR . 0.5 OUTLIER 54.08 22.21 3.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.515 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.404 ' CE ' ' CD1' ' A' ' 657' ' ' LEU . 0.6 OUTLIER -83.93 123.34 75.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.476 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.95 -45.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.475 2.117 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 625' ' ' GLU . 13.9 ptmt -89.47 -55.87 3.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 2.5 pt-20 175.75 -171.52 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.72 0.295 . . . . 0.0 110.712 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.2 p -90.73 77.1 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.843 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -58.64 -76.87 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.444 ' CB ' HD23 ' A' ' 629' ' ' LEU . . . -139.7 -75.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.561 ' HB2' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.17 -127.68 0.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.57 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.451 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.5 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -130.11 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.47 109.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.9 p -85.5 -178.04 6.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 111.408 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -62.96 -21.25 65.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.457 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.12 -49.72 16.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.508 . . . . 0.0 110.95 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 127.19 15.58 2.5 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.003 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -122.67 155.94 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.409 ' CD1' ' HB ' ' A' ' 682' ' ' THR . 47.9 mt -89.66 147.06 24.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . 0.404 ' HA ' ' HB1' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' SER . . . . . . . . . . . . . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.404 ' CD1' ' CE ' ' A' ' 622' ' ' MET . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.402 HG11 ' N ' ' A' ' 662' ' ' GLY . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.402 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.408 ' HA ' HG23 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 648' ' ' PHE . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.471 ' CE2' HD11 ' A' ' 690' ' ' ILE . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.441 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.551 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.459 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.404 ' HA ' HD12 ' A' ' 689' ' ' ILE . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.517 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.409 HG12 ' CD ' ' A' ' 676' ' ' LYS . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.514 ' CD1' HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.414 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . 0.405 ' N ' ' CG1' ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 701' ' ' ILE . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 15.5 p -141.64 108.21 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.9 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.881 0.372 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.01 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -151.66 -44.16 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.988 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.517 ' CD1' ' CD1' ' A' ' 687' ' ' TYR . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.495 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.707 ' O ' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.53 0.205 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.92 171.65 17.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.244 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.8 151.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.66 150.99 50.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.198 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -129.32 123.05 30.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.9 159.65 43.78 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.022 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.6 123.48 13.94 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.668 2.245 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -60.76 178.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -9.11 58.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.443 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.34 -24.29 14.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.956 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 86.34 11.41 72.21 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.803 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -128.52 -4.68 5.34 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.76 157.07 42.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.915 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -114.56 114.43 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 24.0 mm -96.34 141.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . . . . . . . . . . . -137.88 162.58 25.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -100.79 -35.28 9.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -5.03 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.7 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 32.6 p -93.78 20.11 7.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.585 0.231 . . . . 0.0 111.285 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m 61.0 153.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -102.01 160.04 27.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 -36.67 93.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.501 2.134 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -26.28 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 68.49 158.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 71.09 9.37 6.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.501 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -60.11 -86.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.314 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -168.8 -74.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.201 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -135.53 -77.74 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.755 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.614 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.401 ' HA3' ' CB ' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.522 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.417 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.511 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -119.81 92.97 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 110.22 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 43.8 p -80.55 -177.81 6.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.38 -13.48 61.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.346 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.19 -33.69 43.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.44 18.65 6.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.753 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -129.48 158.29 39.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 682' ' ' THR . 80.9 mt -93.2 152.43 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.4 ' HB2' ' CA ' ' A' ' 631' ' ' GLY . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.46 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 662' ' ' GLY . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.431 ' N ' HG13 ' A' ' 661' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . . . . . . . . . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.539 ' CE2' HG13 ' A' ' 690' ' ' ILE . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.404 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.4 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.559 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.477 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.588 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.416 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 613' ' ' ARG . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.402 HG12 ' CG2' ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p -151.64 122.42 7.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.884 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.841 0.353 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.64 175.12 12.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.77 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 687' ' ' TYR . . . -138.28 -59.36 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.126 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.588 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.614 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' HIS . . . . . 0.424 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 92.3 Cg_endo -83.46 129.07 4.94 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.62 2.213 . . . . 0.0 112.548 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.03 151.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.52 150.3 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' TRP . . . . . 0.414 ' CE3' ' HA3' ' A' ' 612' ' ' GLY . 62.7 m95 -133.61 141.23 47.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.86 118.45 30.5 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 140.72 24.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.47 2.114 . . . . 0.0 112.155 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.22 161.92 14.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.022 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -9.19 58.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.376 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.56 -13.94 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.458 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 94.76 -42.37 2.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.961 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.2 62.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.685 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.83 122.17 10.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.788 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.17 114.37 14.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 2.1 mm -114.09 133.63 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.353 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' A' ' 601' ' ' TRP . . . -138.03 161.89 25.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.534 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ARG . . . . . 0.404 ' HA ' ' CD1' ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 1.5 mtpp -97.98 -33.29 11.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' ARG . . . . . 0.403 ' HD2' ' CG2' ' A' ' 620' ' ' THR . 0.0 OUTLIER -67.59 -15.06 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.457 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' THR . . . . . 0.403 ' CG2' ' HD2' ' A' ' 619' ' ' ARG . 3.2 p -104.97 121.58 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.808 0.337 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.8 t -61.5 170.26 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 656' ' ' SER . 0.8 OUTLIER -99.12 161.51 24.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.292 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.06 -13.8 39.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.853 2.369 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -98.64 -42.24 7.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.001 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.416 ' N ' ' HD3' ' A' ' 624' ' ' LYS . 7.3 pt-20 175.62 -179.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.84 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 47.9 m -66.7 131.65 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -100.66 -173.39 29.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.522 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 629' ' ' LEU . . . -92.59 -60.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' LEU . . . . . 0.449 ' HG ' ' C ' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -118.56 -77.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' LEU . . . . . 0.615 ' HG ' ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.582 ' O ' ' C ' ' B' ' 948' ' ' ALA . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' LYS . . . . . 0.414 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 635' ' ' VAL . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.54 91.11 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.55 113.6 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.0 p -82.23 176.94 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -73.34 -11.17 60.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.303 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.45 -28.4 37.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 110.08 23.08 6.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.01 151.47 49.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.54 148.63 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' ILE . . . . . 0.428 HG12 ' CD1' ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' VAL . . . . . 0.468 ' CG1' ' HB2' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' SER . . . . . 0.428 ' HA ' ' HG2' ' A' ' 622' ' ' MET . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 616' ' ' LEU . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 662' ' ' GLY . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 661' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' ARG . . . . . 0.405 ' HA ' ' CG2' ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 702' ' ' ILE . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' TRP . . . . . 0.512 ' CZ2' HD11 ' A' ' 690' ' ' ILE . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' LYS . . . . . 0.487 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' PRO . . . . . 0.428 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' LEU . . . . . 0.589 ' N ' ' CD ' ' A' ' 679' ' ' PRO . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 683' ' ' ASN . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' TYR . . . . . 0.544 ' HD1' HD11 ' B' ' 946' ' ' ILE . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' ILE . . . . . 0.487 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.512 HD11 ' CZ2' ' A' ' 673' ' ' TRP . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' ILE . . . . . 0.445 HD12 HG23 ' A' ' 701' ' ' ILE . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 670' ' ' VAL . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m -151.2 128.35 11.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.79 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -100.03 178.63 4.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -134.56 -53.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.674 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 946' ' ' ILE . . . . . 0.544 HD11 ' HD1' ' A' ' 687' ' ' TYR . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 947' ' ' TRP . . . . . 0.449 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 948' ' ' ALA . . . . . 0.615 ' OXT' ' HG ' ' A' ' 630' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.754 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.614 -0.194 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.73 HG13 ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.825 ' O ' HD13 ' A' ' 657' ' ' LEU . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.714 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.932 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.204 0.05 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.825 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 668' ' ' ASP . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.738 ' O ' HG22 ' A' ' 660' ' ' VAL . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.73 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.439 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.707 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 649' ' ' ILE . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 702' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.825 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t30 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 673' ' ' TRP . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.436 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.74 ' HG2' HG23 ' A' ' 682' ' ' THR . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.904 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.097 HD12 HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.412 ' NZ ' HG22 ' B' ' 946' ' ' ILE . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.452 ' OE2' HD11 ' A' ' 702' ' ' ILE . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.771 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.097 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.537 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.932 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.579 HG13 ' HA2' ' A' ' 662' ' ' GLY . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.708 ' O ' HD13 ' A' ' 657' ' ' LEU . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.525 ' HD2' HD22 ' A' ' 630' ' ' LEU . 13.7 ptmm? . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.962 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 119.87 -0.109 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.919 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.814 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 638' ' ' LYS . . . . . 0.432 ' CE ' HG11 ' A' ' 635' ' ' VAL . 10.0 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.8 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.472 HG12 HD23 ' A' ' 632' ' ' LEU . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 660' ' ' VAL . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.744 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.485 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.736 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.655 ' HA ' HG21 ' A' ' 652' ' ' VAL . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 704' ' ' SER . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.814 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.435 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.435 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 673' ' ' TRP . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.648 HG23 ' CG ' ' A' ' 684' ' ' GLU . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.648 ' CG ' HG23 ' A' ' 682' ' ' THR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.729 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.931 HD12 HD12 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 618' ' ' LYS . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.931 HD12 HD12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.518 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.962 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.479 HG13 ' HA2' ' A' ' 662' ' ' GLY . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.454 HD13 ' HG3' ' A' ' 700' ' ' GLU . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 701' ' ' ILE . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.1 m120 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.856 ' HG2' HD22 ' A' ' 630' ' ' LEU . 2.6 mtpp . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.926 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.856 HD22 ' HG2' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.548 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.882 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.813 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 682' ' ' THR . 65.9 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.828 0.346 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.627 HD13 HD12 ' A' ' 632' ' ' LEU . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 660' ' ' VAL . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.754 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.702 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.498 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.703 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.629 ' HA ' HG21 ' A' ' 652' ' ' VAL . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.625 ' OE1' HD11 ' A' ' 671' ' ' LEU . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.653 HG22 ' CG1' ' A' ' 703' ' ' VAL . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.633 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.435 ' HB2' HG12 ' A' ' 702' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.816 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 18.0 t30 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.418 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 673' ' ' TRP . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.902 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.714 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.521 ' CG ' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.902 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.625 ' HA ' HD13 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.47 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.66 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.995 HD12 HD12 ' B' ' 946' ' ' ILE . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 699' ' ' VAL . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 693' ' ' SER . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 615' ' ' ILE . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.653 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.633 ' OG ' HD21 ' A' ' 671' ' ' LEU . 37.2 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.995 HD12 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.497 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.926 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.416 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.665 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.407 HG21 ' NE2' ' A' ' 698' ' ' GLN . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 630' ' ' LEU . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.777 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.7 t-20 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.444 ' HE2' HD23 ' A' ' 630' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.441 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.791 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.799 HG23 ' N ' ' B' ' 945' ' ' GLY . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 682' ' ' THR . 22.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 668' ' ' ASP . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.784 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.811 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.665 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.473 ' N ' HD13 ' A' ' 664' ' ' LEU . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.71 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.662 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.707 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.791 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.46 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.686 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 687' ' ' TYR . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.913 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.485 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 685' ' ' GLU . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.561 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 615' ' ' ILE . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.475 ' HB3' HD21 ' A' ' 671' ' ' LEU . 14.9 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.799 ' N ' HG23 ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.561 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.449 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.931 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.628 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.56 HG13 ' HA2' ' A' ' 662' ' ' GLY . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.85 HD21 ' N ' ' A' ' 658' ' ' ALA . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.551 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.853 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.449 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.805 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 682' ' ' THR . 31.1 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.723 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.85 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.448 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.64 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.872 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.423 ' HB2' HG12 ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.848 ' HB2' HD11 ' A' ' 678' ' ' LEU . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 33.2 t30 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.498 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 673' ' ' TRP . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.706 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.959 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 678' ' ' LEU . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.545 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.966 HD12 HD12 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' SER . . . . . 0.487 ' OG ' HG22 ' A' ' 699' ' ' VAL . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.487 HG22 ' OG ' ' A' ' 693' ' ' SER . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.872 ' OG ' HD21 ' A' ' 671' ' ' LEU . 22.1 p . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.966 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.505 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.853 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 120.906 0.17 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.682 ' HA ' HD12 ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.626 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.606 HG21 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.759 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.786 ' O ' HD13 ' A' ' 657' ' ' LEU . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 694' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.934 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.866 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.718 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 682' ' ' THR . 89.7 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.343 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.636 HD13 HD12 ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.836 ' O ' HG22 ' A' ' 660' ' ' VAL . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.759 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.645 ' HA ' HG21 ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.66 HG22 ' CG1' ' A' ' 703' ' ' VAL . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.586 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.903 ' HB2' HD11 ' A' ' 678' ' ' LEU . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.903 HD11 ' HB2' ' A' ' 673' ' ' TRP . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.743 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.057 HD12 HD12 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 618' ' ' LYS . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 696' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' GLN . . . . . 0.606 ' NE2' HG21 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.057 HD12 HD12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.527 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.934 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.808 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.432 ' HB ' HG13 ' A' ' 701' ' ' ILE . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 614' ' ' VAL . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.725 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.679 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 682' ' ' THR . 20.9 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 668' ' ' ASP . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 656' ' ' SER . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 630' ' ' LEU . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 631' ' ' GLY . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 656' ' ' SER . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.492 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.405 ' N ' HD13 ' A' ' 664' ' ' LEU . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.645 HG22 ' CG1' ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HB2' HD11 ' A' ' 678' ' ' LEU . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 34.8 t30 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.414 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.926 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.676 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.63 ' HG2' HG23 ' A' ' 682' ' ' THR . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.926 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.927 HD12 HD12 ' B' ' 946' ' ' ILE . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 673' ' ' TRP . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.808 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.835 -0.106 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.927 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.798 0.11 . . . . 0.0 112.965 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.618 HG13 ' HA2' ' A' ' 662' ' ' GLY . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.47 HD11 ' HD3' ' A' ' 613' ' ' ARG . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 630' ' ' LEU . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 630' ' ' LEU . 6.9 ptmt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.893 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.707 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.791 0.329 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.603 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 668' ' ' ASP . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' THR . . . . . 0.453 ' CG2' HG23 ' A' ' 635' ' ' VAL . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.788 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.816 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.813 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.816 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.452 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.728 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.689 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.591 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.927 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 41.7 t30 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 673' ' ' TRP . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.919 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.754 ' HA ' HD13 ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.919 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.575 ' O ' HD22 ' A' ' 691' ' ' LEU . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.738 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 697' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 615' ' ' ILE . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.669 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 671' ' ' LEU . 10.6 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.451 -0.083 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.738 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 662' ' ' GLY . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.798 HD21 ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.803 ' O ' HD13 ' A' ' 657' ' ' LEU . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.796 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.836 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 682' ' ' THR . 27.0 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.805 0.336 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 668' ' ' ASP . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.82 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.798 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.493 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.596 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.88 ' HB2' HD11 ' A' ' 678' ' ' LEU . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.828 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 673' ' ' TRP . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.708 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.943 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.58 HG12 HD11 ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.681 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.828 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.906 HD12 ' CD1' ' B' ' 946' ' ' ILE . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.906 ' CD1' HD12 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.467 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.693 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.716 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.867 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 657' ' ' LEU . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.944 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.573 0.225 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.483 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.721 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 682' ' ' THR . 24.2 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 660' ' ' VAL . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.833 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.867 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.716 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.486 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.746 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 678' ' ' LEU . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.616 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.721 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.1 t30 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.429 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.92 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.826 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.92 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.884 ' HA ' HD13 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.873 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.666 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.825 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.873 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.483 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.944 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.759 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.617 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.748 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.825 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.518 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.937 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.772 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 645' ' ' LEU . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.6 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.669 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 660' ' ' VAL . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.748 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.427 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.656 ' HA ' HG21 ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.672 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.603 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.939 ' HB2' HD11 ' A' ' 678' ' ' LEU . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 43.4 t30 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.438 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.939 HD11 ' HB2' ' A' ' 673' ' ' TRP . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.806 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.856 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.856 ' HG2' HG23 ' A' ' 682' ' ' THR . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.927 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.504 HG12 ' CG1' ' A' ' 690' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 673' ' ' TRP . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 693' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 699' ' ' VAL . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 693' ' ' SER . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.672 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.551 ' OG ' HD21 ' A' ' 671' ' ' LEU . 52.9 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.572 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.508 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.909 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.799 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.678 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.88 HG13 ' HA2' ' A' ' 662' ' ' GLY . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.971 HD21 ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.799 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.513 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.884 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.52 0.2 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.947 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.47 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.771 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.443 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.781 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 682' ' ' THR . 41.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.685 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 660' ' ' VAL . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.971 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.88 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.487 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.678 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 649' ' ' ILE . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 678' ' ' LEU . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 704' ' ' SER . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.781 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 40.5 t30 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 670' ' ' VAL . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.897 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.897 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.902 HD12 HD12 ' B' ' 946' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 671' ' ' LEU . 22.3 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.902 HD12 HD12 ' A' ' 690' ' ' ILE . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.884 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.873 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.734 -0.146 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.704 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 630' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.78 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.787 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 618' ' ' LYS . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.426 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.82 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.674 HD13 ' HA ' ' A' ' 682' ' ' THR . 68.4 mt . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.638 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 660' ' ' VAL . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.735 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 656' ' ' SER . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.49 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.649 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.665 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.453 ' HB2' HG12 ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.82 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 673' ' ' TRP . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.889 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.674 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.654 ' CG ' HG23 ' A' ' 682' ' ' THR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.889 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.642 HG12 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.738 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.952 ' CD1' HD12 ' B' ' 946' ' ' ILE . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 697' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.665 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.952 HD12 ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.787 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.768 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.624 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 662' ' ' GLY . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.871 HD13 HD12 ' A' ' 630' ' ' LEU . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 657' ' ' LEU . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.497 ' HE2' HD23 ' A' ' 630' ' ' LEU . 2.5 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.871 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.74 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.728 0.299 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 668' ' ' ASP . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.781 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.798 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 656' ' ' SER . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.456 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.1 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.719 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.74 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.423 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.421 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 673' ' ' TRP . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.879 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.849 ' HG3' HG23 ' A' ' 682' ' ' THR . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.703 ' O ' HD22 ' A' ' 691' ' ' LEU . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.962 HD12 HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.68 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 671' ' ' LEU . 83.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.487 0.155 . . . . 0.0 113.487 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.962 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.497 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.821 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.822 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.564 HG13 ' HA2' ' A' ' 662' ' ' GLY . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.86 HD21 ' N ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.841 ' O ' HD13 ' A' ' 657' ' ' LEU . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.438 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.871 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.462 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 645' ' ' LEU . 22.2 mmtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.781 HD13 ' HA ' ' A' ' 682' ' ' THR . 13.5 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.487 HG12 HD23 ' A' ' 632' ' ' LEU . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 660' ' ' VAL . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.871 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.441 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.669 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.461 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 704' ' ' SER . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.3 t30 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.454 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 670' ' ' VAL . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.781 ' HA ' HD13 ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.73 ' HG2' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.903 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.556 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.02 HD12 HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 691' ' ' LEU . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.637 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.629 ' HB3' HD21 ' A' ' 671' ' ' LEU . 4.5 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.616 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.02 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.575 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.856 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.615 HG13 ' HA2' ' A' ' 662' ' ' GLY . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 700' ' ' GLU . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.915 HD13 HD12 ' A' ' 630' ' ' LEU . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.818 ' O ' HD13 ' A' ' 657' ' ' LEU . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.744 ' HZ3' HG21 ' A' ' 699' ' ' VAL . 1.6 mttp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.801 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.464 0.173 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.915 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.507 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.728 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 638' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 682' ' ' THR . 29.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.379 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.449 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 638' ' ' LYS . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' A' ' 668' ' ' ASP . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' THR . . . . . 0.447 ' CG2' HG23 ' A' ' 635' ' ' VAL . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.803 ' O ' HG22 ' A' ' 660' ' ' VAL . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.828 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.615 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.423 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.659 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.729 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 649' ' ' ILE . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 704' ' ' SER . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.876 ' HB2' HD11 ' A' ' 678' ' ' LEU . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.9 t30 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.442 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 673' ' ' TRP . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 2.8 p-10 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.936 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.672 ' O ' HD22 ' A' ' 691' ' ' LEU . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.998 HD12 HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.504 ' HD3' HD12 ' A' ' 629' ' ' LEU . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.744 HG21 ' HZ3' ' A' ' 618' ' ' LYS . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.847 ' HG3' HD12 ' A' ' 615' ' ' ILE . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.661 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.421 ' HB3' HD11 ' A' ' 671' ' ' LEU . 80.9 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.538 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-O 120.214 -0.215 . . . . 0.0 113.508 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 0.998 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.805 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 662' ' ' GLY . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ILE . . . . . 0.578 HG21 HE21 ' A' ' 698' ' ' GLN . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.777 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.758 ' O ' HD13 ' A' ' 657' ' ' LEU . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.955 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.247 0.07 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.941 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.782 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.488 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 682' ' ' THR . 62.8 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.795 0.331 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' THR . . . . . 0.409 ' CG2' HG23 ' A' ' 635' ' ' VAL . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.777 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 656' ' ' SER . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.517 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.463 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 649' ' ' ILE . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.567 ' CD ' HD11 ' A' ' 671' ' ' LEU . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.655 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.444 ' HB2' HG12 ' A' ' 702' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.782 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.4 t30 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 673' ' ' TRP . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 689' ' ' ILE . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.101 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' GLN . . . . . 0.578 HE21 HG21 ' A' ' 615' ' ' ILE . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.655 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.767 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.452 -0.082 . . . . 0.0 113.089 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.101 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.528 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.955 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.41 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.796 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.8 m120 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.922 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.5 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.678 HD13 ' HA ' ' A' ' 682' ' ' THR . 47.9 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.664 HD13 HD12 ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 660' ' ' VAL . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.773 ' HA ' HD11 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 656' ' ' SER . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.508 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.456 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 648' ' ' PHE . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.652 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 679' ' ' PRO . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 702' ' ' ILE . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 21.0 t30 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 673' ' ' TRP . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.995 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.678 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.995 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.53 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.023 HD12 HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 693' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 699' ' ' VAL . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 693' ' ' SER . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.652 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 671' ' ' LEU . 15.5 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.654 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.023 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.512 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.847 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.767 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.601 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.587 HG13 ' HA2' ' A' ' 662' ' ' GLY . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.851 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.517 ' O ' HD13 ' A' ' 657' ' ' LEU . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 630' ' ' LEU . 1.5 ptpt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.843 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.651 0.262 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.425 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.757 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.856 HD13 ' HA ' ' A' ' 682' ' ' THR . 80.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.834 0.349 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.601 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 648' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 668' ' ' ASP . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.84 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.851 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 656' ' ' SER . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.587 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.657 ' HA ' HG21 ' A' ' 652' ' ' VAL . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 669' ' ' GLU . . . . . 0.532 ' CD ' HD11 ' A' ' 671' ' ' LEU . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.666 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.418 ' HB2' HG12 ' A' ' 702' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 19.2 t30 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 670' ' ' VAL . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.987 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.856 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.61 ' HG2' HG23 ' A' ' 682' ' ' THR . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.987 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.127 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.666 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.755 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 120.552 -0.027 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.127 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.477 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.843 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 612' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.698 HG13 ' HA2' ' A' ' 662' ' ' GLY . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 616' ' ' LEU . . . . . 0.826 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ASN . . . . . 0.845 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LYS . . . . . 0.65 ' HG2' HD23 ' A' ' 630' ' ' LEU . 1.5 mtpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 629' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 630' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 634' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' ALA . . . . . 0.474 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 649' ' ' ILE . . . . . 0.578 HD13 HD12 ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 651' ' ' LYS . . . . . 0.619 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 656' ' ' SER . . . . . 0.776 ' O ' HG22 ' A' ' 660' ' ' VAL . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 657' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 658' ' ' ALA . . . . . 0.826 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 660' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 661' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 662' ' ' GLY . . . . . 0.698 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' ASP . . . . . 0.491 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 670' ' ' VAL . . . . . 0.696 HG22 ' CG1' ' A' ' 703' ' ' VAL . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 676' ' ' LYS . . . . . 0.517 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' THR . . . . . 0.72 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 684' ' ' GLU . . . . . 0.509 ' CG ' HG23 ' A' ' 682' ' ' THR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 685' ' ' GLU . . . . . 0.922 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.446 HG12 HD11 ' B' ' 946' ' ' ILE . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 687' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 689' ' ' ILE . . . . . 0.517 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.0 HD12 HD12 ' B' ' 946' ' ' ILE . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 701' ' ' ILE . . . . . 0.594 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 702' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.696 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 945' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 946' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 690' ' ' ILE . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 947' ' ' TRP . . . . . 0.464 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 948' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.579 0.228 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.28 171.61 13.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.445 2.097 . . . . 0.0 112.26 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.021 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -123.44 155.35 37.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.662 ' HB3' HD12 ' A' ' 610' ' ' LEU . 56.2 m95 -126.3 119.28 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.483 ' C ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -111.23 156.4 41.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.801 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 134.14 42.59 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.836 2.357 . . . . 0.0 112.338 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 31.0 t -64.87 -175.48 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -79.61 -11.53 59.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.92 -9.06 21.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.647 0.261 . . . . 0.0 111.375 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 73.26 5.4 66.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.039 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -121.09 7.62 10.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.808 0.304 . . . . 0.0 111.332 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.44 167.64 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.8 OUTLIER -121.24 114.51 21.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.653 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.698 HD12 ' OG ' ' A' ' 704' ' ' SER . 17.4 mm -109.58 107.25 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.754 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -96.86 162.95 22.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.614 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.73 HG13 ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.825 ' O ' HD13 ' A' ' 657' ' ' LEU . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.714 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.0 OUTLIER -83.85 55.33 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.05 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.062 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 13.9 p 55.44 68.09 0.92 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.4 t -163.54 31.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.518 ' HB2' ' HD2' ' A' ' 623' ' ' PRO . 1.0 OUTLIER -60.87 159.47 26.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.827 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 623' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 622' ' ' MET . 8.5 Cg_endo -50.09 -24.82 11.67 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.794 2.33 . . . . 0.0 112.183 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -65.6 -58.24 6.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.16 -92.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 3.0 m -128.41 -30.9 2.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.032 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' GLY . . . . . 0.428 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 76.41 -126.78 8.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.603 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -169.12 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.337 . . . . 0.0 111.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.932 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.05 -89.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.825 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.483 HG22 ' C ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -91.85 85.53 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.593 ' HA ' HD23 ' A' ' 645' ' ' LEU . 46.5 tpp -58.47 114.7 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 81.4 p -86.77 -176.11 5.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -8.47 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.386 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.6 mm? -82.46 -34.26 28.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.834 0.35 . . . . 0.0 110.949 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.41 17.9 6.9 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.7 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -130.29 153.91 48.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.3 mt -94.54 154.52 17.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.05 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 668' ' ' ASP . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.738 ' O ' HG22 ' A' ' 660' ' ' VAL . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.73 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.439 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.707 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 649' ' ' ILE . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 702' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.825 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t30 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 673' ' ' TRP . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.436 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.74 ' HG2' HG23 ' A' ' 682' ' ' THR . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.904 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.097 HD12 HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.412 ' NZ ' HG22 ' B' ' 946' ' ' ILE . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.452 ' OE2' HD11 ' A' ' 702' ' ' ILE . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.698 ' OG ' HD12 ' A' ' 611' ' ' ILE . 46.2 m -141.56 111.55 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.752 0.311 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.483 ' C ' HG22 ' A' ' 635' ' ' VAL . 1.7 pm0 -129.87 177.19 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.771 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -147.77 -65.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.692 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.097 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.537 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.932 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.739 0.305 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.59 171.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.603 2.202 . . . . 0.0 112.384 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 614' ' ' VAL . 2.9 t -96.86 152.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.039 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -126.74 155.23 43.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.037 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.462 ' HZ3' HG23 ' A' ' 703' ' ' VAL . 13.0 m95 -129.11 128.09 42.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.967 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 610' ' ' LEU . 9.6 pt20 -118.53 160.13 41.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 602' ' ' GLN . 80.7 Cg_exo -44.88 124.56 5.84 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.258 . . . . 0.0 112.505 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.441 ' CB ' HG12 ' A' ' 611' ' ' ILE . 48.2 t -68.64 158.56 33.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.222 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -21.05 66.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.909 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.05 -27.53 57.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 99.13 -31.83 7.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.959 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -113.34 23.02 13.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 167.65 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.102 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 611' ' ' ILE . 1.8 mm? -122.11 129.47 52.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.727 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.552 HD12 ' OG ' ' A' ' 704' ' ' SER . 12.3 mm -119.97 104.67 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -93.96 162.68 25.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.416 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 599' ' ' VAL . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.708 ' O ' HD13 ' A' ' 657' ' ' LEU . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.525 ' HD2' HD22 ' A' ' 630' ' ' LEU . 13.7 ptmm? -117.04 37.55 3.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.448 ' HD2' ' HB ' ' A' ' 620' ' ' THR . 0.0 OUTLIER -97.73 -32.25 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.237 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 619' ' ' ARG . 3.3 t -114.71 155.37 26.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 622' ' ' MET . 0.2 OUTLIER -65.32 179.98 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.5 ' H ' HG22 ' A' ' 621' ' ' THR . 0.0 OUTLIER -104.65 155.03 38.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.24 -28.0 5.03 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.011 2.474 . . . . 0.0 112.311 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.8 -37.71 74.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.186 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.76 -80.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 16.8 m -115.67 173.19 6.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -133.07 121.19 2.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.439 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.723 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -97.1 -80.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.636 0.255 . . . . 0.0 111.242 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.962 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.88 -95.11 0.49 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.938 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.919 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.814 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' LYS . . . . . 0.432 ' CE ' HG11 ' A' ' 635' ' ' VAL . 10.0 mmtt -100.17 91.45 4.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.557 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.47 113.94 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.2 p -93.63 -177.37 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -11.74 60.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -72.1 -26.14 62.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.943 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 105.55 11.14 29.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.791 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -136.37 168.4 19.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.8 mt -94.4 157.31 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.472 HG12 HD23 ' A' ' 632' ' ' LEU . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 660' ' ' VAL . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.744 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.485 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.736 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.655 ' HA ' HG21 ' A' ' 652' ' ' VAL . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 704' ' ' SER . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.814 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.435 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.435 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 673' ' ' TRP . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.648 HG23 ' CG ' ' A' ' 684' ' ' GLU . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.648 ' CG ' HG23 ' A' ' 682' ' ' THR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.729 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.931 HD12 HD12 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 618' ' ' LYS . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -135.64 107.44 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.994 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.77 160.87 43.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -116.19 -62.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.931 HD12 HD12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.518 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.962 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.707 0.289 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.13 171.69 15.44 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.539 2.159 . . . . 0.0 112.21 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.4 t -99.54 147.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.026 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.8 151.17 51.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.701 ' HB3' HD12 ' A' ' 610' ' ' LEU . 44.1 m95 -126.82 118.39 24.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -115.28 159.27 38.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 142.97 22.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.925 2.417 . . . . 0.0 112.262 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 609' ' ' ARG . 7.4 t -80.62 -175.46 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -9.57 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.324 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -101.31 -20.29 15.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 92.87 -43.14 2.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.665 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.01 7.12 22.45 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' ARG . . . . . 0.406 ' HB3' ' CB ' ' A' ' 604' ' ' SER . 0.0 OUTLIER -125.04 155.83 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.772 0.32 . . . . 0.0 110.647 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -118.63 121.63 40.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.28 146.52 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.996 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.69 160.69 25.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.568 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 599' ' ' VAL . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.479 HG13 ' HA2' ' A' ' 662' ' ' GLY . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.454 HD13 ' HG3' ' A' ' 700' ' ' GLU . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 701' ' ' ILE . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.1 m120 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.856 ' HG2' HD22 ' A' ' 630' ' ' LEU . 2.6 mtpp -73.83 62.28 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -37.06 85.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 618' ' ' LYS . 7.5 p 57.61 19.09 5.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 28.4 p -157.89 65.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 110.373 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.444 ' H ' ' HE3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -70.37 133.22 87.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.053 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.75 -18.52 41.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.405 2.07 . . . . 0.0 112.107 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -32.61 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -82.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.41 ' O ' ' HE3' ' A' ' 622' ' ' MET . 1.7 m 178.17 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 57.75 165.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.493 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.64 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -118.2 -43.5 2.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.926 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -126.55 -91.32 0.52 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.238 179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.856 HD22 ' HG2' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.548 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.882 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.813 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -127.22 93.17 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.54 104.53 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.669 HG21 ' OE2' ' A' ' 669' ' ' GLU . 71.1 p -80.48 180.0 7.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.36 -18.22 65.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -70.99 -29.76 65.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 108.49 15.4 13.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.657 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -131.72 168.73 17.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 682' ' ' THR . 65.9 mt -93.36 149.61 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.627 HD13 HD12 ' A' ' 632' ' ' LEU . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.491 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 660' ' ' VAL . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.754 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.702 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.498 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.703 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.629 ' HA ' HG21 ' A' ' 652' ' ' VAL . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.669 ' OE2' HG21 ' A' ' 640' ' ' THR . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.653 HG22 ' CG1' ' A' ' 703' ' ' VAL . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.633 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.435 ' HB2' HG12 ' A' ' 702' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.816 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 18.0 t30 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.418 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 673' ' ' TRP . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.902 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.714 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.521 ' CG ' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.902 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.625 ' HA ' HD13 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.47 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.66 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.995 HD12 HD12 ' B' ' 946' ' ' ILE . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 699' ' ' VAL . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 693' ' ' SER . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 615' ' ' ILE . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.653 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.633 ' OG ' HD21 ' A' ' 671' ' ' LEU . 37.2 p -142.74 115.87 8.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 650' ' ' THR . 5.2 pt-20 -59.83 -177.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -145.06 -50.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.846 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.995 HD12 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.497 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.926 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 598' ' ' PRO . 45.6 p-80 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.594 0.235 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 597' ' ' HIS . 51.0 Cg_endo -68.58 171.73 12.64 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.349 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.9 t -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.28 148.28 43.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.104 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.82 ' HB3' HD12 ' A' ' 610' ' ' LEU . 30.5 m95 -128.99 126.71 40.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -120.54 162.57 33.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.57 127.64 26.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.721 2.28 . . . . 0.0 112.079 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 21.6 t -60.79 171.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -73.53 -9.35 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.77 -19.98 20.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 84.35 -2.54 87.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.933 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.08 4.56 7.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.779 0.29 . . . . 0.0 111.397 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -129.22 157.94 40.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -110.24 126.09 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.1 141.73 29.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.74 160.64 25.29 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.558 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.665 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.407 HG21 ' NE2' ' A' ' 698' ' ' GLN . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 630' ' ' LEU . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.777 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.3 t30 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.444 ' HE2' HD23 ' A' ' 630' ' ' LEU . 0.1 OUTLIER -116.11 35.97 4.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.958 ' HD2' HG23 ' A' ' 620' ' ' THR . 0.0 OUTLIER -98.99 -26.86 14.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.958 HG23 ' HD2' ' A' ' 619' ' ' ARG . 1.2 p -108.28 -176.77 3.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 60.2 m -96.48 148.95 22.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.833 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.75 153.59 75.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.5 -15.37 24.78 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.558 2.172 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -56.11 -58.4 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.779 0.324 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 178.72 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.948 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.6 m -122.42 -175.98 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.792 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -144.22 72.34 0.36 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.597 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.713 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -63.4 -84.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.579 0.228 . . . . 0.0 110.836 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.84 -89.58 0.58 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.584 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.441 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.791 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.799 HG23 ' N ' ' B' ' 945' ' ' GLY . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -108.2 92.57 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.505 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.38 111.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 20.4 p -82.91 179.01 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.12 -16.32 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.231 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.1 mm? -74.45 -27.01 60.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.773 0.32 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.61 31.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.796 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -124.05 158.0 33.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 682' ' ' THR . 22.1 mt -90.55 146.16 24.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 668' ' ' ASP . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.564 HG21 ' HG3' ' B' ' 944' ' ' GLU . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.784 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.811 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.665 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.473 ' N ' HD13 ' A' ' 664' ' ' LEU . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.71 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.662 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.707 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.791 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.46 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.686 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 687' ' ' TYR . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.913 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.485 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 685' ' ' GLU . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.561 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 615' ' ' ILE . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.475 ' HB3' HD21 ' A' ' 671' ' ' LEU . 14.9 t -143.97 115.45 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.91 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.847 0.356 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.644 ' C ' HG23 ' A' ' 635' ' ' VAL . 2.0 mp0 -82.31 -170.92 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.799 ' N ' HG23 ' A' ' 635' ' ' VAL . . . -128.8 -64.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.092 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.561 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.449 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.931 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 661' ' ' VAL . 41.3 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.584 0.231 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.33 171.62 13.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -120.4 151.93 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.09 150.77 42.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.073 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.638 ' HB3' HD12 ' A' ' 610' ' ' LEU . 12.2 m95 -129.78 127.13 39.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -118.82 156.71 51.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.06 139.32 42.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.914 2.409 . . . . 0.0 112.229 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 609' ' ' ARG . 39.3 t -65.38 -175.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -22.62 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.481 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.92 -25.33 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 102.29 -33.54 6.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.487 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.44 -10.16 41.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' ARG . . . . . 0.417 ' HB2' ' CB ' ' A' ' 604' ' ' SER . 13.2 mtm180 -124.13 160.56 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.638 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -116.49 118.13 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.155 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 21.4 mm -106.74 142.35 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.68 162.45 25.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.628 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.56 HG13 ' HA2' ' A' ' 662' ' ' GLY . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.85 HD21 ' N ' ' A' ' 658' ' ' ALA . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.551 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.1 OUTLIER -105.4 -34.15 7.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -29.05 69.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.771 HG23 HD11 ' A' ' 657' ' ' LEU . 9.0 t -74.1 -39.34 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.761 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.86 -169.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.076 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.23 149.19 54.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -25.68 8.6 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 112.6 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -34.1 30.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.133 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 178.03 151.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.78 129.17 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -95.25 -67.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.724 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -174.29 -71.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.853 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -120.35 -85.4 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.449 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.805 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -88.97 91.55 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.529 ' HA ' HD23 ' A' ' 645' ' ' LEU . 2.1 tpt -58.29 116.63 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -95.72 -177.65 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -72.09 -9.98 59.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.2 mm? -92.22 11.23 26.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.407 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.93 36.61 81.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.692 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -139.55 139.9 36.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 682' ' ' THR . 31.1 mt -88.2 144.18 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.978 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.45 HG21 ' HA ' ' B' ' 944' ' ' GLU . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.723 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.85 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.448 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.64 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.872 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.423 ' HB2' HG12 ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.848 ' HB2' HD11 ' A' ' 678' ' ' LEU . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 33.2 t30 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.498 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 673' ' ' TRP . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.706 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.959 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 678' ' ' LEU . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.545 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.966 HD12 HD12 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' SER . . . . . 0.487 ' OG ' HG22 ' A' ' 699' ' ' VAL . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.487 HG22 ' OG ' ' A' ' 693' ' ' SER . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.872 ' OG ' HD21 ' A' ' 671' ' ' LEU . 22.1 p -147.55 136.85 22.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.882 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 650' ' ' THR . 8.7 pt-20 -86.39 168.9 13.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -121.78 -64.19 0.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.966 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.505 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.853 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 661' ' ' VAL . 2.5 m-70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.703 0.287 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 171.64 11.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.562 2.175 . . . . 0.0 112.277 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -113.63 152.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.89 151.67 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.026 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.74 ' CB ' HD12 ' A' ' 610' ' ' LEU . 47.3 m95 -132.26 138.0 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.68 154.25 73.04 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.38 129.04 14.33 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.798 2.332 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.3 p -101.91 146.77 27.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.8 -8.5 59.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.483 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.75 17.58 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 125.9 25.81 1.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.92 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.67 74.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.98 167.69 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.459 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.74 HD12 ' CB ' ' A' ' 601' ' ' TRP . 2.5 mm? -114.34 114.56 26.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.409 HD12 ' OG ' ' A' ' 704' ' ' SER . 16.6 mm -104.86 137.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.51 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.74 162.94 25.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.096 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.682 ' HA ' HD12 ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 599' ' ' VAL . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.606 HG21 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.759 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.786 ' O ' HD13 ' A' ' 657' ' ' LEU . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 694' ' ' LYS . 0.4 OUTLIER -86.29 55.13 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.71 -21.4 52.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 4.9 p 57.5 32.56 22.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.019 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.6 t -118.0 49.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.462 ' HE2' ' HA3' ' A' ' 627' ' ' GLY . 1.9 mpp? -60.6 145.97 86.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.36 -14.39 43.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.411 2.074 . . . . 0.0 112.333 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -54.55 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 -81.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.77 -43.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' GLY . . . . . 0.462 ' HA3' ' HE2' ' A' ' 622' ' ' MET . . . 96.53 -142.56 16.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.618 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.661 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -154.59 -60.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.934 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -116.59 -91.9 0.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.866 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.718 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -106.05 89.6 3.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.504 ' HA ' HD23 ' A' ' 645' ' ' LEU . 47.3 tpp -58.87 115.89 3.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.985 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 68.4 p -90.12 -174.71 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.9 -10.72 59.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.439 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.0 mm? -79.48 -34.46 41.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.94 6.27 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -132.26 157.27 44.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 682' ' ' THR . 89.7 mt -92.05 152.17 20.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.636 HD13 HD12 ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.62 HG21 ' HA ' ' B' ' 944' ' ' GLU . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.836 ' O ' HG22 ' A' ' 660' ' ' VAL . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.759 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.645 ' HA ' HG21 ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.66 HG22 ' CG1' ' A' ' 703' ' ' VAL . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.586 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.903 ' HB2' HD11 ' A' ' 678' ' ' LEU . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.903 HD11 ' HB2' ' A' ' 673' ' ' TRP . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.743 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.057 HD12 HD12 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 618' ' ' LYS . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' GLN . . . . . 0.606 ' NE2' HG21 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.409 ' OG ' HD12 ' A' ' 611' ' ' ILE . 12.6 m -143.89 104.64 4.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.62 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.2 pm0 -120.09 178.75 4.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -133.36 -54.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.057 HD12 HD12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.527 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.934 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.648 0.261 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.08 171.67 7.26 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.57 2.18 . . . . 0.0 112.228 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 614' ' ' VAL . 2.6 t -113.29 149.96 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.238 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.3 p -133.62 154.74 50.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.22 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.649 ' HB3' HD12 ' A' ' 610' ' ' LEU . 18.8 m95 -129.95 123.94 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.24 156.29 47.26 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.99 130.73 39.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 0.0 112.238 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -177.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.089 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -9.22 59.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.463 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -98.93 -13.13 20.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 111.248 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 76.39 4.12 79.03 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.826 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.23 2.98 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.798 0.299 . . . . 0.0 111.371 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.83 160.47 31.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -118.75 115.43 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.77 146.43 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.808 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.7 162.51 25.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.444 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 599' ' ' VAL . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 614' ' ' VAL . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER -92.79 -35.72 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 697' ' ' PRO . 0.0 OUTLIER -57.13 -30.4 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.367 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 50.0 p -83.95 -59.75 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.066 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.776 ' HA ' HD11 ' A' ' 657' ' ' LEU . 0.0 OUTLIER 57.41 156.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.562 ' HB2' ' HD3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -73.63 123.8 89.72 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 110.694 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.53 -1.27 11.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 113.473 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.562 ' HD3' ' HB2' ' A' ' 622' ' ' MET . 0.0 OUTLIER -88.87 -35.0 16.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 111.309 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.85 -79.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.23 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 133.74 61.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.818 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -69.45 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -122.83 -77.46 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.725 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.679 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -131.71 94.34 3.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.55 104.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.759 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 27.9 p -81.77 -178.57 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.49 -23.43 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.228 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.4 mm? -66.82 -27.45 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.5 13.93 25.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.843 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -128.63 166.5 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 682' ' ' THR . 20.9 mt -90.62 148.24 22.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 668' ' ' ASP . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.671 HG21 ' HA ' ' B' ' 944' ' ' GLU . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 656' ' ' SER . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.776 HD11 ' HA ' ' A' ' 621' ' ' THR . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 631' ' ' GLY . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 656' ' ' SER . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.492 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.405 ' N ' HD13 ' A' ' 664' ' ' LEU . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.645 HG22 ' CG1' ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HB2' HD11 ' A' ' 678' ' ' LEU . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 34.8 t30 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.414 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.926 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.676 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.63 ' HG2' HG23 ' A' ' 682' ' ' THR . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.926 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.927 HD12 HD12 ' B' ' 946' ' ' ILE . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 619' ' ' ARG . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 673' ' ' TRP . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.808 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t -149.41 138.82 21.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.783 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.671 ' HA ' HG21 ' A' ' 650' ' ' THR . 11.5 mt-10 -86.71 179.12 6.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -130.26 -60.35 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.835 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.927 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.428 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 4.8 t60 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 6.0 Cg_exo -77.72 165.43 26.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.7 2.267 . . . . 0.0 112.154 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.07 144.43 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -130.68 152.05 50.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.295 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -130.23 128.1 40.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -116.27 128.11 26.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.81 148.62 91.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.171 . . . . 0.0 112.142 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.406 ' HB3' ' CG ' ' A' ' 609' ' ' ARG . 9.7 t -119.81 146.34 45.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.319 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 607' ' ' GLY . 0.5 OUTLIER -81.62 -8.71 59.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.612 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.08 17.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 605' ' ' LYS . . . 137.66 5.92 1.64 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.193 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.8 64.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 110.46 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' ARG . . . . . 0.724 ' NE ' HD11 ' A' ' 611' ' ' ILE . 11.8 ptt180 -124.78 159.63 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.223 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.86 114.47 27.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.724 HD11 ' NE ' ' A' ' 609' ' ' ARG . 9.0 mm -103.7 140.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.485 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.71 162.68 25.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.965 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.618 HG13 ' HA2' ' A' ' 662' ' ' GLY . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.47 HD11 ' HD3' ' A' ' 613' ' ' ARG . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 630' ' ' LEU . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 630' ' ' LEU . 6.9 ptmt -116.0 33.8 5.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -57.99 2.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 5.1 t -84.41 167.74 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.91 HG22 ' HA ' ' A' ' 626' ' ' SER . 0.2 OUTLIER -91.98 167.75 11.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.798 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 2.7 tpp -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.99 -25.29 52.93 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.412 2.075 . . . . 0.0 112.203 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -36.15 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -81.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.047 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.91 ' HA ' HG22 ' A' ' 621' ' ' THR . 1.4 p -172.83 -176.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -161.64 148.88 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.436 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.638 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -74.56 -58.89 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.94 -84.61 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.362 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.893 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.707 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -119.82 86.93 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 48.0 tpp -59.36 115.72 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 4.6 p -102.92 -177.1 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.12 -16.03 60.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.3 mm? -68.51 -26.14 65.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 98.94 9.61 51.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.791 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.56 168.83 17.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.2 mt -94.01 151.46 19.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.603 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 668' ' ' ASP . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.917 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.788 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.816 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.813 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.816 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.452 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.728 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.689 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.591 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.927 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 41.7 t30 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 673' ' ' TRP . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.919 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.754 ' HA ' HD13 ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.919 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.575 ' O ' HD22 ' A' ' 691' ' ' LEU . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.738 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 615' ' ' ILE . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.669 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 671' ' ' LEU . 10.6 t -146.78 109.87 4.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.873 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.735 0.302 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.917 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.2 pt-20 -100.64 -177.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -149.19 -41.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.976 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.738 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' A' ' 598' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.561 0.22 . . . . 0.0 111.44 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 597' ' ' HIS . 83.8 Cg_endo -82.66 167.5 14.87 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.398 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 614' ' ' VAL . 2.4 t -97.95 148.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.825 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.83 151.21 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.292 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.723 ' HB3' HD12 ' A' ' 610' ' ' LEU . 59.6 m95 -132.65 135.21 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.886 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.671 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -130.43 151.38 78.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.969 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 120.01 7.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.242 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 6.7 t -81.03 164.94 22.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -8.31 59.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.79 -16.22 57.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.576 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 128.4 -33.71 3.09 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.86 30.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.85 136.57 37.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 110.6 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 601' ' ' TRP . 2.6 mm? -107.88 114.46 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.79 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 7.4 mm -99.61 140.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.98 160.12 25.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.717 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 662' ' ' GLY . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.798 HD21 ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.803 ' O ' HD13 ' A' ' 657' ' ' LEU . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -103.84 36.32 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -98.99 -46.24 5.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.329 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 17.5 p -96.41 176.17 6.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.718 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.98 144.72 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.408 ' HG2' ' CA ' ' A' ' 626' ' ' SER . 3.0 ptp -59.39 153.28 49.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.38 -3.94 13.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.821 2.347 . . . . 0.0 113.236 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -98.58 -24.75 14.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.666 0.269 . . . . 0.0 111.163 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.89 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.408 ' CA ' ' HG2' ' A' ' 622' ' ' MET . 2.1 m 178.62 -43.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 88.41 -160.46 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.378 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.726 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -128.46 -52.35 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -125.7 -80.72 0.62 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.796 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.836 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -103.57 90.49 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.499 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.1 OUTLIER -60.11 126.08 26.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 77.5 p -92.31 -176.36 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -75.42 -7.23 53.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.469 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.7 mm? -83.74 -33.8 24.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.67 21.54 6.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -132.36 150.73 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 682' ' ' THR . 27.0 mt -88.57 144.71 26.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 668' ' ' ASP . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.82 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.798 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.493 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.596 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.88 ' HB2' HD11 ' A' ' 678' ' ' LEU . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.828 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 673' ' ' TRP . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.708 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.943 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.58 HG12 HD11 ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.681 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.828 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.906 HD12 ' CD1' ' B' ' 946' ' ' ILE . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t -151.75 112.06 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.918 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -127.75 169.74 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -124.36 -72.17 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.602 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.906 ' CD1' HD12 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.467 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.654 0.264 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 171.57 17.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.565 2.177 . . . . 0.0 112.206 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.7 t -103.14 151.52 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.5 p -134.92 154.8 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.221 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.706 ' HB3' HD12 ' A' ' 610' ' ' LEU . 69.5 m95 -129.03 121.56 28.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -118.23 144.02 34.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.03 141.2 93.57 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.705 2.27 . . . . 0.0 112.143 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 76.8 p -60.63 178.96 0.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.746 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -62.56 -54.55 38.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.03 -27.68 69.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.348 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.17 32.59 11.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.082 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -125.63 -24.29 3.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.55 0.214 . . . . 0.0 111.222 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.3 152.68 33.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -108.14 123.72 49.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.765 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.512 HD12 ' OG ' ' A' ' 704' ' ' SER . 22.5 mm -114.43 140.85 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.265 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.78 159.01 24.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.423 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.693 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.716 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.867 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 657' ' ' LEU . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -102.15 -36.48 8.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -29.25 17.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 41.2 p -87.46 135.21 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.011 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 27.7 m -80.72 146.17 31.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.488 ' HA ' ' HD3' ' A' ' 623' ' ' PRO . 1.6 mpp? -66.27 140.15 96.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.928 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 622' ' ' MET . 2.9 Cg_exo -75.26 -29.12 8.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.764 2.309 . . . . 0.0 112.496 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -30.48 13.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.223 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -145.39 -163.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.0 m -95.67 -77.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.028 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.54 165.2 25.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.793 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -98.82 -60.58 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.944 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -127.9 -80.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.612 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.483 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.721 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -115.37 91.85 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.437 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.2 OUTLIER -58.37 119.07 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 24.8 p -92.23 -178.9 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -10.64 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.363 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.5 mm? -84.11 -31.87 25.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 107.61 22.69 7.24 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.614 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -129.77 144.35 51.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 682' ' ' THR . 24.2 mt -86.83 143.88 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.489 HG21 ' HA ' ' B' ' 944' ' ' GLU . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 660' ' ' VAL . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.833 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.867 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.716 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.486 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.746 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 678' ' ' LEU . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.616 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.721 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.1 t30 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.429 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.92 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.826 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.92 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.884 ' HA ' HD13 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.873 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.666 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.825 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 611' ' ' ILE . 65.4 m -146.35 113.27 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 650' ' ' THR . 65.5 mt-10 61.22 166.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -146.0 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.873 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.483 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.944 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.3 171.58 17.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.554 2.169 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -110.86 151.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.4 p -134.33 154.08 51.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.373 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.696 ' HB3' HD12 ' A' ' 610' ' ' LEU . 15.0 m95 -131.89 130.06 41.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -123.19 163.62 32.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.84 134.06 60.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.69 2.26 . . . . 0.0 112.193 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.4 t -60.69 -176.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.061 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -81.52 -9.17 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -103.88 -17.37 15.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.63 0.252 . . . . 0.0 111.194 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 82.67 11.81 81.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.808 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.8 -3.11 7.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 0.218 . . . . 0.0 111.487 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.97 40.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -113.74 114.46 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 703' ' ' VAL . 32.2 mm -100.83 144.45 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.759 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.9 161.38 25.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.594 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.617 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.748 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -104.73 -36.63 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -61.35 -25.89 67.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.002 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 80.9 p -84.6 134.35 34.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.741 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.86 142.7 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.11 167.46 30.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.14 -29.74 87.66 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 0.0 111.825 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -35.89 10.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.917 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.8 66.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.7 t -137.08 -19.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -62.56 -128.75 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.718 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.514 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -171.61 -39.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.824 0.345 . . . . 0.0 111.588 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -121.23 -89.64 0.6 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.827 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.825 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.518 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.937 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.772 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 645' ' ' LEU . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -106.15 94.44 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.33 112.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.4 p -88.65 -177.68 5.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -16.28 64.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -71.88 -28.73 63.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 106.1 13.11 24.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.742 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.39 167.62 18.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.6 mt -93.62 150.2 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.669 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 660' ' ' VAL . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.748 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.427 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.656 ' HA ' HG21 ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.672 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.603 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.939 ' HB2' HD11 ' A' ' 678' ' ' LEU . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 43.4 t30 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.438 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.939 HD11 ' HB2' ' A' ' 673' ' ' TRP . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.806 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.856 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.856 ' HG2' HG23 ' A' ' 682' ' ' THR . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.927 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.504 HG12 ' CG1' ' A' ' 690' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 673' ' ' TRP . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 699' ' ' VAL . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 693' ' ' SER . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.672 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.551 ' OG ' HD21 ' A' ' 671' ' ' LEU . 52.9 p -144.21 104.18 4.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.922 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 943' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 635' ' ' VAL . 16.8 pt-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.84 0.353 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -106.35 168.29 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -130.34 -69.14 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.572 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.508 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.909 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.568 0.223 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.75 171.71 12.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.453 2.102 . . . . 0.0 112.198 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.6 t -120.06 150.55 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 2.0 p -138.46 157.21 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.223 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.45 ' CE3' ' HA3' ' A' ' 612' ' ' GLY . 73.0 m95 -130.74 129.01 41.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 603' ' ' PRO . 0.8 OUTLIER -130.88 142.35 45.24 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 603' ' ' PRO . . . . . 0.741 ' HA ' HD22 ' A' ' 610' ' ' LEU . 35.5 Cg_exo -60.86 156.15 45.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -65.8 -179.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.653 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -65.26 -50.36 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -63.19 -27.6 69.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.37 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 89.89 33.01 9.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.191 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -24.99 3.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.683 0.278 . . . . 0.0 111.265 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.95 167.61 10.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 603' ' ' PRO . 0.2 OUTLIER -126.86 117.82 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 14.3 mm -115.73 142.2 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.799 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.93 162.52 25.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.678 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.88 HG13 ' HA2' ' A' ' 662' ' ' GLY . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.971 HD21 ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.799 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.513 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.2 OUTLIER -101.56 -31.67 10.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -73.58 -28.73 62.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 617' ' ' ASN . 60.5 p -59.26 -20.87 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.95 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.66 161.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.775 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.747 ' SD ' HD12 ' A' ' 657' ' ' LEU . 2.3 mpp? -102.77 164.97 14.53 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.141 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.79 -21.15 14.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.991 2.461 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -41.64 47.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.411 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.58 -61.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.764 0.316 . . . . 0.0 111.301 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.4 p -175.37 -35.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 627' ' ' GLY . . . . . 0.409 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 79.41 -97.64 1.59 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.676 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -168.79 -67.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.791 0.329 . . . . 0.0 111.629 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.884 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.3 -82.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.947 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.47 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.771 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.443 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.781 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -122.23 100.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.43 106.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.797 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 80.8 p -74.47 174.04 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.259 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.56 -21.16 62.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.271 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.67 -40.08 19.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.04 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 121.56 17.22 3.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.874 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -115.82 141.73 47.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 682' ' ' THR . 41.2 mt -87.02 147.27 25.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.761 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.685 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.557 HG21 ' HA ' ' B' ' 944' ' ' GLU . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 660' ' ' VAL . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.971 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.88 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.487 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.678 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 649' ' ' ILE . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 678' ' ' LEU . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 704' ' ' SER . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.781 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 40.5 t30 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 670' ' ' VAL . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.897 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.897 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.902 HD12 HD12 ' B' ' 946' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 671' ' ' LEU . 22.3 p -141.71 113.93 8.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.557 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.8 mp0 -98.85 172.43 7.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -118.74 -64.66 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.682 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.902 HD12 HD12 ' A' ' 690' ' ' ILE . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.884 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 661' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.51 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.56 166.74 17.53 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.561 2.174 . . . . 0.0 112.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.17 151.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -132.84 152.9 51.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.291 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.81 ' HB3' HD12 ' A' ' 610' ' ' LEU . 52.6 m95 -131.62 131.86 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -122.07 157.96 56.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.92 128.91 9.5 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.787 2.325 . . . . 0.0 112.394 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.55 144.17 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.348 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -81.65 -8.48 59.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.566 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.76 17.71 0.09 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 128.36 21.56 1.45 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.98 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 t0 69.55 72.72 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -126.04 167.63 15.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 601' ' ' TRP . 2.1 mm? -115.73 114.37 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.888 0.375 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.34 139.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.775 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.873 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.79 162.69 25.56 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.734 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.704 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 630' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.78 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.4 OUTLIER -97.29 -29.89 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.414 ' NE ' ' HB ' ' A' ' 620' ' ' THR . 0.7 OUTLIER -98.95 -31.03 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.591 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.589 ' O ' ' HB ' ' A' ' 621' ' ' THR . 7.1 t -112.24 172.07 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.169 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 620' ' ' THR . 17.5 m 74.75 -7.45 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.057 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 625' ' ' GLU . 47.9 tpp -104.65 122.69 42.7 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.708 0.29 . . . . 0.0 111.255 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.36 -45.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.695 2.263 . . . . 0.0 112.729 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -86.21 -56.66 3.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.945 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 622' ' ' MET . 6.0 mt-10 73.9 100.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.346 . . . . 0.0 110.878 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.2 m -68.72 -47.04 67.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 123.66 37.54 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.836 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -136.91 -103.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.929 -0.16 . . . . 0.0 110.789 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -126.79 -146.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 618' ' ' LYS . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.426 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.82 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -112.06 97.76 6.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.513 ' HA ' HD23 ' A' ' 645' ' ' LEU . 2.0 ttm -59.03 107.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.1 p -74.54 -177.53 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -19.14 62.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.0 mm? -75.15 -29.07 60.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 111.28 15.18 10.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.736 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -125.13 160.59 28.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.674 HD13 ' HA ' ' A' ' 682' ' ' THR . 68.4 mt -91.39 149.26 21.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.638 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 660' ' ' VAL . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.735 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 656' ' ' SER . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.49 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.649 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.665 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.453 ' HB2' HG12 ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.82 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 673' ' ' TRP . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.889 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.674 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.654 ' CG ' HG23 ' A' ' 682' ' ' THR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.889 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.642 HG12 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.738 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.952 ' CD1' HD12 ' B' ' 946' ' ' ILE . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.665 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t -147.77 126.61 12.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.912 0.387 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.71 178.82 7.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -127.97 -62.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.633 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.952 HD12 ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.787 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 598' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 597' ' ' HIS . 77.0 Cg_endo -79.16 170.49 17.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.403 2.069 . . . . 0.0 112.275 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.4 t -109.18 146.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.6 p -135.8 155.66 50.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.691 ' HB3' HD12 ' A' ' 610' ' ' LEU . 47.8 m95 -129.49 123.64 32.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.59 ' O ' HD13 ' A' ' 610' ' ' LEU . 9.6 pt20 -122.57 159.32 53.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.73 138.19 41.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.821 2.347 . . . . 0.0 112.338 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 611' ' ' ILE . 9.0 p -81.12 -177.45 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.081 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -9.44 59.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.395 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 -25.09 29.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.733 0.302 . . . . 0.0 110.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 95.1 -25.29 24.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.738 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.89 16.06 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -128.19 157.23 41.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.878 0.37 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -119.15 126.75 52.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 703' ' ' VAL . 12.6 mm -110.37 146.65 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.768 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.23 159.14 24.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.408 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.624 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 662' ' ' GLY . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.871 HD13 HD12 ' A' ' 630' ' ' LEU . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 657' ' ' LEU . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.497 ' HE2' HD23 ' A' ' 630' ' ' LEU . 2.5 ptpt -112.23 39.73 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.447 ' H ' ' CD ' ' A' ' 619' ' ' ARG . 0.0 OUTLIER -73.71 -35.39 65.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.521 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.445 HG22 HH11 ' A' ' 619' ' ' ARG . 11.4 t -138.64 -170.65 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.258 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m -58.3 151.59 19.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.049 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -104.87 158.68 31.51 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.025 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.49 -17.93 43.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.61 2.207 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 622' ' ' MET . 0.0 OUTLIER -80.4 3.28 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.06 -176.96 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.818 0.342 . . . . 0.0 110.993 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.69 -64.46 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.32 42.7 3.64 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.388 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.847 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -55.69 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.454 0.168 . . . . 0.0 110.92 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -130.44 -78.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.871 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.74 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -103.54 88.14 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.481 ' N ' HD23 ' A' ' 645' ' ' LEU . 0.3 OUTLIER -58.37 116.23 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 25.3 p -97.22 -177.61 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -73.97 -7.89 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.424 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.618 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.3 mm? -90.5 11.51 21.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.627 0.251 . . . . 0.0 111.45 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.83 29.62 70.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.658 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 145.09 38.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.8 mt -90.73 154.25 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 668' ' ' ASP . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.573 HG21 ' HG3' ' B' ' 944' ' ' GLU . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.781 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.798 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 656' ' ' SER . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.456 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.1 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.719 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.74 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.423 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.421 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 673' ' ' TRP . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.879 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.849 ' HG3' HG23 ' A' ' 682' ' ' THR . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.703 ' O ' HD22 ' A' ' 691' ' ' LEU . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.962 HD12 HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.68 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 671' ' ' LEU . 83.5 p -146.28 117.27 7.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.855 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 943' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 635' ' ' VAL . 22.4 tt0 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.573 ' HG3' HG21 ' A' ' 650' ' ' THR . 1.4 mt-10 -88.71 -175.02 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -145.2 -47.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.487 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.962 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.497 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.821 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.714 0.292 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.4 171.58 17.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -103.93 152.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.2 152.78 42.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.634 ' HB3' HD12 ' A' ' 610' ' ' LEU . 24.6 m95 -131.3 131.9 44.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -119.83 142.06 32.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 610' ' ' LEU . 21.0 Cg_endo -60.68 139.58 86.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.6 t -60.65 176.06 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -54.49 42.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.92 -27.66 69.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.318 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.0 10.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.159 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.38 -22.41 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.585 0.231 . . . . 0.0 111.217 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 152.78 30.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.854 0.359 . . . . 0.0 110.917 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -115.52 114.47 25.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.589 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 12.5 mm -105.63 143.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.265 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.822 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.69 159.06 24.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.564 HG13 ' HA2' ' A' ' 662' ' ' GLY . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.86 HD21 ' N ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.841 ' O ' HD13 ' A' ' 657' ' ' LEU . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.438 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER -106.27 -28.53 10.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.28 70.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.655 HG23 HD11 ' A' ' 657' ' ' LEU . 9.0 t -59.54 135.49 57.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.711 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 3.6 m -67.59 148.75 51.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 111.256 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.534 ' HG2' ' H ' ' A' ' 625' ' ' GLU . 0.0 OUTLIER -104.98 167.53 9.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.898 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 -46.93 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.815 2.344 . . . . 0.0 112.686 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.41 62.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.514 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.534 ' H ' ' HG2' ' A' ' 622' ' ' MET . 0.7 OUTLIER 62.34 126.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.533 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -46.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 97.19 73.48 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.702 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.862 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -155.9 -97.96 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 0.186 . . . . 0.0 111.325 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.862 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -117.81 -132.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.431 -0.107 . . . . 0.0 110.816 -179.384 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.871 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 645' ' ' LEU . 22.2 mmtt -121.26 95.2 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.464 ' HE3' ' HG ' ' A' ' 645' ' ' LEU . 0.0 OUTLIER -59.12 111.59 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.697 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.44 179.65 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.284 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.28 -20.58 66.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 5.9 mt -83.25 -41.62 18.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.057 0.456 . . . . 0.0 110.947 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 123.25 17.12 3.35 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.804 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -113.71 141.87 46.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 110.77 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.781 HD13 ' HA ' ' A' ' 682' ' ' THR . 13.5 mt -86.78 146.0 26.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.487 HG12 HD23 ' A' ' 632' ' ' LEU . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.721 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 660' ' ' VAL . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.871 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.441 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.669 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.461 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 704' ' ' SER . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.3 t30 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.454 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 670' ' ' VAL . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.781 ' HA ' HD13 ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.73 ' HG2' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.903 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.556 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.02 HD12 HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 691' ' ' LEU . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.637 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.629 ' HB3' HD21 ' A' ' 671' ' ' LEU . 4.5 t -144.1 119.87 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.721 ' HA ' HG21 ' A' ' 650' ' ' THR . 0.3 OUTLIER -154.1 177.77 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.616 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -150.16 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.02 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.575 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.856 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 2.6 t60 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 93.9 Cg_endo -80.64 168.52 17.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.456 2.104 . . . . 0.0 112.404 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.657 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -92.94 151.92 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 151.22 41.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.772 ' HB3' HD12 ' A' ' 610' ' ' LEU . 38.4 m95 -129.96 126.69 38.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -119.3 155.66 53.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.45 132.27 34.58 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.784 2.323 . . . . 0.0 112.257 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.2 t -60.79 -175.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -9.31 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.17 -10.16 15.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.271 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.45 82.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.817 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.64 -0.14 8.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.566 0.222 . . . . 0.0 111.459 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -133.05 167.54 20.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.773 0.321 . . . . 0.0 110.841 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.5 OUTLIER -121.71 114.48 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.749 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.82 141.03 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.8 162.66 25.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 599' ' ' VAL . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 700' ' ' GLU . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.915 HD13 HD12 ' A' ' 630' ' ' LEU . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.818 ' O ' HD13 ' A' ' 657' ' ' LEU . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.744 ' HZ3' HG21 ' A' ' 699' ' ' VAL . 1.6 mttp -94.35 -29.23 15.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -81.22 -28.03 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 617' ' ' ASN . 10.9 t -57.85 -22.66 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.092 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 626' ' ' SER . 0.6 OUTLIER 69.44 170.99 0.3 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.173 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' A' ' 626' ' ' SER . 0.0 OUTLIER -104.58 165.63 12.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 -20.4 14.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -84.51 -56.03 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.151 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -173.01 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 621' ' ' THR . 0.3 OUTLIER 75.44 163.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 167.22 -29.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.696 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.908 ' O ' HD13 ' A' ' 629' ' ' LEU . . . -84.18 -105.53 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.626 0.213 . . . . 0.0 111.133 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.908 HD13 ' O ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -137.14 -83.46 0.34 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.377 -0.202 . . . . 0.0 111.03 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.915 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.507 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.728 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt -123.49 117.53 25.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.97 104.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.246 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.462 HG21 ' HZ ' ' A' ' 648' ' ' PHE . 0.5 OUTLIER -84.09 -173.89 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.39 -22.15 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.284 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.3 mm? -69.99 -26.92 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 102.99 11.26 34.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -128.86 170.3 13.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 682' ' ' THR . 29.3 mt -96.43 149.17 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.449 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.462 ' HZ ' HG21 ' A' ' 640' ' ' THR . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' A' ' 668' ' ' ASP . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.907 HG21 ' HA ' ' B' ' 944' ' ' GLU . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.803 ' O ' HG22 ' A' ' 660' ' ' VAL . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.828 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.615 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.423 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.659 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.729 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 649' ' ' ILE . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 704' ' ' SER . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.876 ' HB2' HD11 ' A' ' 678' ' ' LEU . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.9 t30 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.442 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 673' ' ' TRP . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 2.8 p-10 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.936 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.672 ' O ' HD22 ' A' ' 691' ' ' LEU . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.998 HD12 HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.504 ' HD3' HD12 ' A' ' 629' ' ' LEU . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.744 HG21 ' HZ3' ' A' ' 618' ' ' LYS . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.847 ' HG3' HD12 ' A' ' 615' ' ' ILE . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.661 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.421 ' HB3' HD11 ' A' ' 671' ' ' LEU . 80.9 p -141.52 122.49 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.86 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.907 ' HA ' HG21 ' A' ' 650' ' ' THR . 1.9 pt-20 -158.54 177.32 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.538 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -162.45 -43.67 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.508 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 0.998 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.805 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.57 0.224 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.06 171.59 13.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.537 2.158 . . . . 0.0 112.315 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.732 HG21 HG22 ' A' ' 614' ' ' VAL . 2.7 t -111.52 152.14 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.028 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.39 158.28 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.038 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.638 ' CB ' HD12 ' A' ' 610' ' ' LEU . 14.7 m95 -132.2 121.82 24.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 611' ' ' ILE . 3.4 pm0 -109.66 156.18 40.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.9 127.24 22.45 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.679 2.253 . . . . 0.0 112.222 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 16.0 t -60.83 -175.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -80.87 -9.36 59.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.68 -14.26 22.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 78.54 0.15 78.27 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.14 8.26 8.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.798 0.299 . . . . 0.0 111.349 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.76 164.76 26.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.796 0.332 . . . . 0.0 110.84 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.638 HD12 ' CB ' ' A' ' 601' ' ' TRP . 0.5 OUTLIER -120.97 114.45 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.975 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 602' ' ' GLN . 31.9 mm -102.49 141.14 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -132.68 160.0 23.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.567 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.732 HG22 HG21 ' A' ' 599' ' ' VAL . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ILE . . . . . 0.578 HG21 HE21 ' A' ' 698' ' ' GLN . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.777 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.758 ' O ' HD13 ' A' ' 657' ' ' LEU . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER -88.92 -31.1 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -32.41 72.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 75.6 p -94.82 96.93 9.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.404 ' OG1' ' HA ' ' A' ' 626' ' ' SER . 6.3 t -56.92 177.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.501 ' HE1' ' HA3' ' A' ' 627' ' ' GLY . 0.0 OUTLIER -98.81 165.52 14.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.76 -45.63 6.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.119 2.546 . . . . 0.0 113.468 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -53.39 -40.25 64.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 6.0 pt-20 178.02 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.566 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.404 ' HA ' ' OG1' ' A' ' 621' ' ' THR . 3.6 m -94.9 134.26 37.74 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.626 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' GLY . . . . . 0.501 ' HA3' ' HE1' ' A' ' 622' ' ' MET . . . -99.14 177.23 29.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.66 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.667 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -86.79 -63.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.955 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.64 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.941 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.782 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.572 HG22 ' C ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -112.1 90.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.474 ' HA ' HD23 ' A' ' 645' ' ' LEU . 1.3 ttm -58.58 113.42 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.3 p -84.68 178.57 7.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.79 -13.6 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.298 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.9 mm? -78.31 -32.28 49.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.0 16.39 9.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.653 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.14 155.76 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.952 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 682' ' ' THR . 62.8 mt -90.41 150.12 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.555 HG21 ' HA ' ' B' ' 944' ' ' GLU . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.777 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 656' ' ' SER . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.517 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.463 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 649' ' ' ILE . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.567 ' CD ' HD11 ' A' ' 671' ' ' LEU . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.655 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.444 ' HB2' HG12 ' A' ' 702' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.782 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.4 t30 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 673' ' ' TRP . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 689' ' ' ILE . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.101 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' GLN . . . . . 0.578 HE21 HG21 ' A' ' 615' ' ' ILE . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.655 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t -151.84 144.67 24.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.015 0.436 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.572 ' C ' HG22 ' A' ' 635' ' ' VAL . 4.8 mp0 60.72 177.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.767 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -155.68 -58.1 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.101 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.528 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.955 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.705 ' HA ' HG23 ' A' ' 661' ' ' VAL . 41.8 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 597' ' ' HIS . 85.5 Cg_endo -82.88 128.03 5.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.344 2.03 . . . . 0.0 112.322 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.502 HG21 HG22 ' A' ' 614' ' ' VAL . 2.7 t -92.46 151.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -123.19 151.69 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.69 ' HB3' HD12 ' A' ' 610' ' ' LEU . 29.5 m95 -130.01 131.28 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 603' ' ' PRO . 0.0 OUTLIER -123.4 161.55 44.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 603' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 602' ' ' GLN . 80.5 Cg_exo -45.4 125.71 7.66 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.729 2.286 . . . . 0.0 112.569 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.418 ' HA ' HG12 ' A' ' 611' ' ' ILE . 46.6 t -66.33 175.67 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -20.52 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.269 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -88.42 -16.9 31.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 93.38 -43.32 2.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -95.03 14.68 21.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.465 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 604' ' ' SER . 4.0 mpt_? -122.6 158.65 29.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.753 0.311 . . . . 0.0 110.597 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -121.08 116.36 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 604' ' ' SER . 26.4 mm -105.85 146.32 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.75 162.35 25.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.502 HG22 HG21 ' A' ' 599' ' ' VAL . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.796 ' O ' HD13 ' A' ' 657' ' ' LEU . 2.7 m-80 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -101.29 -31.05 11.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.13 12.13 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 621' ' ' THR . 9.6 t -167.16 -177.2 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 0.0 111.539 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 621' ' ' THR . 0.5 OUTLIER 54.08 22.21 3.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.515 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.843 ' CE ' HD11 ' A' ' 657' ' ' LEU . 0.6 OUTLIER -83.93 123.34 75.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.476 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.95 -45.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.475 2.117 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 625' ' ' GLU . 13.9 ptmt -89.47 -55.87 3.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 2.5 pt-20 175.75 -171.52 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.72 0.295 . . . . 0.0 110.712 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.2 p -90.73 77.1 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.843 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -58.64 -76.87 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.753 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -139.7 -75.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.17 -127.68 0.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.57 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.922 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -130.11 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.412 ' HE1' ' O ' ' A' ' 643' ' ' GLY . 0.6 OUTLIER -58.47 109.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.68 HG21 ' OE2' ' A' ' 669' ' ' GLU . 1.9 p -85.5 -178.04 6.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 111.408 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -62.96 -21.25 65.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.457 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 644' ' ' ARG . 3.3 mt -76.12 -49.72 16.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.508 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' O ' ' HE1' ' A' ' 639' ' ' MET . . . 127.19 15.58 2.5 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.003 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 644' ' ' ARG . . . . . 0.419 ' CZ ' HD13 ' A' ' 642' ' ' LEU . 28.2 ptt180 -122.67 155.94 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.678 HD13 ' HA ' ' A' ' 682' ' ' THR . 47.9 mt -89.66 147.06 24.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.664 HD13 HD12 ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 660' ' ' VAL . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.843 HD11 ' CE ' ' A' ' 622' ' ' MET . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.773 ' HA ' HD11 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 656' ' ' SER . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 597' ' ' HIS . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.508 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.456 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.68 ' OE2' HG21 ' A' ' 640' ' ' THR . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.652 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 679' ' ' PRO . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 702' ' ' ILE . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 21.0 t30 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 673' ' ' TRP . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.995 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.678 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.995 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.53 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.023 HD12 HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 699' ' ' VAL . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 693' ' ' SER . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.652 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 671' ' ' LEU . 15.5 p -141.64 108.21 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.9 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.881 0.372 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 635' ' ' VAL . 0.9 OUTLIER -59.01 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.654 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -151.66 -44.16 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.988 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.023 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.512 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.847 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.53 0.205 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.92 171.65 17.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.244 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -101.8 151.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.66 150.99 50.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.198 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.655 ' HB3' HD12 ' A' ' 610' ' ' LEU . 56.7 m95 -129.32 123.05 30.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' GLN . . . . . 0.542 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -118.9 159.65 43.78 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.022 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.6 123.48 13.94 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.668 2.245 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -60.76 178.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -9.11 58.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.443 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.34 -24.29 14.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.956 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 86.34 11.41 72.21 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.803 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -128.52 -4.68 5.34 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.76 157.07 42.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.915 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 601' ' ' TRP . 1.2 mm? -114.56 114.43 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 24.0 mm -96.34 141.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.767 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.88 162.58 25.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.601 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.731 HG22 HG21 ' A' ' 599' ' ' VAL . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.851 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.517 ' O ' HD13 ' A' ' 657' ' ' LEU . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 630' ' ' LEU . 1.5 ptpt -100.79 -35.28 9.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 697' ' ' PRO . 0.0 OUTLIER -75.21 -5.03 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.7 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 32.6 p -93.78 20.11 7.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.585 0.231 . . . . 0.0 111.285 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m 61.0 153.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 657' ' ' LEU . 2.2 mpp? -102.01 160.04 27.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 -36.67 93.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.501 2.134 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -26.28 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 68.49 158.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 71.09 9.37 6.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.501 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -60.11 -86.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.314 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.904 ' O ' HD13 ' A' ' 629' ' ' LEU . . . -168.8 -74.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.904 HD13 ' O ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -135.53 -77.74 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.755 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.425 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.757 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -119.81 92.97 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.523 ' N ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.31 110.22 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 43.8 p -80.55 -177.81 6.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.38 -13.48 61.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.346 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.551 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.9 mm? -79.19 -33.69 43.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.44 18.65 6.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.753 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -129.48 158.29 39.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.856 HD13 ' HA ' ' A' ' 682' ' ' THR . 80.9 mt -93.2 152.43 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.601 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 668' ' ' ASP . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' THR . . . . . 0.827 HG21 ' HA ' ' B' ' 944' ' ' GLU . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.84 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.851 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 656' ' ' SER . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.587 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.657 ' HA ' HG21 ' A' ' 652' ' ' VAL . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.532 ' CD ' HD11 ' A' ' 671' ' ' LEU . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.666 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.418 ' HB2' HG12 ' A' ' 702' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 19.2 t30 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 670' ' ' VAL . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.987 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.856 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.61 ' HG2' HG23 ' A' ' 682' ' ' THR . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.987 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.127 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 619' ' ' ARG . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 698' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.666 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p -151.64 122.42 7.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.884 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.841 0.353 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 944' ' ' GLU . . . . . 0.827 ' HA ' HG21 ' A' ' 650' ' ' THR . 0.3 OUTLIER -150.64 175.12 12.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.77 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.755 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -138.28 -59.36 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.126 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.127 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.477 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.843 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' HIS . . . . . 0.833 ' HA ' HG23 ' A' ' 661' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 92.3 Cg_endo -83.46 129.07 4.94 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.62 2.213 . . . . 0.0 112.548 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.03 151.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.52 150.3 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' TRP . . . . . 0.604 ' HZ3' HG23 ' A' ' 703' ' ' VAL . 62.7 m95 -133.61 141.23 47.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.86 118.45 30.5 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 140.72 24.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.47 2.114 . . . . 0.0 112.155 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 604' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 609' ' ' ARG . 0.1 OUTLIER -91.22 161.92 14.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.022 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -9.19 58.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.376 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.56 -13.94 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.458 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 94.76 -42.37 2.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.961 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.2 62.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.685 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 604' ' ' SER . 1.0 OUTLIER -146.83 122.17 10.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.788 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 610' ' ' LEU . . . . . 0.67 ' C ' HD13 ' A' ' 611' ' ' ILE . 0.4 OUTLIER -132.17 114.37 14.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 611' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 610' ' ' LEU . 2.1 mm -114.09 133.63 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.353 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -138.03 161.89 25.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.534 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.698 HG13 ' HA2' ' A' ' 662' ' ' GLY . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 616' ' ' LEU . . . . . 0.826 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ASN . . . . . 0.845 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LYS . . . . . 0.65 ' HG2' HD23 ' A' ' 630' ' ' LEU . 1.5 mtpp -97.98 -33.29 11.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 619' ' ' ARG . . . . . 0.875 ' HD2' HG23 ' A' ' 620' ' ' THR . 0.0 OUTLIER -67.59 -15.06 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.457 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 620' ' ' THR . . . . . 0.875 HG23 ' HD2' ' A' ' 619' ' ' ARG . 3.2 p -104.97 121.58 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.808 0.337 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.8 t -61.5 170.26 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' MET . . . . . 0.44 ' HG3' ' HG ' ' A' ' 657' ' ' LEU . 0.8 OUTLIER -99.12 161.51 24.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.292 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.06 -13.8 39.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.853 2.369 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 625' ' ' GLU . 0.0 OUTLIER -98.64 -42.24 7.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.001 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.421 ' N ' ' HD3' ' A' ' 624' ' ' LYS . 7.3 pt-20 175.62 -179.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.84 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 47.9 m -66.7 131.65 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -100.66 -173.39 29.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.522 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.643 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -92.59 -60.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.56 -77.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 630' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.54 91.11 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' MET . . . . . 0.623 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.8 OUTLIER -58.55 113.6 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.0 p -82.23 176.94 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -73.34 -11.17 60.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.303 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.7 mm? -80.45 -28.4 37.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 110.08 23.08 6.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.01 151.47 49.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.2 mt -86.54 148.63 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ALA . . . . . 0.474 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' ILE . . . . . 0.578 HD13 HD12 ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' LYS . . . . . 0.619 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' SER . . . . . 0.776 ' O ' HG22 ' A' ' 660' ' ' VAL . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 657' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.826 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 660' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 661' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 597' ' ' HIS . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' GLY . . . . . 0.698 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' ASP . . . . . 0.491 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.696 HG22 ' CG1' ' A' ' 703' ' ' VAL . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 676' ' ' LYS . . . . . 0.517 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.72 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.509 ' CG ' HG23 ' A' ' 682' ' ' THR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 685' ' ' GLU . . . . . 0.922 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.446 HG12 HD11 ' B' ' 946' ' ' ILE . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 687' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' ILE . . . . . 0.517 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.0 HD12 HD12 ' B' ' 946' ' ' ILE . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 701' ' ' ILE . . . . . 0.594 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.696 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m -151.2 128.35 11.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.79 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -100.03 178.63 4.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 945' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -134.56 -53.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.674 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 946' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 690' ' ' ILE . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 947' ' ' TRP . . . . . 0.464 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 948' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.754 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.614 -0.194 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.73 HG13 ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.825 ' O ' HD13 ' A' ' 657' ' ' LEU . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.714 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.932 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.204 0.05 . . . . 0.0 110.933 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.825 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 668' ' ' ASP . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.738 ' O ' HG22 ' A' ' 660' ' ' VAL . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.73 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.439 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.707 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 649' ' ' ILE . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 702' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.825 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 673' ' ' TRP . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.436 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.74 ' HG2' HG23 ' A' ' 682' ' ' THR . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.904 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.097 HD12 HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.412 ' NZ ' HG22 ' B' ' 946' ' ' ILE . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.452 ' OE2' HD11 ' A' ' 702' ' ' ILE . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.771 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.097 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.537 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.932 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.579 HG13 ' HA2' ' A' ' 662' ' ' GLY . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.708 ' O ' HD13 ' A' ' 657' ' ' LEU . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.525 ' HD2' HD22 ' A' ' 630' ' ' LEU . 13.7 ptmm? . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.962 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 119.87 -0.109 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.919 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.814 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . 0.432 ' CE ' HG11 ' A' ' 635' ' ' VAL . 10.0 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.8 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.86 0.362 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.472 HG12 HD23 ' A' ' 632' ' ' LEU . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 660' ' ' VAL . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.744 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.485 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.736 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.655 ' HA ' HG21 ' A' ' 652' ' ' VAL . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 704' ' ' SER . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.814 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.435 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.435 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 673' ' ' TRP . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.648 HG23 ' CG ' ' A' ' 684' ' ' GLU . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.648 ' CG ' HG23 ' A' ' 682' ' ' THR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.729 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.931 HD12 HD12 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 618' ' ' LYS . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.931 HD12 HD12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.518 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.962 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.479 HG13 ' HA2' ' A' ' 662' ' ' GLY . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.454 HD13 ' HG3' ' A' ' 700' ' ' GLU . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 701' ' ' ILE . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 657' ' ' LEU . 12.0 m-80 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.856 ' HG2' HD22 ' A' ' 630' ' ' LEU . 2.6 mtpp . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.926 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.856 HD22 ' HG2' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.548 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.882 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.813 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 682' ' ' THR . 65.9 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.828 0.346 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.627 HD13 HD12 ' A' ' 632' ' ' LEU . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 660' ' ' VAL . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.754 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.702 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.498 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.703 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.629 ' HA ' HG21 ' A' ' 652' ' ' VAL . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.625 ' OE1' HD11 ' A' ' 671' ' ' LEU . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.653 HG22 ' CG1' ' A' ' 703' ' ' VAL . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.633 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.435 ' HB2' HG12 ' A' ' 702' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.816 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.418 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 673' ' ' TRP . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.902 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.714 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.521 ' CG ' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.902 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.625 ' HA ' HD13 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.47 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.66 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.995 HD12 HD12 ' B' ' 946' ' ' ILE . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 699' ' ' VAL . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 693' ' ' SER . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 615' ' ' ILE . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.653 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.633 ' OG ' HD21 ' A' ' 671' ' ' LEU . 37.2 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.995 HD12 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.497 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.926 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.416 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.665 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.407 HG21 ' NE2' ' A' ' 698' ' ' GLN . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 630' ' ' LEU . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.777 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.3 t30 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.444 ' HE2' HD23 ' A' ' 630' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.441 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.791 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.799 HG23 ' N ' ' B' ' 945' ' ' GLY . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 682' ' ' THR . 22.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 668' ' ' ASP . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.784 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.811 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.665 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.473 ' N ' HD13 ' A' ' 664' ' ' LEU . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.71 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.662 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.707 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.791 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.46 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.686 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 687' ' ' TYR . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.913 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.485 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 685' ' ' GLU . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.561 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 615' ' ' ILE . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.475 ' HB3' HD21 ' A' ' 671' ' ' LEU . 14.9 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.799 ' N ' HG23 ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.561 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.449 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.931 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.628 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.56 HG13 ' HA2' ' A' ' 662' ' ' GLY . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.85 HD21 ' N ' ' A' ' 658' ' ' ALA . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.551 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.853 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.449 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.805 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 682' ' ' THR . 31.1 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.723 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.85 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.448 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.64 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.872 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.423 ' HB2' HG12 ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.848 ' HB2' HD11 ' A' ' 678' ' ' LEU . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.498 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 673' ' ' TRP . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.706 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.959 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 678' ' ' LEU . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.545 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.966 HD12 HD12 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . 0.487 ' OG ' HG22 ' A' ' 699' ' ' VAL . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.487 HG22 ' OG ' ' A' ' 693' ' ' SER . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.872 ' OG ' HD21 ' A' ' 671' ' ' LEU . 22.1 p . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.966 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.505 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.853 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 120.906 0.17 . . . . 0.0 113.096 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.682 ' HA ' HD12 ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.626 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.606 HG21 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.759 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.786 ' O ' HD13 ' A' ' 657' ' ' LEU . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 694' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.934 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.866 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.718 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 682' ' ' THR . 89.7 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.819 0.343 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.636 HD13 HD12 ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.836 ' O ' HG22 ' A' ' 660' ' ' VAL . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.759 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.645 ' HA ' HG21 ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.66 HG22 ' CG1' ' A' ' 703' ' ' VAL . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.586 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.903 ' HB2' HD11 ' A' ' 678' ' ' LEU . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.903 HD11 ' HB2' ' A' ' 673' ' ' TRP . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.743 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.057 HD12 HD12 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 618' ' ' LYS . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . 0.606 ' NE2' HG21 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.057 HD12 HD12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.527 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.934 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.808 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.432 ' HB ' HG13 ' A' ' 701' ' ' ILE . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 614' ' ' VAL . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.725 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.679 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 682' ' ' THR . 20.9 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.775 0.321 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 668' ' ' ASP . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . 0.423 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 656' ' ' SER . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 630' ' ' LEU . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 631' ' ' GLY . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 656' ' ' SER . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.492 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.405 ' N ' HD13 ' A' ' 664' ' ' LEU . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.645 HG22 ' CG1' ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HB2' HD11 ' A' ' 678' ' ' LEU . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.414 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.926 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.676 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.63 ' HG2' HG23 ' A' ' 682' ' ' THR . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.926 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.927 HD12 HD12 ' B' ' 946' ' ' ILE . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 673' ' ' TRP . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.808 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.835 -0.106 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.927 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.798 0.11 . . . . 0.0 112.965 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.618 HG13 ' HA2' ' A' ' 662' ' ' GLY . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.47 HD11 ' HD3' ' A' ' 613' ' ' ARG . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 630' ' ' LEU . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 630' ' ' LEU . 6.9 ptmt . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.893 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.707 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.2 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.791 0.329 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.603 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 668' ' ' ASP . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . 0.453 ' CG2' HG23 ' A' ' 635' ' ' VAL . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.788 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.816 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.813 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.816 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.452 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.728 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.689 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.591 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.927 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 673' ' ' TRP . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.919 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.754 ' HA ' HD13 ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.919 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.575 ' O ' HD22 ' A' ' 691' ' ' LEU . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.738 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 615' ' ' ILE . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.669 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 671' ' ' LEU . 10.6 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.451 -0.083 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.738 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 662' ' ' GLY . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.798 HD21 ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.803 ' O ' HD13 ' A' ' 657' ' ' LEU . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.796 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.836 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 682' ' ' THR . 27.0 mt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.805 0.336 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 668' ' ' ASP . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.82 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.798 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.493 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.596 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.88 ' HB2' HD11 ' A' ' 678' ' ' LEU . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.828 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 673' ' ' TRP . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.708 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.943 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.58 HG12 HD11 ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.681 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.828 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.906 HD12 ' CD1' ' B' ' 946' ' ' ILE . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.906 ' CD1' HD12 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.467 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.693 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.716 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.867 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 657' ' ' LEU . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.944 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.573 0.225 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.483 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.721 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 682' ' ' THR . 24.2 mt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.851 0.358 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 633' ' ' LYS . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 660' ' ' VAL . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.833 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.867 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.716 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.486 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.746 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 678' ' ' LEU . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.616 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.721 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.429 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.92 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.826 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.92 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.884 ' HA ' HD13 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.873 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.666 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.825 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 65.4 m . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 113.906 0.322 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.873 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.483 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.944 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.759 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.617 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.748 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 110.827 -0.064 . . . . 0.0 110.827 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.825 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.518 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.937 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.772 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 645' ' ' LEU . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.6 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.769 0.319 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.669 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 660' ' ' VAL . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.748 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.427 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.656 ' HA ' HG21 ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.672 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.603 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.939 ' HB2' HD11 ' A' ' 678' ' ' LEU . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.438 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.939 HD11 ' HB2' ' A' ' 673' ' ' TRP . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.806 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.856 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.856 ' HG2' HG23 ' A' ' 682' ' ' THR . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.927 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.504 HG12 ' CG1' ' A' ' 690' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 673' ' ' TRP . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 699' ' ' VAL . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 693' ' ' SER . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.672 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.551 ' OG ' HD21 ' A' ' 671' ' ' LEU . 52.9 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.572 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.508 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.909 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.799 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.678 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.88 HG13 ' HA2' ' A' ' 662' ' ' GLY . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.971 HD21 ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.799 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.513 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.884 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.52 0.2 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.947 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.47 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.771 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.443 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.781 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 682' ' ' THR . 41.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.685 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 660' ' ' VAL . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.971 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.88 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.487 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.678 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 649' ' ' ILE . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 678' ' ' LEU . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 704' ' ' SER . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.781 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 670' ' ' VAL . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.897 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.897 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.902 HD12 HD12 ' B' ' 946' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 671' ' ' LEU . 22.3 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.902 HD12 HD12 ' A' ' 690' ' ' ILE . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.884 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.873 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.401 0 N-CA-C 112.734 -0.146 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.704 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 630' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.78 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.787 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 618' ' ' LYS . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.426 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.82 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.674 HD13 ' HA ' ' A' ' 682' ' ' THR . 68.4 mt . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.746 0.308 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.638 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 660' ' ' VAL . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.735 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 656' ' ' SER . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.49 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.649 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.665 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.453 ' HB2' HG12 ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.82 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 673' ' ' TRP . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.889 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.674 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.654 ' CG ' HG23 ' A' ' 682' ' ' THR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.889 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.642 HG12 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.738 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.952 ' CD1' HD12 ' B' ' 946' ' ' ILE . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.665 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.952 HD12 ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.787 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.768 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.624 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 662' ' ' GLY . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.871 HD13 HD12 ' A' ' 630' ' ' LEU . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 657' ' ' LEU . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.497 ' HE2' HD23 ' A' ' 630' ' ' LEU . 2.5 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.871 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.74 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.8 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.728 0.299 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 668' ' ' ASP . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.781 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.798 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 656' ' ' SER . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.456 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.719 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.74 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.423 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.421 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 673' ' ' TRP . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.879 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.849 ' HG3' HG23 ' A' ' 682' ' ' THR . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.703 ' O ' HD22 ' A' ' 691' ' ' LEU . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.962 HD12 HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.68 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 671' ' ' LEU . 83.5 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 113.487 0.155 . . . . 0.0 113.487 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.962 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.497 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.821 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.822 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.564 HG13 ' HA2' ' A' ' 662' ' ' GLY . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.86 HD21 ' N ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.841 ' O ' HD13 ' A' ' 657' ' ' LEU . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.438 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.871 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.462 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 645' ' ' LEU . 22.2 mmtt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.781 HD13 ' HA ' ' A' ' 682' ' ' THR . 13.5 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.765 0.317 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.487 HG12 HD23 ' A' ' 632' ' ' LEU . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 660' ' ' VAL . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.871 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.441 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.669 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.461 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 704' ' ' SER . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.454 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 670' ' ' VAL . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.781 ' HA ' HD13 ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.73 ' HG2' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.903 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.556 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.02 HD12 HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 691' ' ' LEU . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.637 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.629 ' HB3' HD21 ' A' ' 671' ' ' LEU . 4.5 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.616 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.02 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.575 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.856 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.396 -0.281 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.615 HG13 ' HA2' ' A' ' 662' ' ' GLY . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 700' ' ' GLU . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.915 HD13 HD12 ' A' ' 630' ' ' LEU . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.818 ' O ' HD13 ' A' ' 657' ' ' LEU . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.744 ' HZ3' HG21 ' A' ' 699' ' ' VAL . 1.6 mttp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.801 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.464 0.173 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.915 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.507 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.728 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 682' ' ' THR . 29.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.379 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.449 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 638' ' ' LYS . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' A' ' 668' ' ' ASP . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . 0.447 ' CG2' HG23 ' A' ' 635' ' ' VAL . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.803 ' O ' HG22 ' A' ' 660' ' ' VAL . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.828 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.615 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.423 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.659 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.729 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 649' ' ' ILE . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 704' ' ' SER . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.876 ' HB2' HD11 ' A' ' 678' ' ' LEU . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . 0.593 HD22 HG22 ' A' ' 699' ' ' VAL . 5.2 t-20 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.442 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 673' ' ' TRP . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.7 p30 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.936 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.672 ' O ' HD22 ' A' ' 691' ' ' LEU . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.998 HD12 HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.504 ' HD3' HD12 ' A' ' 629' ' ' LEU . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.744 HG21 ' HZ3' ' A' ' 618' ' ' LYS . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.847 ' HG3' HD12 ' A' ' 615' ' ' ILE . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.661 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.421 ' HB3' HD11 ' A' ' 671' ' ' LEU . 80.9 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.538 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.457 0 CA-C-O 120.214 -0.215 . . . . 0.0 113.508 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 0.998 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.805 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.517 HG13 ' HA2' ' A' ' 662' ' ' GLY . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . 0.578 HG21 HE21 ' A' ' 698' ' ' GLN . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.777 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.758 ' O ' HD13 ' A' ' 657' ' ' LEU . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.955 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.247 0.07 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.941 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.782 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.488 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 682' ' ' THR . 62.8 mt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.795 0.331 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . 0.409 ' CG2' HG23 ' A' ' 635' ' ' VAL . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.777 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 656' ' ' SER . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.517 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.463 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 649' ' ' ILE . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.567 ' CD ' HD11 ' A' ' 671' ' ' LEU . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.655 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.444 ' HB2' HG12 ' A' ' 702' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.782 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 673' ' ' TRP . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 689' ' ' ILE . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.101 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . 0.578 HE21 HG21 ' A' ' 615' ' ' ILE . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.655 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.767 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.452 -0.082 . . . . 0.0 113.089 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.101 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.528 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.955 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.41 ' CG1' ' HA2' ' A' ' 662' ' ' GLY . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.796 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.8 m120 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.922 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.5 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.678 HD13 ' HA ' ' A' ' 682' ' ' THR . 47.9 mt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.871 0.367 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.664 HD13 HD12 ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 660' ' ' VAL . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.773 ' HA ' HD11 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 656' ' ' SER . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.508 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.456 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.412 ' HB2' ' CE1' ' A' ' 648' ' ' PHE . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.652 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 679' ' ' PRO . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 702' ' ' ILE . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 673' ' ' TRP . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.995 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.678 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.995 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.53 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.023 HD12 HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 699' ' ' VAL . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 693' ' ' SER . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.652 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 671' ' ' LEU . 15.5 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.654 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.023 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.512 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.847 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.767 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.601 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.587 HG13 ' HA2' ' A' ' 662' ' ' GLY . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.851 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.517 ' O ' HD13 ' A' ' 657' ' ' LEU . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 630' ' ' LEU . 1.5 ptpt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.843 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.651 0.262 . . . . 0.0 110.755 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.425 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.757 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.856 HD13 ' HA ' ' A' ' 682' ' ' THR . 80.9 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.834 0.349 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.601 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 668' ' ' ASP . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.84 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.851 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 656' ' ' SER . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.587 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.657 ' HA ' HG21 ' A' ' 652' ' ' VAL . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . 0.532 ' CD ' HD11 ' A' ' 671' ' ' LEU . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.666 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.418 ' HB2' HG12 ' A' ' 702' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 670' ' ' VAL . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.987 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.856 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.61 ' HG2' HG23 ' A' ' 682' ' ' THR . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.987 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.127 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.666 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.755 ' C ' HD13 ' B' ' 946' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 120.552 -0.027 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.127 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.477 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.843 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 702' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.464 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.698 HG13 ' HA2' ' A' ' 662' ' ' GLY . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' LEU . . . . . 0.826 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ASN . . . . . 0.845 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LYS . . . . . 0.65 ' HG2' HD23 ' A' ' 630' ' ' LEU . 1.5 mtpp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 110.779 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' ALA . . . . . 0.474 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' ILE . . . . . 0.578 HD13 HD12 ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . 0.619 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' SER . . . . . 0.776 ' O ' HG22 ' A' ' 660' ' ' VAL . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' ALA . . . . . 0.826 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' GLY . . . . . 0.698 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' ASP . . . . . 0.491 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' VAL . . . . . 0.696 HG22 ' CG1' ' A' ' 703' ' ' VAL . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' LYS . . . . . 0.517 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' THR . . . . . 0.72 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' GLU . . . . . 0.509 ' CG ' HG23 ' A' ' 682' ' ' THR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' GLU . . . . . 0.922 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.446 HG12 HD11 ' B' ' 946' ' ' ILE . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' ILE . . . . . 0.517 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.0 HD12 HD12 ' B' ' 946' ' ' ILE . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' ILE . . . . . 0.594 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.696 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 945' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 946' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 690' ' ' ILE . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 947' ' ' TRP . . . . . 0.464 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 948' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.579 0.228 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.28 171.61 13.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.445 2.097 . . . . 0.0 112.26 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.021 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -123.44 155.35 37.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.662 ' HB3' HD12 ' A' ' 610' ' ' LEU . 56.2 m95 -126.3 119.28 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.483 ' C ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -111.23 156.4 41.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.801 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 134.14 42.59 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.836 2.357 . . . . 0.0 112.338 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 31.0 t -64.87 -175.48 0.2 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 7.8 ttpp -79.61 -11.53 59.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.92 -9.06 21.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.647 0.261 . . . . 0.0 111.375 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 73.26 5.4 66.48 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.039 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -121.09 7.62 10.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.808 0.304 . . . . 0.0 111.332 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.44 167.64 21.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.842 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.8 OUTLIER -121.24 114.51 21.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.653 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.698 HD12 ' OG ' ' A' ' 704' ' ' SER . 17.4 mm -109.58 107.25 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.34 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.754 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -96.86 162.95 22.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.614 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.646 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.2 OUTLIER -108.95 123.36 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.73 HG13 ' HA2' ' A' ' 662' ' ' GLY . 61.0 t -113.0 124.61 69.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.388 . . . . 0.0 111.593 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 9.2 mm -109.57 120.16 60.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.269 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.16 146.73 45.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.825 ' O ' HD13 ' A' ' 657' ' ' LEU . 4.4 m120 -122.82 127.09 48.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.752 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.714 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.0 OUTLIER -83.85 55.33 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 111.053 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -22.05 42.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.062 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 13.9 p 55.44 68.09 0.92 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.4 t -163.54 31.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.518 ' HB2' ' HD2' ' A' ' 623' ' ' PRO . 1.0 OUTLIER -60.87 159.47 26.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.827 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 622' ' ' MET . 8.5 Cg_endo -50.09 -24.82 11.67 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.794 2.33 . . . . 0.0 112.183 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -65.6 -58.24 6.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.16 -92.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.979 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 3.0 m -128.41 -30.9 2.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.698 0.285 . . . . 0.0 111.032 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . 0.428 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 76.41 -126.78 8.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.603 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -169.12 -56.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.809 0.337 . . . . 0.0 111.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.932 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.05 -89.77 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -127.17 -43.38 1.65 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.335 -0.228 . . . . 0.0 111.209 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 153.73 7.62 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 C-N-CA 119.696 -1.24 . . . . 0.0 115.108 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.819 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.48 147.3 15.65 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.215 1.008 . . . . 0.0 111.936 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 0.2 OUTLIER -96.45 131.75 42.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.825 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.7 t -117.14 154.21 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.305 0.574 . . . . 0.0 111.904 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.483 HG22 ' C ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -116.17 161.69 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.426 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -138.64 152.39 22.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.579 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.02 35.01 28.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -91.85 85.53 5.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.334 . . . . 0.0 110.841 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.593 ' HA ' HD23 ' A' ' 645' ' ' LEU . 46.5 tpp -58.47 114.7 2.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 81.4 p -86.77 -176.11 5.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.01 -8.47 57.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.386 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.6 mm? -82.46 -34.26 28.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.834 0.35 . . . . 0.0 110.949 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.41 17.9 6.9 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.7 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -130.29 153.91 48.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.3 mt -94.54 154.52 17.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.05 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.61 -162.8 11.44 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.537 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -124.9 141.62 52.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 80.7 m-85 -134.35 141.62 46.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 668' ' ' ASP . 24.1 mt -78.92 118.04 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -33.2 59.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.334 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 11.2 ptmm? -166.74 159.85 14.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.076 0.465 . . . . 0.0 111.727 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -133.84 126.24 50.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.94 106.34 9.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.404 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -54.89 108.21 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.185 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.58 -24.67 7.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.228 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.738 ' O ' HG22 ' A' ' 660' ' ' VAL . 45.9 m -66.8 171.7 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.716 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.8 mt -55.54 -52.7 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -49.52 -28.91 6.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.64 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.92 -48.91 8.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.662 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.16 -46.85 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.802 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.8 p -94.5 -29.24 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.73 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -85.25 -56.71 2.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.146 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.439 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 69.33 59.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.707 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.9 174.98 9.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' A' ' 652' ' ' VAL . 49.4 mtm-85 -137.82 158.54 44.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.981 0.42 . . . . 0.0 111.279 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.29 122.68 11.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.761 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.14 -22.49 6.31 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.554 ' HB2' HD12 ' A' ' 649' ' ' ILE . 12.7 m-20 -64.74 144.15 57.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.734 0.302 . . . . 0.0 110.348 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 39.1 tt0 -101.61 114.39 28.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -94.2 102.53 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.511 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.6 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -83.03 0.2 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.297 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' HG12 ' A' ' 702' ' ' ILE . 3.1 mt-10 -144.24 127.15 16.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.794 0.331 . . . . 0.0 111.495 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.825 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.3 t-105 -130.94 115.5 16.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.361 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 63.02 38.74 10.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.921 0.391 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.13 14.81 66.64 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.272 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.01 145.7 31.97 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 117.024 0.412 . . . . 0.0 110.775 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -81.63 118.89 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.39 1.393 . . . . 0.0 110.925 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.771 HD11 ' HB2' ' A' ' 673' ' ' TRP . 21.8 mt -90.1 -36.1 0.4 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.406 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.3 Cg_exo -41.27 112.88 0.22 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.263 1.975 . . . . 0.0 112.659 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.21 -13.63 31.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.495 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -93.23 138.81 31.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.902 0.382 . . . . 0.0 111.097 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.7 t -88.57 -177.6 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.436 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.1 p-10 -48.79 -47.53 42.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.56 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.74 ' HG2' HG23 ' A' ' 682' ' ' THR . 11.4 pt-20 -64.95 -33.35 75.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.327 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.904 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 14.2 mm-40 -64.75 -61.08 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 70.8 t -48.81 -40.93 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.615 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.554 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.6 m-85 -48.64 -51.49 27.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.812 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -64.69 -43.68 92.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.005 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -57.76 -63.47 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.097 HD12 HG13 ' B' ' 946' ' ' ILE . 5.0 mt -57.44 -56.62 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.532 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -45.95 -50.06 15.12 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.085 0.469 . . . . 0.0 111.037 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.27 -29.42 67.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.676 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 2.5 m -91.5 -14.11 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.321 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.412 ' NZ ' HG22 ' B' ' 946' ' ' ILE . 2.7 mtmm -65.02 -19.7 66.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 111.069 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.5 t -86.37 -25.35 25.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.51 143.39 90.17 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 -4.27 14.91 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.551 2.168 . . . . 0.0 112.702 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -145.95 149.74 34.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.868 0.366 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 77.0 t -142.05 151.9 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.221 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.452 ' OE2' HD11 ' A' ' 702' ' ' ILE . 1.3 tt0 -128.5 107.63 9.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.104 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.64 138.9 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 111.578 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.3 mm -118.21 147.74 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.42 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -132.08 178.75 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.783 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.698 ' OG ' HD12 ' A' ' 611' ' ' ILE . 46.2 m -141.56 111.55 6.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.752 0.311 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.483 ' C ' HG22 ' A' ' 635' ' ' VAL . 1.7 pm0 -129.87 177.19 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.771 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -147.77 -65.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.692 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.097 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -140.64 150.99 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.537 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -90.46 123.07 33.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.16 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.932 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.385 -0.816 . . . . 0.0 110.435 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.739 0.305 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.59 171.54 6.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.603 2.202 . . . . 0.0 112.384 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 614' ' ' VAL . 2.9 t -96.86 152.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.039 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -126.74 155.23 43.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.037 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.462 ' HZ3' HG23 ' A' ' 703' ' ' VAL . 13.0 m95 -129.11 128.09 42.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.967 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 610' ' ' LEU . 9.6 pt20 -118.53 160.13 41.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 602' ' ' GLN . 80.7 Cg_exo -44.88 124.56 5.84 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.258 . . . . 0.0 112.505 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.441 ' CB ' HG12 ' A' ' 611' ' ' ILE . 48.2 t -68.64 158.56 33.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.222 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -21.05 66.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.909 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.05 -27.53 57.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 99.13 -31.83 7.81 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.959 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -113.34 23.02 13.65 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.01 167.65 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.102 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.49 ' O ' HD13 ' A' ' 611' ' ' ILE . 1.8 mm? -122.11 129.47 52.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.727 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.552 HD12 ' OG ' ' A' ' 704' ' ' SER . 12.3 mm -119.97 104.67 15.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -93.96 162.68 25.25 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.416 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 702' ' ' ILE . 7.7 ptt180 -111.88 121.06 44.02 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 599' ' ' VAL . 47.5 t -114.36 129.17 70.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.057 0.456 . . . . 0.0 111.753 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.4 mm -113.63 120.28 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.261 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.9 mt -118.58 151.17 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 111.276 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.708 ' O ' HD13 ' A' ' 657' ' ' LEU . 2.7 m120 -126.0 121.72 33.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.084 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.525 ' HD2' HD22 ' A' ' 630' ' ' LEU . 13.7 ptmm? -117.04 37.55 3.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.448 ' HD2' ' HB ' ' A' ' 620' ' ' THR . 0.0 OUTLIER -97.73 -32.25 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.237 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 619' ' ' ARG . 3.3 t -114.71 155.37 26.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.027 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 622' ' ' MET . 0.2 OUTLIER -65.32 179.98 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.5 ' H ' HG22 ' A' ' 621' ' ' THR . 0.0 OUTLIER -104.65 155.03 38.05 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.046 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.24 -28.0 5.03 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.011 2.474 . . . . 0.0 112.311 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.8 -37.71 74.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.186 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.76 -80.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 16.8 m -115.67 173.19 6.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -133.07 121.19 2.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.439 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.723 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -97.1 -80.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.636 0.255 . . . . 0.0 111.242 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.962 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.88 -95.11 0.49 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.938 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.919 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -121.62 -46.18 2.26 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.981 0.355 . . . . 0.0 110.754 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 155.16 6.74 0.08 OUTLIER Glycine 0 CA--C 1.526 0.739 0 C-N-CA 119.829 -1.177 . . . . 0.0 114.87 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -156.64 149.3 23.63 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.24 1.02 . . . . 0.0 112.036 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD3' ' CE3' ' B' ' 947' ' ' TRP . 4.0 ttpt -95.58 135.23 37.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.814 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -123.31 152.94 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.465 0.65 . . . . 0.0 112.423 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.28 125.34 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.975 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.94 164.74 13.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 81.1 32.07 33.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.541 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . 0.432 ' CE ' HG11 ' A' ' 635' ' ' VAL . 10.0 mmtt -100.17 91.45 4.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.557 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.47 113.94 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.2 p -93.63 -177.37 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.07 -11.74 60.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -72.1 -26.14 62.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.728 0.299 . . . . 0.0 110.943 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 105.55 11.14 29.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.791 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -136.37 168.4 19.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.8 mt -94.4 157.31 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.944 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.74 -161.58 10.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.563 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.85 138.92 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.523 0.202 . . . . 0.0 111.22 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 46.4 m-85 -127.56 134.12 49.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.675 0.274 . . . . 0.0 110.793 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.472 HG12 HD23 ' A' ' 632' ' ' LEU . 41.7 mt -74.51 115.11 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -31.2 58.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.408 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 15.0 ptmt -171.2 158.02 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.067 0.461 . . . . 0.0 111.821 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.31 135.42 63.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.753 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -85.17 106.38 16.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.692 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -57.7 103.94 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.21 -25.71 5.41 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.237 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.844 ' O ' HG22 ' A' ' 660' ' ' VAL . 8.0 t -69.57 175.01 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -59.24 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.217 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.744 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.32 -28.64 3.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.673 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.28 -51.5 5.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.797 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -71.68 -46.21 63.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.1 p -98.58 -31.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -76.96 -59.1 3.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.354 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.485 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 72.87 61.77 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.736 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -141.9 173.06 11.86 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.655 ' HA ' HG21 ' A' ' 652' ' ' VAL . 62.9 mtt180 -139.85 160.53 39.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.93 0.395 . . . . 0.0 111.388 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.84 125.54 21.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.24 -21.35 6.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.063 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.45 146.32 54.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.717 0.294 . . . . 0.0 110.578 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 648' ' ' PHE . 51.7 tt0 -104.32 109.15 20.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.182 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.642 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.4 t -90.07 110.84 22.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.736 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 704' ' ' SER . 0.0 OUTLIER -93.83 1.14 56.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.804 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.439 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.0 mt-10 -141.72 126.49 18.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.763 0.316 . . . . 0.0 111.338 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.814 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.6 t-105 -130.99 112.29 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.184 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 66.4 38.37 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.901 0.382 . . . . 0.0 110.609 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.94 15.28 71.53 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.364 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.435 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -108.86 144.78 30.31 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 110.801 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.435 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.1 Cg_endo -81.03 118.93 3.44 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.353 1.368 . . . . 0.0 110.98 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 673' ' ' TRP . 27.7 mt -88.46 -37.26 0.45 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.365 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 57.4 Cg_exo -39.45 114.62 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.398 2.065 . . . . 0.0 112.747 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.8 -12.34 45.94 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.434 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -96.13 136.58 36.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.648 HG23 ' CG ' ' A' ' 684' ' ' GLU . 2.1 t -87.2 -179.29 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' N ' ' OG1' ' A' ' 682' ' ' THR . 9.9 p30 -50.46 -44.63 55.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.414 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.648 ' CG ' HG23 ' A' ' 682' ' ' THR . 8.0 pt-20 -62.82 -40.73 98.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -61.55 -58.89 6.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.29 -43.21 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.81 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.729 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.1 m-30 -48.33 -43.23 33.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -71.39 -38.29 71.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.506 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -62.79 -65.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.931 HD12 HD12 ' B' ' 946' ' ' ILE . 6.0 mt -51.58 -53.19 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.384 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -51.72 -49.77 61.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.168 0.509 . . . . 0.0 110.897 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.76 -27.99 67.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.684 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 53.9 p -93.81 -11.66 30.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.432 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 618' ' ' LYS . 0.2 OUTLIER -64.82 -22.6 67.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 111.007 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.74 -14.99 35.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.471 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.63 132.16 78.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.739 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.88 -15.81 28.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.42 2.08 . . . . 0.0 112.548 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -143.73 157.43 44.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.933 0.397 . . . . 0.0 111.041 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.56 150.62 24.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -128.86 106.6 9.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.937 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -115.25 137.28 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.141 0.496 . . . . 0.0 111.78 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.4 mm -117.92 147.08 21.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.408 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.642 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.7 m -128.37 177.84 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 111.949 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -135.64 107.44 7.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.768 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.994 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.832 0.348 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -151.77 160.87 43.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -116.19 -62.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.931 HD12 HD12 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -145.76 158.2 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 110.996 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.518 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.5 OUTLIER -90.37 122.6 33.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.57 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.962 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.433 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.707 0.289 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.13 171.69 15.44 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.539 2.159 . . . . 0.0 112.21 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.4 t -99.54 147.78 6.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.026 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.8 151.17 51.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.237 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.701 ' HB3' HD12 ' A' ' 610' ' ' LEU . 44.1 m95 -126.82 118.39 24.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -115.28 159.27 38.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 142.97 22.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.925 2.417 . . . . 0.0 112.262 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 609' ' ' ARG . 7.4 t -80.62 -175.46 5.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 -9.57 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.324 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -101.31 -20.29 15.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 92.87 -43.14 2.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.665 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.01 7.12 22.45 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . 0.406 ' HB3' ' CB ' ' A' ' 604' ' ' SER . 0.0 OUTLIER -125.04 155.83 39.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.772 0.32 . . . . 0.0 110.647 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -118.63 121.63 40.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.015 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.28 146.52 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.996 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.69 160.69 25.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.568 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.695 ' O ' HG22 ' A' ' 599' ' ' VAL . 18.5 ptt180 -113.38 121.28 43.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.479 HG13 ' HA2' ' A' ' 662' ' ' GLY . 38.6 t -118.31 131.83 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 111.982 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.454 HD13 ' HG3' ' A' ' 700' ' ' GLU . 5.4 mm -114.83 124.19 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.979 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 701' ' ' ILE . 7.9 mt -124.76 151.2 45.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.077 0.465 . . . . 0.0 111.654 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 657' ' ' LEU . 12.0 m-80 -118.77 119.91 35.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.152 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.856 ' HG2' HD22 ' A' ' 630' ' ' LEU . 2.6 mtpp -73.83 62.28 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 111.159 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -37.06 85.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 618' ' ' LYS . 7.5 p 57.61 19.09 5.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.067 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 28.4 p -157.89 65.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.009 0.433 . . . . 0.0 110.373 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.444 ' H ' ' HE3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -70.37 133.22 87.35 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.053 -179.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.75 -18.52 41.96 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.405 2.07 . . . . 0.0 112.107 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.42 -32.61 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 -82.06 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.016 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.41 ' O ' ' HE3' ' A' ' 622' ' ' MET . 1.7 m 178.17 -45.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 57.75 165.56 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.493 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.64 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -118.2 -43.5 2.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.167 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.926 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -126.55 -91.32 0.52 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.238 179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.856 HD22 ' HG2' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -119.33 -44.23 2.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.569 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.548 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.55 11.29 0.07 OUTLIER Glycine 0 CA--C 1.525 0.689 0 C-N-CA 119.659 -1.257 . . . . 0.0 115.113 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.882 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.79 151.43 18.3 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.249 1.024 . . . . 0.0 112.069 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -101.46 131.32 47.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.813 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.4 t -121.37 153.37 25.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 112.247 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -113.8 156.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.627 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -125.98 146.52 16.28 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.464 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.63 66.28 1.65 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.544 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -127.22 93.17 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.343 . . . . 0.0 111.004 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.54 104.53 0.22 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.813 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.669 HG21 ' OE2' ' A' ' 669' ' ' GLU . 71.1 p -80.48 180.0 7.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.36 -18.22 65.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.277 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -70.99 -29.76 65.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.825 0.345 . . . . 0.0 110.822 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 108.49 15.4 13.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.657 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -131.72 168.73 17.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 682' ' ' THR . 65.9 mt -93.36 149.61 21.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.84 -159.67 8.81 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.543 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -127.74 143.45 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 0.0 111.252 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -134.14 143.1 47.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.722 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.627 HD13 HD12 ' A' ' 632' ' ' LEU . 28.6 mt -84.49 120.31 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 110.962 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.491 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.1 p -81.22 -30.95 34.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.629 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 19.1 ptmt -168.95 151.01 4.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.0 0.429 . . . . 0.0 111.778 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.82 137.23 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.904 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -84.42 106.36 15.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.687 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -59.74 103.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.029 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.93 -20.54 6.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.901 ' O ' HG22 ' A' ' 660' ' ' VAL . 74.4 m -74.59 173.98 9.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.98 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.754 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.6 OUTLIER -57.32 -53.88 53.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.5 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.702 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.74 -29.81 3.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.877 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -87.66 -51.13 6.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.702 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 656' ' ' SER . 1.1 m -70.12 -45.87 74.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.9 p -98.47 -30.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.87 -53.95 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.341 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.498 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.7 OUTLIER 68.21 66.89 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 111.818 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.703 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 173.01 11.92 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.629 ' HA ' HG21 ' A' ' 652' ' ' VAL . 10.3 mtp85 -140.75 162.39 35.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.76 123.55 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.777 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.81 -23.31 6.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.879 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.65 140.54 58.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.761 0.315 . . . . 0.0 110.5 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.669 ' OE2' HG21 ' A' ' 640' ' ' THR . 20.4 tt0 -99.54 110.97 23.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.653 HG22 ' CG1' ' A' ' 703' ' ' VAL . 48.9 t -93.32 106.12 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.633 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.8 OUTLIER -86.18 3.88 40.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.435 ' HB2' HG12 ' A' ' 702' ' ' ILE . 54.7 mt-10 -150.2 127.67 11.49 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.91 0.386 . . . . 0.0 111.69 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.816 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.8 t-105 -130.81 115.84 17.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.154 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 67.16 37.08 3.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.996 0.426 . . . . 0.0 110.721 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.8 16.56 72.42 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.379 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.418 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.54 151.31 43.77 Favored Pre-proline 0 CA--C 1.519 -0.223 0 CA-C-N 117.168 0.484 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 85.5 Cg_endo -84.81 119.06 2.16 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.667 1.578 . . . . 0.0 111.109 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 673' ' ' TRP . 22.0 mt -89.95 -36.52 0.4 Allowed Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.349 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.48 113.64 0.28 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.266 1.977 . . . . 0.0 112.645 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.58 -14.97 29.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.564 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.902 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.41 141.61 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.807 0.337 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.714 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.5 t -90.53 -175.49 4.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 682' ' ' THR . 11.6 p30 -50.07 -46.95 53.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.493 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.521 ' CG ' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -64.43 -38.85 92.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.068 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.902 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 3.7 mt-10 -62.45 -60.99 2.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.625 ' HA ' HD13 ' A' ' 689' ' ' ILE . 83.8 t -47.06 -42.67 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.891 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.47 ' O ' HD22 ' A' ' 691' ' ' LEU . 21.9 m-30 -49.94 -44.75 50.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.95 -42.06 94.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.66 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.9 mp -59.38 -66.59 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.296 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.995 HD12 HD12 ' B' ' 946' ' ' ILE . 3.8 mt -53.26 -54.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.63 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.3 mp -51.32 -50.4 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.104 0.478 . . . . 0.0 110.969 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -56.74 -25.6 55.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.747 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 699' ' ' VAL . 17.2 t -95.07 -11.03 29.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 0.8 OUTLIER -59.81 -25.9 65.34 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.27 -4.68 51.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.418 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 126.73 70.49 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.801 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.0 -14.81 24.62 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.434 2.089 . . . . 0.0 112.733 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.68 155.4 43.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 111.2 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.619 HG22 ' OG ' ' A' ' 693' ' ' SER . 71.5 t -141.88 151.55 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.186 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 615' ' ' ILE . 31.0 tt0 -129.35 108.15 10.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.079 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.721 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -114.23 137.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.018 0.437 . . . . 0.0 111.698 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.8 mm -116.06 144.74 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.654 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.653 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.5 m -129.76 178.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.046 0.451 . . . . 0.0 111.705 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.633 ' OG ' HD21 ' A' ' 671' ' ' LEU . 37.2 p -142.74 115.87 8.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.76 0.314 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.491 ' HA ' HG21 ' A' ' 650' ' ' THR . 5.2 pt-20 -59.83 -177.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -145.06 -50.87 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.846 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.995 HD12 HD12 ' A' ' 690' ' ' ILE . 1.6 mt -147.31 158.16 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.213 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.497 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -99.71 124.19 44.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.901 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.926 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.541 -0.743 . . . . 0.0 110.43 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 598' ' ' PRO . 45.6 p-80 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.594 0.235 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 597' ' ' HIS . 51.0 Cg_endo -68.58 171.73 12.64 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.614 2.209 . . . . 0.0 112.349 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.9 t -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.28 148.28 43.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.104 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.82 ' HB3' HD12 ' A' ' 610' ' ' LEU . 30.5 m95 -128.99 126.71 40.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.822 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -120.54 162.57 33.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.065 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.57 127.64 26.88 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.721 2.28 . . . . 0.0 112.079 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 21.6 t -60.79 171.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -73.53 -9.35 58.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.77 -19.98 20.54 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.739 0.304 . . . . 0.0 111.111 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 84.35 -2.54 87.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.933 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.08 4.56 7.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.779 0.29 . . . . 0.0 111.397 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -129.22 157.94 40.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -110.24 126.09 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.1 141.73 29.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.74 160.64 25.29 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.558 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.649 ' HA ' HD12 ' A' ' 702' ' ' ILE . 24.0 mtm180 -108.1 118.67 37.36 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.665 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.0 t -114.21 125.55 71.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.84 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.407 HG21 ' NE2' ' A' ' 698' ' ' GLN . 7.4 mm -112.96 122.44 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.098 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 630' ' ' LEU . 6.8 mt -119.15 148.59 42.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.493 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.777 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.3 t30 -121.58 120.16 34.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.574 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.444 ' HE2' HD23 ' A' ' 630' ' ' LEU . 0.1 OUTLIER -116.11 35.97 4.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.958 ' HD2' HG23 ' A' ' 620' ' ' THR . 0.0 OUTLIER -98.99 -26.86 14.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.958 HG23 ' HD2' ' A' ' 619' ' ' ARG . 1.2 p -108.28 -176.77 3.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 60.2 m -96.48 148.95 22.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.833 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.75 153.59 75.6 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.5 -15.37 24.78 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.558 2.172 . . . . 0.0 112.522 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -56.11 -58.4 8.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.779 0.324 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 178.72 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.948 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.6 m -122.42 -175.98 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.792 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -144.22 72.34 0.36 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.597 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.713 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -63.4 -84.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.579 0.228 . . . . 0.0 110.836 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -117.84 -89.58 0.58 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.584 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -125.24 -59.85 1.37 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.48 24.8 0.02 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.688 -1.244 . . . . 0.0 114.605 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.663 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.59 154.45 22.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.222 1.011 . . . . 0.0 111.938 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.441 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -113.96 127.39 55.94 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.791 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.18 157.22 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.471 0.653 . . . . 0.0 112.411 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.799 HG23 ' N ' ' B' ' 945' ' ' GLY . 0.3 OUTLIER -138.52 130.8 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.125 178.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -113.37 177.24 17.93 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.713 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 77.91 32.25 45.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.505 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -108.2 92.57 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 0.0 111.069 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.505 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.38 111.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 20.4 p -82.91 179.01 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.104 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.12 -16.32 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.231 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.1 mm? -74.45 -27.01 60.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.773 0.32 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.61 31.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.796 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -124.05 158.0 33.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 682' ' ' THR . 22.1 mt -90.55 146.16 24.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.74 -165.58 12.3 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.85 139.21 53.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.64 0.257 . . . . 0.0 111.156 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.88 140.76 51.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.819 0.342 . . . . 0.0 110.83 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 668' ' ' ASP . 51.3 mt -76.14 121.36 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.234 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.564 HG21 ' HG3' ' B' ' 944' ' ' GLU . 0.0 OUTLIER -79.52 -35.43 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.376 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.4 ptmm? -168.7 152.64 5.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.134 0.492 . . . . 0.0 111.663 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.92 134.36 65.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.739 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 106.42 12.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.565 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 102.83 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.51 -19.09 7.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.574 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 23.4 m -74.37 173.83 9.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.978 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.784 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.1 mt -59.06 -52.83 64.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.352 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.811 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.62 -29.15 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.797 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -85.52 -49.67 7.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -74.36 -48.19 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.3 p -90.89 -28.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.612 0.244 . . . . 0.0 111.539 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.665 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.11 -56.12 2.37 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.022 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.473 ' N ' HD13 ' A' ' 664' ' ' LEU . 6.1 t-80 71.04 62.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.71 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.06 175.13 9.81 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.662 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.6 ptt-85 -141.3 164.23 30.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.864 0.364 . . . . 0.0 111.246 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.61 123.93 16.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.806 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.1 -25.01 6.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.733 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.646 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.19 142.89 56.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.331 . . . . 0.0 110.369 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -102.42 107.87 19.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.304 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.707 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.1 t -90.75 99.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.471 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.632 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.3 OUTLIER -81.38 0.03 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.216 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 6.4 mm-40 -142.02 126.74 18.04 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.828 0.347 . . . . 0.0 111.595 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.791 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.4 t-105 -130.97 112.88 13.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.291 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 67.08 36.17 4.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.975 0.417 . . . . 0.0 110.802 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 72.06 18.41 77.8 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.529 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.46 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -112.95 148.86 40.3 Favored Pre-proline 0 CA--C 1.52 -0.207 0 CA-C-N 117.129 0.465 . . . . 0.0 110.765 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.3 Cg_endo -83.0 119.05 2.78 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.571 1.514 . . . . 0.0 111.022 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.5 mt -88.46 -38.47 0.46 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.281 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 59.2 Cg_exo -40.02 112.71 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.356 2.037 . . . . 0.0 112.713 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.03 -11.96 34.32 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.711 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -94.04 139.07 31.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.862 0.363 . . . . 0.0 110.962 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.686 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.1 t -89.17 -176.61 5.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.437 ' N ' ' OG1' ' A' ' 682' ' ' THR . 10.5 t-20 -51.13 -43.49 61.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.35 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 687' ' ' TYR . 1.5 mt-10 -66.75 -36.55 82.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.042 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.913 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 7.4 mm-40 -62.23 -61.78 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.485 ' HA ' HD13 ' A' ' 689' ' ' ILE . 93.9 t -46.33 -43.9 5.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.843 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.9 m-30 -47.12 -44.99 22.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -65.5 -44.17 87.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.943 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 685' ' ' GLU . 5.2 mp -64.9 -47.94 86.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.561 ' CD1' HG13 ' B' ' 946' ' ' ILE . 1.6 mm -58.7 -65.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.9 mp -45.32 -49.91 12.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.455 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -23.31 66.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.151 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 58.7 p -101.57 -13.88 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.6 OUTLIER -75.36 -14.33 60.47 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.192 -179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 1.4 m -93.57 -15.86 24.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.198 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 15.3 mt-10 -77.55 135.1 65.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.8 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 33.6 Cg_exo -57.67 -18.15 31.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.485 2.123 . . . . 0.0 112.617 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 615' ' ' ILE . 53.6 tt0 -139.34 154.17 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 111.201 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.48 149.25 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.074 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.11 108.95 10.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.942 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -119.91 138.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 111.713 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.1 mm -117.83 145.76 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.452 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -127.46 179.97 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.041 0.448 . . . . 0.0 111.851 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.475 ' HB3' HD21 ' A' ' 671' ' ' LEU . 14.9 t -143.97 115.45 8.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.831 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.91 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.847 0.356 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.644 ' C ' HG23 ' A' ' 635' ' ' VAL . 2.0 mp0 -82.31 -170.92 3.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.83 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.799 ' N ' HG23 ' A' ' 635' ' ' VAL . . . -128.8 -64.74 0.12 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.092 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.561 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -139.11 153.64 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.063 0.459 . . . . 0.0 111.596 -179.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.449 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -94.44 116.72 29.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.931 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.279 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 661' ' ' VAL . 41.3 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.584 0.231 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.33 171.62 13.66 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.511 2.14 . . . . 0.0 112.29 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -120.4 151.93 23.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.09 150.77 42.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.073 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.638 ' HB3' HD12 ' A' ' 610' ' ' LEU . 12.2 m95 -129.78 127.13 39.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -118.82 156.71 51.57 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.001 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.06 139.32 42.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.914 2.409 . . . . 0.0 112.229 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 609' ' ' ARG . 39.3 t -65.38 -175.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -22.62 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.481 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.92 -25.33 10.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 102.29 -33.54 6.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.487 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.44 -10.16 41.27 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . 0.417 ' HB2' ' CB ' ' A' ' 604' ' ' SER . 13.2 mtm180 -124.13 160.56 27.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.684 0.278 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.638 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -116.49 118.13 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.155 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 21.4 mm -106.74 142.35 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.68 162.45 25.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.676 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.628 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 ttm180 -114.29 124.32 51.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.56 HG13 ' HA2' ' A' ' 662' ' ' GLY . 34.5 t -119.74 130.49 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 111.68 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 615' ' ' ILE . 2.9 mp -113.05 127.74 70.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.291 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.85 HD21 ' N ' ' A' ' 658' ' ' ALA . 4.9 mt -129.55 135.3 48.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 111.466 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.652 ' O ' HD13 ' A' ' 657' ' ' LEU . 3.0 m120 -107.88 143.89 35.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.771 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.551 ' HG2' HD22 ' A' ' 630' ' ' LEU . 0.1 OUTLIER -105.4 -34.15 7.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.069 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -29.05 69.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.361 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.771 HG23 HD11 ' A' ' 657' ' ' LEU . 9.0 t -74.1 -39.34 63.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.761 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.86 -169.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.076 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.23 149.19 54.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -25.68 8.6 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.649 2.233 . . . . 0.0 112.6 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -34.1 30.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.133 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 178.03 151.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.78 129.17 40.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -95.25 -67.91 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.724 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -174.29 -71.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 111.216 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.853 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -120.35 -85.4 0.66 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.782 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.849 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -120.6 -57.59 1.89 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.616 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 158.62 28.76 0.02 OUTLIER Glycine 0 C--N 1.338 0.643 0 C-N-CA 119.905 -1.141 . . . . 0.0 114.306 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.45 154.7 23.31 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.747 0.774 . . . . 0.0 111.486 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.449 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -114.22 125.72 54.24 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.805 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.2 t -119.01 155.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.523 0.678 . . . . 0.0 112.43 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -127.99 125.34 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.724 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -112.77 168.16 12.55 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.601 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.11 24.92 74.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.563 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -88.97 91.55 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.529 ' HA ' HD23 ' A' ' 645' ' ' LEU . 2.1 tpt -58.29 116.63 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 19.1 p -95.72 -177.65 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -72.09 -9.98 59.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.2 mm? -92.22 11.23 26.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.407 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.93 36.61 81.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.692 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -139.55 139.9 36.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.834 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 682' ' ' THR . 31.1 mt -88.2 144.18 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.978 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.34 -165.82 12.97 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.569 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -123.98 141.57 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.497 0.189 . . . . 0.0 111.233 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 635' ' ' VAL . 69.3 m-85 -136.52 136.48 39.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.802 0.334 . . . . 0.0 111.07 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.4 mt -77.2 120.61 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.242 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.45 HG21 ' HA ' ' B' ' 944' ' ' GLU . 1.8 p -83.69 -31.48 26.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.534 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 6.1 ptmm? -170.57 148.68 3.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.225 0.536 . . . . 0.0 111.948 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -120.75 137.9 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.684 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.73 106.42 13.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.65 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.18 101.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.78 -22.06 7.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.451 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.723 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.4 p -68.92 173.54 5.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 0.0 110.94 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.1 mt -56.35 -53.37 58.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.268 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.85 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.56 -27.98 2.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.828 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.02 -49.19 7.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.863 0.363 . . . . 0.0 111.763 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -75.43 -49.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.165 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.7 p -89.87 -28.84 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 111.534 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -88.88 -57.07 1.86 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.448 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.2 t-160 70.77 57.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.34 175.71 9.04 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.64 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.9 OUTLIER -141.39 162.86 34.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.244 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -58.28 125.31 22.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.27 -24.69 6.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.905 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -61.37 142.88 56.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.724 0.297 . . . . 0.0 110.495 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -100.82 105.26 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -88.16 102.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.872 HD21 ' OG ' ' A' ' 704' ' ' SER . 0.2 OUTLIER -84.23 3.0 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.228 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.423 ' HB2' HG12 ' A' ' 702' ' ' ILE . 6.7 mt-10 -145.86 128.64 16.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.71 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.848 ' HB2' HD11 ' A' ' 678' ' ' LEU . 14.6 t-105 -130.82 115.14 16.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.207 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 67.87 36.64 3.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.916 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.87 20.08 77.38 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.525 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.498 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -118.2 150.54 47.79 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.123 0.462 . . . . 0.0 110.897 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.418 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.4 Cg_endo -80.07 118.92 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.359 1.373 . . . . 0.0 110.916 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 673' ' ' TRP . 72.8 mt -85.03 -39.23 0.63 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.195 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.9 Cg_exo -40.15 115.89 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.378 2.052 . . . . 0.0 112.662 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.78 -15.42 41.0 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.483 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.6 138.06 31.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.821 0.343 . . . . 0.0 110.988 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.706 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -88.87 -178.51 5.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 682' ' ' THR . 26.1 p-10 -53.73 -41.76 67.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.75 -36.9 84.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.986 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.959 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.37 -61.12 2.56 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.586 HG22 HD22 ' A' ' 678' ' ' LEU . 69.2 t -53.31 -40.61 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.814 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.545 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.5 m-30 -48.4 -49.43 34.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.93 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -70.22 -35.7 74.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.4 mp -65.17 -65.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.966 HD12 HD12 ' B' ' 946' ' ' ILE . 7.6 mt -49.01 -51.15 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.002 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -53.8 -49.2 68.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.097 0.475 . . . . 0.0 110.642 179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.83 -27.86 63.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.427 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . 0.487 ' OG ' HG22 ' A' ' 699' ' ' VAL . 24.8 t -87.81 -11.25 48.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.471 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -64.5 -28.09 69.42 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.3 t -74.76 -21.54 59.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.298 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -84.0 137.1 40.6 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.835 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.05 -6.82 19.66 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.449 2.099 . . . . 0.0 112.498 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -138.39 150.46 46.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 111.042 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.487 HG22 ' OG ' ' A' ' 693' ' ' SER . 40.6 t -139.43 145.9 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.707 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -121.61 108.7 13.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.289 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.593 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -117.88 137.48 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 111.542 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -116.48 144.58 23.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.815 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.8 m -128.26 177.87 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.988 0.423 . . . . 0.0 111.61 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.872 ' OG ' HD21 ' A' ' 671' ' ' LEU . 22.1 p -147.55 136.85 22.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.882 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 650' ' ' THR . 8.7 pt-20 -86.39 168.9 13.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -121.78 -64.19 0.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.966 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -140.83 157.85 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 111.48 -179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.505 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -93.58 122.08 35.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.721 178.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.853 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.007 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 661' ' ' VAL . 2.5 m-70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.703 0.287 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 171.64 11.94 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.562 2.175 . . . . 0.0 112.277 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.67 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -113.63 152.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.89 151.67 37.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.026 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.74 ' CB ' HD12 ' A' ' 610' ' ' LEU . 47.3 m95 -132.26 138.0 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.68 154.25 73.04 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.38 129.04 14.33 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.798 2.332 . . . . 0.0 112.363 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.3 p -101.91 146.77 27.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.294 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.8 -8.5 59.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.483 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.75 17.58 0.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 125.9 25.81 1.33 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.92 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.67 74.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.98 167.69 19.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.459 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.74 HD12 ' CB ' ' A' ' 601' ' ' TRP . 2.5 mm? -114.34 114.56 26.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.409 HD12 ' OG ' ' A' ' 704' ' ' SER . 16.6 mm -104.86 137.45 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.51 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.74 162.94 25.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.096 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.682 ' HA ' HD12 ' A' ' 702' ' ' ILE . 47.0 mtt-85 -107.3 119.56 39.72 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.67 HG22 HG21 ' A' ' 599' ' ' VAL . 46.1 t -113.36 121.77 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.606 HG21 ' NE2' ' A' ' 698' ' ' GLN . 4.2 mp -111.87 123.13 67.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.268 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.759 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -120.34 151.36 39.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.545 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.786 ' O ' HD13 ' A' ' 657' ' ' LEU . 11.7 m120 -123.24 126.25 46.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 694' ' ' LYS . 0.4 OUTLIER -86.29 55.13 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.969 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.71 -21.4 52.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 4.9 p 57.5 32.56 22.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.019 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 7.6 t -118.0 49.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.462 ' HE2' ' HA3' ' A' ' 627' ' ' GLY . 1.9 mpp? -60.6 145.97 86.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.36 -14.39 43.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.411 2.074 . . . . 0.0 112.333 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -54.55 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 -81.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.77 -43.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.838 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . 0.462 ' HA3' ' HE2' ' A' ' 622' ' ' MET . . . 96.53 -142.56 16.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.618 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.661 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -154.59 -60.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.858 0.361 . . . . 0.0 111.11 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.934 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -116.59 -91.9 0.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.866 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -125.0 -42.37 2.03 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.188 -0.32 . . . . 0.0 111.063 179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 152.23 11.29 0.08 OUTLIER Glycine 0 CA--C 1.526 0.763 0 C-N-CA 119.59 -1.29 . . . . 0.0 115.023 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.871 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.69 150.16 17.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.131 0.965 . . . . 0.0 112.053 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.453 ' HD2' ' CD2' ' B' ' 947' ' ' TRP . 1.3 tptp -100.16 129.57 46.2 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.718 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.04 154.48 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.371 0.605 . . . . 0.0 112.172 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.472 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.81 159.31 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.619 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -129.59 142.3 13.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.405 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 84.21 51.63 3.88 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -106.05 89.6 3.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.504 ' HA ' HD23 ' A' ' 645' ' ' LEU . 47.3 tpp -58.87 115.89 3.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.985 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 68.4 p -90.12 -174.71 4.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.9 -10.72 59.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.439 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.545 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.0 mm? -79.48 -34.46 41.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.94 6.27 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -132.26 157.27 44.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 682' ' ' THR . 89.7 mt -92.05 152.17 20.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.1 -164.08 12.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.553 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -122.66 145.5 48.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.37 . . . . 0.0 111.272 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -137.5 141.61 41.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.605 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.636 HD13 HD12 ' A' ' 632' ' ' LEU . 27.1 mt -84.62 120.4 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.858 0.361 . . . . 0.0 111.115 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.62 HG21 ' HA ' ' B' ' 944' ' ' GLU . 17.6 p -81.06 -31.5 34.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.549 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.5 OUTLIER -167.46 152.84 7.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.083 0.468 . . . . 0.0 111.679 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -123.21 136.17 60.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.845 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.95 106.43 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.648 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.52 101.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.959 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.61 -22.24 6.97 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.455 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.836 ' O ' HG22 ' A' ' 660' ' ' VAL . 16.9 m -69.28 172.13 7.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.763 0.316 . . . . 0.0 110.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -57.42 -52.29 65.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.759 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.66 -28.26 2.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.764 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -49.88 6.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -72.89 -45.64 55.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.8 p -97.66 -30.32 3.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.727 0.298 . . . . 0.0 111.618 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -81.4 -55.04 3.33 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.087 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.512 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.3 65.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -142.77 172.97 11.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.645 ' HA ' HG21 ' A' ' 652' ' ' VAL . 44.6 mtt180 -141.36 162.41 35.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 111.261 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.88 123.78 15.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.894 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.62 -23.39 6.71 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.926 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.34 144.14 57.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.759 0.314 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -103.05 114.31 28.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.66 HG22 ' CG1' ' A' ' 703' ' ' VAL . 49.5 t -93.97 105.42 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.577 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.586 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.8 OUTLIER -84.17 0.97 46.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.2 mt-10 -147.07 127.56 14.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 111.639 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.903 ' HB2' HD11 ' A' ' 678' ' ' LEU . 9.9 t-105 -130.83 114.29 15.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.246 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.57 38.2 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.949 0.404 . . . . 0.0 110.713 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.88 71.71 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.991 -0.624 . . . . 0.0 113.307 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -112.96 147.61 37.6 Favored Pre-proline 0 CA--C 1.519 -0.242 0 CA-C-N 117.045 0.422 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.3 Cg_endo -81.19 118.92 3.39 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.483 1.455 . . . . 0.0 110.804 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.903 HD11 ' HB2' ' A' ' 673' ' ' TRP . 26.3 mt -88.99 -35.94 0.42 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.461 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.7 Cg_exo -41.22 114.37 0.31 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.248 1.965 . . . . 0.0 112.666 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.52 -13.05 47.29 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 1.017 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.48 137.14 32.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.7 t -88.4 179.02 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 11.0 p30 -48.92 -45.92 42.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.356 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 1.0 OUTLIER -64.02 -37.95 89.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 1.017 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.6 OUTLIER -62.44 -60.49 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 97.3 t -48.87 -43.26 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.838 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.743 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.7 m-30 -47.58 -44.94 26.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.747 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.79 -41.21 75.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.925 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.1 mp -61.15 -66.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.177 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.057 HD12 HD12 ' B' ' 946' ' ' ILE . 6.3 mt -52.31 -53.59 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.61 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -53.29 -50.3 65.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.097 0.475 . . . . 0.0 110.92 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.93 -25.6 43.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.775 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 52.4 p -94.52 -11.91 28.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.44 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.474 ' HA ' ' HZ3' ' A' ' 618' ' ' LYS . 22.2 mttm -61.28 -25.74 67.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.25 -17.01 41.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.331 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 9.0 mm-40 -80.87 126.7 77.04 Favored Pre-proline 0 N--CA 1.456 -0.171 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.745 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.4 Cg_exo -59.3 -14.26 23.78 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.425 2.083 . . . . 0.0 112.652 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . 0.606 ' NE2' HG21 ' A' ' 615' ' ' ILE . 30.9 tt0 -137.56 153.21 50.0 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 111.259 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.09 143.36 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -117.8 108.83 15.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.116 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 616' ' ' LEU . 1.2 pt -117.88 138.77 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.077 0.465 . . . . 0.0 111.526 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 612' ' ' GLY . 6.9 mm -119.34 146.71 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.596 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.66 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.3 m -131.35 178.78 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.677 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.409 ' OG ' HD12 ' A' ' 611' ' ' ILE . 12.6 m -143.89 104.64 4.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.801 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.791 0.329 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.62 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.2 pm0 -120.09 178.75 4.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -133.36 -54.37 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.057 HD12 HD12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -146.31 158.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.072 0.463 . . . . 0.0 111.195 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.527 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.6 OUTLIER -93.77 124.98 38.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.013 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.934 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.457 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.648 0.261 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.08 171.67 7.26 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.57 2.18 . . . . 0.0 112.228 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 614' ' ' VAL . 2.6 t -113.29 149.96 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.238 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.3 p -133.62 154.74 50.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.22 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.649 ' HB3' HD12 ' A' ' 610' ' ' LEU . 18.8 m95 -129.95 123.94 31.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.937 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.24 156.29 47.26 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.952 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.99 130.73 39.31 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 0.0 112.238 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.01 -177.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.089 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -9.22 59.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.463 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -98.93 -13.13 20.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 111.248 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 76.39 4.12 79.03 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.826 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.23 2.98 7.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.798 0.299 . . . . 0.0 111.371 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.83 160.47 31.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -118.75 115.43 24.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.817 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.77 146.43 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.808 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.7 162.51 25.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.444 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.614 ' HA ' HD12 ' A' ' 702' ' ' ILE . 1.2 mmt180 -116.97 125.6 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.655 0.264 . . . . 0.0 110.72 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 599' ' ' VAL . 45.7 t -116.68 127.41 74.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.023 0.439 . . . . 0.0 111.766 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 614' ' ' VAL . 0.8 OUTLIER -109.96 123.59 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.987 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 630' ' ' LEU . 8.6 mt -126.22 151.34 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.038 0.447 . . . . 0.0 111.618 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.3 t30 -124.26 128.62 49.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.516 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.449 ' HG2' ' CD2' ' A' ' 630' ' ' LEU . 0.7 OUTLIER -92.79 -35.72 13.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.682 -179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 697' ' ' PRO . 0.0 OUTLIER -57.13 -30.4 64.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.367 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 50.0 p -83.95 -59.75 2.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.066 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.776 ' HA ' HD11 ' A' ' 657' ' ' LEU . 0.0 OUTLIER 57.41 156.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.908 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.562 ' HB2' ' HD3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -73.63 123.8 89.72 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 110.694 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.53 -1.27 11.45 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 113.473 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.562 ' HD3' ' HB2' ' A' ' 622' ' ' MET . 0.0 OUTLIER -88.87 -35.0 16.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.785 0.326 . . . . 0.0 111.309 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.85 -79.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.971 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.23 -68.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 133.74 61.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.499 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.818 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -69.45 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -122.83 -77.46 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.641 0.258 . . . . 0.0 110.654 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -134.33 -52.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.275 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 159.41 16.91 0.03 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.074 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.725 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.03 154.48 21.83 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.476 1.138 . . . . 0.0 112.085 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -108.67 128.89 55.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.679 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.2 t -123.96 155.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.476 0.655 . . . . 0.0 112.399 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.503 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.79 159.53 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.605 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -126.28 145.15 15.57 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 80.32 70.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.541 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -131.71 94.34 3.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.55 104.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.759 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 27.9 p -81.77 -178.57 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.132 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.49 -23.43 66.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.228 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.4 mm? -66.82 -27.45 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.967 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 104.5 13.93 25.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.843 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -128.63 166.5 18.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 682' ' ' THR . 20.9 mt -90.62 148.24 22.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.07 -163.91 11.68 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.548 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.57 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -124.31 141.84 51.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 111.215 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.79 143.49 50.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.624 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 668' ' ' ASP . 28.4 mt -85.61 122.56 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.96 0.41 . . . . 0.0 111.207 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.671 HG21 ' HA ' ' B' ' 944' ' ' GLU . 41.5 p -86.18 -28.54 23.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.731 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -170.52 146.26 2.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.122 0.487 . . . . 0.0 112.024 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -116.59 137.45 50.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 656' ' ' SER . 0.2 OUTLIER -77.91 106.46 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.485 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.54 97.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 127.74 -31.36 3.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.557 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 t -60.29 174.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.015 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.776 HD11 ' HA ' ' A' ' 621' ' ' THR . 0.6 OUTLIER -58.6 -50.13 74.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 631' ' ' GLY . . . -50.75 -27.34 6.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.2 -55.19 3.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.161 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 656' ' ' SER . 0.6 OUTLIER -68.98 -55.23 16.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.032 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.4 p -91.53 -37.55 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.568 0.223 . . . . 0.0 111.549 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.492 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -65.2 -57.38 11.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.916 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.405 ' N ' HD13 ' A' ' 664' ' ' LEU . 7.6 t-80 72.8 52.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.83 172.8 12.47 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 178.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.576 ' HA ' HG21 ' A' ' 652' ' ' VAL . 43.6 mtt180 -143.81 166.14 25.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.946 0.403 . . . . 0.0 111.176 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.1 122.71 13.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.917 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.35 -23.37 6.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.925 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.3 OUTLIER -65.24 143.54 57.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 0.0 110.415 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -103.46 112.84 25.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.645 HG22 ' CG1' ' A' ' 703' ' ' VAL . 42.8 t -93.63 104.95 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.732 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.584 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.47 4.1 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.459 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.5 mt-10 -148.67 128.29 13.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 111.528 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HB2' HD11 ' A' ' 678' ' ' LEU . 8.2 t-105 -130.67 112.44 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.017 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 69.07 38.44 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.759 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.97 18.01 72.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.29 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.87 148.8 39.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.995 0.398 . . . . 0.0 110.805 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.414 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 89.9 Cg_endo -81.89 118.94 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.535 1.49 . . . . 0.0 110.889 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 80.0 mt -88.13 -37.46 0.46 Allowed Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.414 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.6 Cg_exo -39.9 112.91 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.339 2.026 . . . . 0.0 112.73 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.71 37.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.452 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.926 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.8 139.83 30.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.804 0.335 . . . . 0.0 111.033 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.676 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.7 t -92.77 -177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.439 ' N ' ' OG1' ' A' ' 682' ' ' THR . 12.1 t-20 -51.13 -42.57 60.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.67 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.63 ' HG2' HG23 ' A' ' 682' ' ' THR . 14.8 pt-20 -67.57 -38.43 84.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.434 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.926 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.7 -59.12 5.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 85.3 t -51.15 -42.59 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.724 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.468 ' O ' HD22 ' A' ' 691' ' ' LEU . 2.4 m-30 -47.45 -44.91 25.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -72.52 -38.97 67.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.84 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.9 mp -60.92 -61.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.927 HD12 HD12 ' B' ' 946' ' ' ILE . 10.3 mt -54.85 -52.18 45.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.338 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -52.94 -48.52 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.086 0.47 . . . . 0.0 110.92 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.81 -24.34 67.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.748 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 19.0 m -97.68 -8.64 28.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.767 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -6.93 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.605 0.24 . . . . 0.0 111.353 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.55 -22.11 15.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.707 0.289 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -62.35 154.98 69.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 619' ' ' ARG . 59.8 Cg_endo -72.42 -12.3 27.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.668 2.245 . . . . 0.0 112.645 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -154.32 163.12 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.967 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 616' ' ' LEU . 74.4 t -136.09 141.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.09 106.27 10.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 673' ' ' TRP . 0.9 OUTLIER -115.04 135.82 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 111.606 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.808 HG23 ' O ' ' A' ' 612' ' ' GLY . 11.3 mm -115.17 144.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.628 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.645 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.3 m -128.7 179.14 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 46.9 t -149.41 138.82 21.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.783 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.671 ' HA ' HG21 ' A' ' 650' ' ' THR . 11.5 mt-10 -86.71 179.12 6.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -130.26 -60.35 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.835 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.927 HD12 HD12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -141.7 158.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.3 0.572 . . . . 0.0 111.672 -179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -93.32 122.81 36.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.048 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.902 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.484 -0.769 . . . . 0.0 111.23 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.428 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 4.8 t60 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 6.0 Cg_exo -77.72 165.43 26.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.7 2.267 . . . . 0.0 112.154 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.2 t -93.07 144.43 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -130.68 152.05 50.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.295 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -130.23 128.1 40.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.933 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -116.27 128.11 26.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.81 148.62 91.87 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.556 2.171 . . . . 0.0 112.142 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.406 ' HB3' ' CG ' ' A' ' 609' ' ' ARG . 9.7 t -119.81 146.34 45.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.319 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 607' ' ' GLY . 0.5 OUTLIER -81.62 -8.71 59.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.612 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.08 17.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 605' ' ' LYS . . . 137.66 5.92 1.64 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.193 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.8 64.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.143 0.497 . . . . 0.0 110.46 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . 0.724 ' NE ' HD11 ' A' ' 611' ' ' ILE . 11.8 ptt180 -124.78 159.63 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.223 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.86 114.47 27.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 0.0 111.171 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.724 HD11 ' NE ' ' A' ' 609' ' ' ARG . 9.0 mm -103.7 140.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.485 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.738 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.71 162.68 25.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.965 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 9.3 ttm105 -115.17 124.36 51.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.618 HG13 ' HA2' ' A' ' 662' ' ' GLY . 36.3 t -118.12 129.66 74.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 111.896 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.47 HD11 ' HD3' ' A' ' 613' ' ' ARG . 8.3 mm -111.94 123.35 67.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.753 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.893 HD13 HD12 ' A' ' 630' ' ' LEU . 7.2 mt -122.81 147.35 46.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.0 111.596 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 657' ' ' LEU . 1.6 t30 -119.78 124.91 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.57 ' HB3' HD23 ' A' ' 630' ' ' LEU . 6.9 ptmt -116.0 33.8 5.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 -57.99 2.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.093 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 5.1 t -84.41 167.74 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.91 HG22 ' HA ' ' A' ' 626' ' ' SER . 0.2 OUTLIER -91.98 167.75 11.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.798 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 2.7 tpp -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.99 -25.29 52.93 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.412 2.075 . . . . 0.0 112.203 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -36.15 32.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.68 -81.83 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.047 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.91 ' HA ' HG22 ' A' ' 621' ' ' THR . 1.4 p -172.83 -176.96 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -161.64 148.88 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.436 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.638 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -74.56 -58.89 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.94 -84.61 0.65 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.362 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.893 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -125.97 -59.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' A' ' 658' ' ' ALA . . . 164.87 22.31 0.02 OUTLIER Glycine 0 CA--C 1.525 0.715 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.701 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.73 154.22 22.07 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 118.279 1.04 . . . . 0.0 111.885 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HG2' ' CE3' ' B' ' 947' ' ' TRP . 0.1 OUTLIER -116.3 131.94 56.8 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.707 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 5.0 t -125.12 156.92 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.328 0.585 . . . . 0.0 111.937 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -111.82 161.2 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.656 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -127.83 147.61 17.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.68 62.31 2.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.57 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -119.82 86.93 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.94 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 48.0 tpp -59.36 115.72 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 4.6 p -102.92 -177.1 3.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.12 -16.03 60.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.385 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.484 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.3 mm? -68.51 -26.14 65.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.991 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 98.94 9.61 51.68 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.791 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -131.56 168.83 17.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.857 0.36 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 682' ' ' THR . 81.2 mt -94.01 151.46 19.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -152.12 -161.66 10.33 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.66 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.603 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -126.15 146.83 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 111.218 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -137.57 139.17 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.784 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.591 HD12 ' HB2' ' A' ' 668' ' ' ASP . 47.2 mt -77.45 119.21 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.917 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.1 p -83.19 -30.68 27.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.527 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 10.8 ptmt -165.31 154.35 12.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.142 0.496 . . . . 0.0 111.714 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.1 133.38 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.907 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.42 106.39 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.458 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -58.46 104.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.145 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.96 5.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.41 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.788 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.6 m -71.25 173.05 8.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 0.0 110.966 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.816 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.0 OUTLIER -56.18 -52.64 63.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.475 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.813 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.73 -32.93 3.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.969 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -83.74 -49.81 8.75 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.799 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -71.09 -49.87 46.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.816 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.5 p -89.78 -28.04 5.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.618 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -92.13 -53.53 2.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.188 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.452 ' N ' HD13 ' A' ' 664' ' ' LEU . 8.8 t-80 65.81 63.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.827 0.346 . . . . 0.0 111.708 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.728 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.7 176.0 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.689 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -139.79 160.95 38.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.921 0.391 . . . . 0.0 111.308 -179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.52 123.29 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.755 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.02 5.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.956 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.591 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.8 m-20 -65.48 143.81 57.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.749 0.309 . . . . 0.0 110.454 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -102.48 112.77 25.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.178 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.67 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.8 t -92.16 105.65 16.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.2 OUTLIER -84.37 2.29 41.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 38.1 mt-10 -149.24 126.44 11.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.472 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.927 ' HB2' HD11 ' A' ' 678' ' ' LEU . 17.0 t-105 -130.89 121.34 25.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.479 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 61.32 37.71 16.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 110.856 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.86 67.04 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.266 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -110.64 147.06 35.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 117.03 0.415 . . . . 0.0 110.817 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 91.0 Cg_endo -81.56 118.84 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.417 1.411 . . . . 0.0 110.912 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 673' ' ' TRP . 16.2 mt -88.66 -37.1 0.44 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.272 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.5 Cg_exo -41.69 113.32 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.23 1.953 . . . . 0.0 112.569 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.56 -12.87 32.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.508 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.919 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -97.47 133.25 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.887 0.375 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.754 ' HA ' HD13 ' A' ' 645' ' ' LEU . 6.6 t -81.21 -170.48 2.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.725 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 3.2 p-10 -55.07 -51.54 66.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.325 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -35.8 72.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.242 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.919 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 2.1 mm-40 -63.61 -61.13 2.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 75.4 t -47.74 -41.78 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.575 ' O ' HD22 ' A' ' 691' ' ' LEU . 7.0 m-30 -49.27 -48.68 45.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.783 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -64.42 -43.59 93.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.994 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.3 mp -58.15 -64.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.738 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.11 -54.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.359 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.575 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -46.0 -49.95 15.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.011 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -60.78 -27.92 68.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 45.6 t -94.95 -9.92 32.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.657 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -57.08 -26.99 61.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.797 0.332 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 68.0 m -102.65 8.85 39.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.609 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 3.9 mm-40 -80.9 131.69 59.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.574 0.226 . . . . 0.0 110.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 47.4 Cg_exo -55.9 -19.25 24.86 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.429 2.086 . . . . 0.0 112.526 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -151.11 156.94 42.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 111.193 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 616' ' ' LEU . 51.1 t -134.62 142.61 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.973 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 615' ' ' ILE . 23.3 tt0 -125.03 108.89 12.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.039 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.669 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.38 137.46 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.11 0.481 . . . . 0.0 111.825 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.738 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.7 mm -116.62 144.71 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.595 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.67 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.1 m -130.41 179.02 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.062 0.458 . . . . 0.0 111.727 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.487 ' HB3' HD21 ' A' ' 671' ' ' LEU . 10.6 t -146.78 109.87 4.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.816 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.873 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.735 0.302 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.917 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.2 pt-20 -100.64 -177.51 3.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -149.19 -41.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.976 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.738 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.95 144.62 25.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.37 . . . . 0.0 111.458 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -95.91 117.81 31.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.909 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.3 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' A' ' 598' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.561 0.22 . . . . 0.0 111.44 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 597' ' ' HIS . 83.8 Cg_endo -82.66 167.5 14.87 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.587 2.191 . . . . 0.0 112.398 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 614' ' ' VAL . 2.4 t -97.95 148.15 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.825 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -130.83 151.21 51.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.292 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.723 ' HB3' HD12 ' A' ' 610' ' ' LEU . 59.6 m95 -132.65 135.21 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.886 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.671 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -130.43 151.38 78.49 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.969 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.2 120.01 7.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.662 2.242 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 6.7 t -81.03 164.94 22.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.425 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -8.31 59.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.427 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -62.79 -16.22 57.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.576 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 128.4 -33.71 3.09 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.976 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.86 30.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.85 136.57 37.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.717 0.294 . . . . 0.0 110.6 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.723 HD12 ' HB3' ' A' ' 601' ' ' TRP . 2.6 mm? -107.88 114.46 28.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.79 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 7.4 mm -99.61 140.95 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.98 160.12 25.25 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.717 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 702' ' ' ILE . 10.2 ptm180 -110.46 119.26 38.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.818 HG13 ' HA2' ' A' ' 662' ' ' GLY . 58.9 t -113.28 123.15 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 111.698 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.3 mm -109.09 119.08 57.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.12 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.798 HD21 ' N ' ' A' ' 658' ' ' ALA . 7.2 mt -116.73 148.71 40.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.927 0.394 . . . . 0.0 111.211 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.803 ' O ' HD13 ' A' ' 657' ' ' LEU . 10.6 t-20 -126.8 116.93 21.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -103.84 36.32 2.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.793 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -98.99 -46.24 5.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.329 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 17.5 p -96.41 176.17 6.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.718 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.98 144.72 42.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.408 ' HG2' ' CA ' ' A' ' 626' ' ' SER . 3.0 ptp -59.39 153.28 49.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.38 -3.94 13.79 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.821 2.347 . . . . 0.0 113.236 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -98.58 -24.75 14.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.666 0.269 . . . . 0.0 111.163 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.89 -82.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.408 ' CA ' ' HG2' ' A' ' 622' ' ' MET . 2.1 m 178.62 -43.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.032 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 88.41 -160.46 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.378 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.726 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -128.46 -52.35 1.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.986 0.422 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -125.7 -80.72 0.62 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.774 ' HB2' HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -128.24 -44.85 1.4 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.712 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 155.51 12.1 0.06 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 119.457 -1.354 . . . . 0.0 115.889 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.796 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -161.11 154.04 21.06 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.586 1.193 . . . . 0.0 112.12 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HG3' ' CE3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -105.01 129.75 53.38 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.836 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.7 t -114.21 154.28 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -129.26 125.05 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.729 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -108.47 174.87 19.19 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.44 26.9 58.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.578 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -103.57 90.49 3.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.324 . . . . 0.0 110.79 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.499 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.1 OUTLIER -60.11 126.08 26.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 77.5 p -92.31 -176.36 4.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -75.42 -7.23 53.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.469 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.7 mm? -83.74 -33.8 24.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.864 0.364 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.67 21.54 6.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -132.36 150.73 52.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 682' ' ' THR . 27.0 mt -88.57 144.71 26.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -146.21 -162.32 9.72 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.548 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -128.63 147.85 50.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.261 . . . . 0.0 111.262 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 82.7 m-85 -134.54 137.22 43.62 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.762 0.315 . . . . 0.0 110.852 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 668' ' ' ASP . 48.7 mt -75.18 119.69 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 2.9 p -81.97 -32.56 30.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 9.3 ptmm? -164.44 154.73 14.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.087 0.47 . . . . 0.0 111.651 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.35 132.41 69.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.861 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.81 106.43 10.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.509 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -54.93 103.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.222 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 121.84 -27.37 6.23 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.778 ' O ' HG22 ' A' ' 660' ' ' VAL . 67.2 p -60.57 168.69 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.9 0.381 . . . . 0.0 110.831 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.82 ' O ' HG12 ' A' ' 661' ' ' VAL . 2.8 mt -57.15 -49.18 76.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.798 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -48.09 -36.51 13.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -49.88 11.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.846 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.778 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -70.74 -55.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.1 p -83.98 -29.31 7.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.818 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -90.57 -51.38 2.71 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.11 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.493 ' C ' HD13 ' A' ' 664' ' ' LEU . 0.8 OUTLIER 65.07 68.8 0.5 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -139.34 174.61 10.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 79.4 mtt180 -139.54 161.83 36.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.424 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.49 124.32 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.884 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.28 -22.56 6.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.999 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.9 OUTLIER -66.6 140.42 57.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 110.566 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -100.0 115.1 28.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.143 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.682 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.8 t -94.54 105.33 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.596 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.6 OUTLIER -85.29 -0.74 55.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.3 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -142.47 127.72 18.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.822 0.344 . . . . 0.0 111.389 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.88 ' HB2' HD11 ' A' ' 678' ' ' LEU . 18.8 t-105 -130.85 129.93 42.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 55.2 37.37 28.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.041 0.448 . . . . 0.0 110.718 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 62.53 25.33 66.99 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.401 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.828 ' HD3' HG12 ' A' ' 689' ' ' ILE . 2.3 ptmt -117.56 161.12 35.3 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.158 0.479 . . . . 0.0 110.889 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -87.95 118.73 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.79 1.66 . . . . 0.0 111.179 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 673' ' ' TRP . 55.4 mt -93.38 -31.75 0.31 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.409 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 68.6 Cg_exo -41.84 111.82 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.259 1.973 . . . . 0.0 112.604 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 110.02 -10.47 31.77 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.38 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.943 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -97.4 133.19 42.32 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.811 0.338 . . . . 0.0 110.89 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.708 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -85.8 -178.92 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.419 ' N ' ' OG1' ' A' ' 682' ' ' THR . 29.0 p-10 -52.39 -41.85 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.247 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.6 OUTLIER -66.33 -38.55 87.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.843 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.943 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -62.36 -61.61 2.33 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.58 HG12 HD11 ' B' ' 946' ' ' ILE . 86.2 t -46.38 -42.42 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.89 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.681 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.2 m-30 -48.33 -44.8 34.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.004 0.43 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.63 -36.92 65.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.777 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.828 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.3 mp -63.85 -65.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.064 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.906 HD12 ' CD1' ' B' ' 946' ' ' ILE . 7.8 mt -51.54 -53.6 15.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.554 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.681 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.3 OUTLIER -48.65 -47.88 40.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.008 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.63 -25.19 64.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.774 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 10.5 p -91.83 -11.14 37.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.499 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -65.65 -27.36 68.32 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.763 0.316 . . . . 0.0 110.778 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.0 m -74.38 -22.66 59.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -81.9 138.39 46.57 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.93 -3.0 13.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.516 2.144 . . . . 0.0 112.727 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.21 146.12 38.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 0.0 111.139 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 74.1 t -141.88 147.59 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.69 106.89 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.097 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -113.78 137.81 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.054 0.454 . . . . 0.0 111.443 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 612' ' ' GLY . 8.2 mm -118.1 145.52 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.611 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.682 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -128.77 178.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.975 0.417 . . . . 0.0 111.586 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 35.3 t -151.75 112.06 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.918 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -127.75 169.74 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -124.36 -72.17 0.23 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.602 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.906 ' CD1' HD12 ' A' ' 690' ' ' ILE . 1.2 mt -140.49 158.22 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.124 0.488 . . . . 0.0 111.482 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.467 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.2 OUTLIER -92.13 123.49 35.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.835 178.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.404 -0.807 . . . . 0.0 110.867 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.654 0.264 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 171.57 17.94 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.565 2.177 . . . . 0.0 112.206 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.7 t -103.14 151.52 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.5 p -134.92 154.8 51.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.221 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.706 ' HB3' HD12 ' A' ' 610' ' ' LEU . 69.5 m95 -129.03 121.56 28.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -118.23 144.02 34.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.03 141.2 93.57 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.705 2.27 . . . . 0.0 112.143 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 76.8 p -60.63 178.96 0.18 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.746 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -62.56 -54.55 38.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.03 -27.68 69.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.348 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.17 32.59 11.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.082 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -125.63 -24.29 3.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.55 0.214 . . . . 0.0 111.222 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.3 152.68 33.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.867 0.365 . . . . 0.0 110.858 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.706 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -108.14 123.72 49.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.765 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.512 HD12 ' OG ' ' A' ' 704' ' ' SER . 22.5 mm -114.43 140.85 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.265 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.78 159.01 24.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.423 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.693 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -108.82 118.51 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.716 HG13 ' HA2' ' A' ' 662' ' ' GLY . 40.8 t -112.54 122.93 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 111.908 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.15 119.49 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.745 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.867 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.8 mt -121.46 151.37 40.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.08 0.467 . . . . 0.0 111.714 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 657' ' ' LEU . 27.4 m-80 -132.83 121.91 23.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.641 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -102.15 -36.48 8.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.21 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -29.25 17.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.34 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 41.2 p -87.46 135.21 33.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.011 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 27.7 m -80.72 146.17 31.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.748 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.488 ' HA ' ' HD3' ' A' ' 623' ' ' PRO . 1.6 mpp? -66.27 140.15 96.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.928 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 622' ' ' MET . 2.9 Cg_exo -75.26 -29.12 8.16 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.764 2.309 . . . . 0.0 112.496 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 -30.48 13.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.223 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -145.39 -163.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.0 m -95.67 -77.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.028 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.54 165.2 25.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.793 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -98.82 -60.58 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.944 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -127.9 -80.97 0.59 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.612 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -132.15 -43.66 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.99 179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 160.48 4.42 0.06 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 119.105 -1.522 . . . . 0.0 116.038 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.69 149.33 16.57 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.145 1.472 . . . . 0.0 112.982 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.483 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 0.3 OUTLIER -101.28 129.83 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.479 178.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.721 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -111.99 153.78 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.539 0.685 . . . . 0.0 112.441 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 1.0 OUTLIER -125.98 125.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.468 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -109.0 170.73 14.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.861 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 70.91 48.44 33.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.717 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -115.37 91.85 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.696 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.437 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.2 OUTLIER -58.37 119.07 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.018 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 24.8 p -92.23 -178.9 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -10.64 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.363 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.5 mm? -84.11 -31.87 25.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 107.61 22.69 7.24 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.614 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -129.77 144.35 51.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 682' ' ' THR . 24.2 mt -86.83 143.88 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -148.82 -165.16 12.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.68 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -125.43 149.24 48.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.541 0.21 . . . . 0.0 111.327 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 635' ' ' VAL . 89.0 m-85 -139.25 137.76 36.2 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.701 0.286 . . . . 0.0 111.205 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.8 mt -74.06 119.37 21.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.489 HG21 ' HA ' ' B' ' 944' ' ' GLU . 6.4 p -81.06 -31.69 34.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 8.8 ptmt -163.81 154.86 16.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.02 0.438 . . . . 0.0 111.618 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -127.83 132.28 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.092 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -80.47 106.33 12.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -59.69 105.4 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 123.99 -27.37 5.65 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 660' ' ' VAL . 0.4 OUTLIER -65.17 171.81 3.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.888 0.375 . . . . 0.0 110.822 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.833 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.6 mp -56.64 -51.33 69.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.397 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.867 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.8 -34.37 8.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.773 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.18 -49.54 11.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -72.21 -50.38 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.833 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.6 p -87.84 -30.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.716 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.12 -52.24 2.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.3 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.486 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.0 t-80 63.46 70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.324 . . . . 0.0 111.594 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.746 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.59 174.96 9.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.7 ' HA ' HG21 ' A' ' 652' ' ' VAL . 5.5 mmt85 -137.29 159.92 40.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.895 0.379 . . . . 0.0 111.231 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.41 123.03 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.746 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.99 -23.11 5.92 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.762 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.616 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.4 OUTLIER -62.51 141.43 58.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.73 0.3 . . . . 0.0 110.477 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -99.52 110.9 23.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.138 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.702 ' O ' HD12 ' A' ' 678' ' ' LEU . 58.9 t -93.37 98.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.527 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.616 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -79.39 -1.83 38.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.293 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 4.0 mm-40 -142.19 125.99 17.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.86 0.362 . . . . 0.0 111.417 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.721 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 19.6 t-105 -131.22 114.03 14.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.179 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.83 36.32 6.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.639 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.96 76.21 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.495 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -111.26 144.8 31.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 117.357 0.579 . . . . 0.0 110.908 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.429 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 90.5 Cg_endo -80.41 118.98 3.67 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.437 1.425 . . . . 0.0 110.757 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.702 HD12 ' O ' ' A' ' 670' ' ' VAL . 41.7 mt -88.73 -31.8 0.39 Allowed Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.601 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 77.8 Cg_exo -42.5 109.44 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.123 1.882 . . . . 0.0 112.527 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.25 -8.09 37.95 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.661 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.92 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -89.78 129.72 36.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.826 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.8 t -85.67 -179.22 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 4.7 m120 -45.16 -58.47 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.578 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -59.31 -33.53 71.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.589 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.92 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.4 tp10 -62.59 -61.73 2.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.884 ' HA ' HD13 ' A' ' 689' ' ' ILE . 88.0 t -46.24 -45.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.106 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.485 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 6.7 m-30 -48.26 -45.11 34.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -62.06 -34.34 76.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.686 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.884 HD13 ' HA ' ' A' ' 686' ' ' VAL . 4.2 mp -67.37 -64.41 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.657 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.873 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -52.72 -59.27 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.202 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.5 mp -47.1 -49.1 22.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 111.004 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.9 -24.42 66.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.019 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 51.1 p -100.7 -11.78 19.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.882 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -62.61 -19.11 63.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.0 110.963 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 9.4 t -99.93 -14.2 18.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.095 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.7 138.69 90.86 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.712 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.66 -14.12 38.06 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.475 2.117 . . . . 0.0 112.736 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -156.07 162.94 40.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.872 0.367 . . . . 0.0 111.284 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 53.4 t -140.18 151.19 21.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.307 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -129.38 110.07 11.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.878 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.666 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -117.86 139.3 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 111.869 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.825 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.2 mm -118.7 146.39 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.35 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -129.92 179.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.063 0.459 . . . . 0.0 111.676 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.512 ' OG ' HD12 ' A' ' 611' ' ' ILE . 65.4 m -146.35 113.27 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.946 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.741 0.305 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 650' ' ' THR . 65.5 mt-10 61.22 166.17 0.09 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -146.0 -55.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.906 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.873 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -134.35 156.93 41.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.483 ' CE2' ' HD2' ' A' ' 633' ' ' LYS . 0.0 OUTLIER -104.03 114.28 28.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.593 178.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.944 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.022 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.65 0.262 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.3 171.58 17.99 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.554 2.169 . . . . 0.0 112.264 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -110.86 151.84 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.4 p -134.33 154.08 51.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.373 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.696 ' HB3' HD12 ' A' ' 610' ' ' LEU . 15.0 m95 -131.89 130.06 41.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -123.19 163.62 32.66 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.84 134.06 60.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.69 2.26 . . . . 0.0 112.193 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 7.4 t -60.69 -176.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.061 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -81.52 -9.17 59.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -103.88 -17.37 15.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.63 0.252 . . . . 0.0 111.194 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 82.67 11.81 81.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.808 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.8 -3.11 7.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 0.218 . . . . 0.0 111.487 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.97 40.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.2 OUTLIER -113.74 114.46 26.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 703' ' ' VAL . 32.2 mm -100.83 144.45 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.093 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.759 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.9 161.38 25.49 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.594 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.617 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.8 ptp180 -113.37 121.86 45.62 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 662' ' ' GLY . 46.4 t -117.18 131.87 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.009 0.433 . . . . 0.0 111.976 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 13.2 mm -114.47 122.18 68.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.263 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.748 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.7 mt -122.3 150.36 42.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.024 0.44 . . . . 0.0 111.366 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -126.3 131.14 51.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.493 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -104.73 -36.63 7.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.703 0.287 . . . . 0.0 111.513 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -61.35 -25.89 67.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.002 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 80.9 p -84.6 134.35 34.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.741 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.86 142.7 38.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.11 167.46 30.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.14 -29.74 87.66 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.656 2.238 . . . . 0.0 111.825 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -35.89 10.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.917 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.8 66.38 0.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.7 t -137.08 -19.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.589 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -62.56 -128.75 0.01 OUTLIER Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.718 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.514 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -171.61 -39.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.824 0.345 . . . . 0.0 111.588 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.909 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -121.23 -89.64 0.6 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.827 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.825 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -124.62 -41.82 2.12 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.79 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.518 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 153.17 7.57 0.09 OUTLIER Glycine 0 CA--C 1.523 0.571 0 C-N-CA 119.604 -1.284 . . . . 0.0 115.112 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.937 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.15 147.52 16.33 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.231 1.015 . . . . 0.0 112.276 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HE2' ' CZ2' ' B' ' 947' ' ' TRP . 10.2 ttmm -101.32 130.29 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.772 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -114.37 155.81 15.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.451 0.643 . . . . 0.0 112.289 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.03 125.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.719 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -104.76 168.15 15.84 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.651 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 645' ' ' LEU . . . 78.59 35.36 32.69 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.519 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -106.15 94.44 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.33 112.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.4 p -88.65 -177.68 5.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.995 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -16.28 64.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.2 mm? -71.88 -28.73 63.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.85 0.357 . . . . 0.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 106.1 13.11 24.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.742 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.39 167.62 18.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 682' ' ' THR . 73.6 mt -93.62 150.2 20.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -150.38 -169.97 17.05 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.528 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.669 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -116.04 139.56 50.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.509 0.195 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 635' ' ' VAL . 28.0 m-85 -130.44 133.6 46.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.77 0.319 . . . . 0.0 110.978 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 632' ' ' LEU . 38.0 mt -74.46 118.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 60.9 p -78.33 -32.5 49.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.368 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 13.7 ptmt -168.51 155.16 7.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 111.63 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.12 132.0 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.685 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.55 111.47 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.01 98.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.0 7.4 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.712 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.866 ' O ' HG22 ' A' ' 660' ' ' VAL . 62.8 p -68.12 174.17 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.037 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 617' ' ' ASN . 0.9 OUTLIER -58.09 -52.46 65.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.093 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.748 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.81 -28.75 2.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -88.0 -52.23 5.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -71.99 -55.23 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.108 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.9 p -87.56 -32.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.635 0.255 . . . . 0.0 111.508 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -75.78 -58.47 3.78 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.168 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.427 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 73.56 55.89 0.11 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.649 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -138.3 174.19 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.656 ' HA ' HG21 ' A' ' 652' ' ' VAL . 22.2 mmt180 -140.65 162.36 35.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.058 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.78 123.81 16.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.92 -20.93 6.67 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.171 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 140.78 57.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.753 0.311 . . . . 0.0 110.581 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -99.27 113.11 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.106 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.672 HG22 ' CG1' ' A' ' 703' ' ' VAL . 55.1 t -93.97 105.81 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.767 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.603 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.42 1.16 49.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -146.29 127.96 15.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.375 . . . . 0.0 111.598 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.939 ' HB2' HD11 ' A' ' 678' ' ' LEU . 22.4 t-105 -130.93 115.65 16.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.361 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.57 38.89 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.1 17.63 72.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.386 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.438 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -113.62 148.42 39.71 Favored Pre-proline 0 CA--C 1.518 -0.274 0 CA-C-N 116.988 0.394 . . . . 0.0 110.639 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -81.29 118.78 3.33 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.272 1.314 . . . . 0.0 110.99 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.939 HD11 ' HB2' ' A' ' 673' ' ' TRP . 64.0 mt -89.43 -28.8 0.35 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.806 ' HD2' ' N ' ' A' ' 678' ' ' LEU . 3.5 Cg_endo -48.18 115.75 1.68 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.592 1.528 . . . . 0.0 112.202 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.57 -10.64 42.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.704 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.86 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.851 0.357 . . . . 0.0 111.107 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.856 HG23 ' HG2' ' A' ' 684' ' ' GLU . 1.9 t -91.26 -178.67 5.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.744 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' N ' ' OG1' ' A' ' 682' ' ' THR . 6.5 p-10 -48.41 -45.67 36.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.621 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.856 ' HG2' HG23 ' A' ' 682' ' ' THR . 2.5 pt-20 -67.09 -36.32 81.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.062 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.927 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -62.05 -61.54 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.504 HG12 ' CG1' ' A' ' 690' ' ' ILE . 96.3 t -46.57 -44.9 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.883 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.47 ' CE1' HD13 ' B' ' 946' ' ' ILE . 4.6 m-30 -46.44 -44.02 17.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.669 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -67.44 -45.06 77.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.841 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.6 mp -62.75 -50.37 80.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.958 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 673' ' ' TRP . 1.3 mm -58.01 -65.55 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.966 0.412 . . . . 0.0 110.639 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 1.6 mp -45.68 -50.3 13.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.306 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.19 -30.23 66.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.652 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 699' ' ' VAL . 32.6 t -89.4 -14.62 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.202 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -25.23 64.21 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.901 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.5 -27.45 46.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.092 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.66 144.67 88.85 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.901 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.32 -6.83 18.94 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.622 2.215 . . . . 0.0 112.705 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.43 158.07 43.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.817 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 693' ' ' SER . 72.5 t -141.07 152.9 20.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 0.0 111.545 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.33 107.62 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.883 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.27 137.07 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.6 mm -116.1 145.37 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.656 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.672 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.1 m -130.46 179.51 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.074 0.464 . . . . 0.0 111.74 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.551 ' OG ' HD21 ' A' ' 671' ' ' LEU . 52.9 p -144.21 104.18 4.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.922 -179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 635' ' ' VAL . 16.8 pt-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.84 0.353 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -106.35 168.29 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . . . . . . . . . . . -130.34 -69.14 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.572 HG13 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -131.96 153.74 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.966 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.508 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -96.03 122.04 38.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.238 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.909 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.491 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.568 0.223 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.75 171.71 12.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.453 2.102 . . . . 0.0 112.198 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.6 t -120.06 150.55 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.987 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 2.0 p -138.46 157.21 46.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.223 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.45 ' CE3' ' HA3' ' A' ' 612' ' ' GLY . 73.0 m95 -130.74 129.01 41.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 603' ' ' PRO . 0.8 OUTLIER -130.88 142.35 45.24 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . 0.741 ' HA ' HD22 ' A' ' 610' ' ' LEU . 35.5 Cg_exo -60.86 156.15 45.26 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.511 2.141 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -65.8 -179.61 0.72 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.653 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -65.26 -50.36 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -63.19 -27.6 69.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.37 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 89.89 33.01 9.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.191 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.23 -24.99 3.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.683 0.278 . . . . 0.0 111.265 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.95 167.61 10.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 603' ' ' PRO . 0.2 OUTLIER -126.86 117.82 23.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 14.3 mm -115.73 142.2 29.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.799 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.93 162.52 25.59 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.367 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.678 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.8 mtm105 -106.58 118.73 37.43 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.88 HG13 ' HA2' ' A' ' 662' ' ' GLY . 60.8 t -109.52 118.9 57.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.98 0.419 . . . . 0.0 111.673 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.94 119.64 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.363 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.971 HD21 ' N ' ' A' ' 658' ' ' ALA . 2.4 mt -121.47 149.43 43.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.799 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.7 m120 -132.89 138.68 47.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.027 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.513 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.2 OUTLIER -101.56 -31.67 10.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -73.58 -28.73 62.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.559 HG23 ' HB3' ' A' ' 617' ' ' ASN . 60.5 p -59.26 -20.87 57.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.95 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.66 161.93 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.775 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.747 ' SD ' HD12 ' A' ' 657' ' ' LEU . 2.3 mpp? -102.77 164.97 14.53 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.141 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.79 -21.15 14.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.991 2.461 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.35 -41.64 47.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.411 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.58 -61.2 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.764 0.316 . . . . 0.0 111.301 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.4 p -175.37 -35.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . 0.409 ' HA3' ' CE ' ' A' ' 622' ' ' MET . . . 79.41 -97.64 1.59 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.676 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -168.79 -67.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.791 0.329 . . . . 0.0 111.629 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.884 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.3 -82.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.947 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.53 -49.72 0.98 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.983 179.693 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.47 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 161.26 10.95 0.04 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.768 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.771 HD13 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -160.79 154.13 21.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.924 1.362 . . . . 0.0 112.458 179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.443 ' HD2' ' CZ3' ' B' ' 947' ' ' TRP . 3.6 tttt -105.04 131.18 52.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.781 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -119.89 156.6 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.552 0.691 . . . . 0.0 112.549 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -126.36 125.51 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.632 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -107.03 161.12 13.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.658 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 78.16 54.9 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.599 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -122.23 100.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.048 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -58.43 106.65 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.797 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 80.8 p -74.47 174.04 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.259 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.56 -21.16 62.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.271 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.67 -40.08 19.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.04 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 121.56 17.22 3.97 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.874 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -115.82 141.73 47.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.763 0.316 . . . . 0.0 110.812 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 682' ' ' THR . 41.2 mt -87.02 147.27 25.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.761 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.71 -158.46 8.89 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.539 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.685 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -121.24 142.54 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.618 0.247 . . . . 0.0 111.237 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 635' ' ' VAL . 41.0 m-85 -131.88 130.79 42.11 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.78 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' A' ' 668' ' ' ASP . 35.3 mt -73.16 116.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.557 HG21 ' HA ' ' B' ' 944' ' ' GLU . 21.9 p -78.69 -31.1 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.338 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.584 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 2.8 ptmt -168.68 157.23 8.36 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.26 133.38 65.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 106.43 10.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.658 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 101.68 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.83 -21.5 6.61 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.367 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 660' ' ' VAL . 58.1 m -68.9 171.32 8.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 110.736 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.2 mt -58.81 -51.45 69.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.971 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.41 -31.11 2.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.89 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.53 -46.44 12.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.793 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 656' ' ' SER . 0.1 OUTLIER -77.95 -49.24 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 657' ' ' LEU . 1.4 p -83.1 -43.95 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 0.0 111.348 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.88 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -79.96 -51.19 5.18 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.224 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.487 ' C ' HD13 ' A' ' 664' ' ' LEU . 2.3 t-80 66.14 67.57 0.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.727 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -137.63 176.27 8.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.678 ' HA ' HG21 ' A' ' 652' ' ' VAL . 2.2 mtp180 -139.97 160.94 38.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.584 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.98 124.82 19.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 123.61 -20.79 7.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.183 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' A' ' 649' ' ' ILE . 18.9 m-20 -65.74 148.85 51.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.731 0.301 . . . . 0.0 110.747 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -107.48 106.55 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.155 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 678' ' ' LEU . 53.4 t -87.68 101.78 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 704' ' ' SER . 2.5 mt -82.49 -1.17 49.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 702' ' ' ILE . 5.8 mt-10 -142.5 127.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.36 . . . . 0.0 111.724 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.781 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 12.1 t-105 -130.66 110.37 11.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.046 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 68.85 37.95 2.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 110.879 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.5 17.88 73.09 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.445 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.85 145.94 33.07 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.985 0.393 . . . . 0.0 110.857 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 98.2 Cg_endo -79.83 118.96 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.295 1.33 . . . . 0.0 110.626 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 670' ' ' VAL . 84.1 mt -87.5 -38.91 0.5 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.273 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.9 Cg_exo -41.13 115.14 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.342 2.028 . . . . 0.0 112.776 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 107.13 -15.21 39.88 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.606 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.897 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -94.57 138.32 32.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.073 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.6 t -89.97 -175.11 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 682' ' ' THR . 5.3 p-10 -51.76 -47.13 64.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.348 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 687' ' ' TYR . 0.4 OUTLIER -62.06 -37.12 83.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.943 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.897 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.3 OUTLIER -63.91 -61.53 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.4 -41.08 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.827 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 18.2 m-30 -47.9 -48.07 31.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.704 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.61 -39.56 84.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.825 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.7 mp -61.27 -65.75 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.052 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.902 HD12 HD12 ' B' ' 946' ' ' ILE . 5.6 mt -51.82 -54.53 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.587 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.7 mp -49.39 -49.35 45.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.134 0.493 . . . . 0.0 111.033 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.79 -24.14 66.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 28.2 t -101.03 -13.12 18.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 19.8 pttt -74.8 -18.31 60.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.703 0.287 . . . . 0.0 111.21 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.1 -29.72 28.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.849 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.53 154.55 87.88 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.88 -9.5 19.56 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.654 2.236 . . . . 0.0 112.798 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -144.93 157.55 44.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 111.105 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 616' ' ' LEU . 61.3 t -140.92 151.45 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.98 108.93 10.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.935 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.607 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -120.87 139.8 46.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.073 0.463 . . . . 0.0 111.612 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.9 mm -119.25 147.05 23.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.334 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.6 m -129.62 178.23 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.127 0.489 . . . . 0.0 111.752 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 671' ' ' LEU . 22.3 p -141.71 113.93 8.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.872 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.866 0.365 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.557 ' HA ' HG21 ' A' ' 650' ' ' THR . 2.8 mp0 -98.85 172.43 7.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 635' ' ' VAL . . . -118.74 -64.66 0.3 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.682 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.902 HD12 HD12 ' A' ' 690' ' ' ILE . 0.3 OUTLIER -138.84 157.87 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.067 0.46 . . . . 0.0 111.254 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -92.32 118.18 30.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.997 178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.884 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.772 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 661' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.51 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.56 166.74 17.53 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.561 2.174 . . . . 0.0 112.34 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.8 t -121.17 151.35 24.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.2 p -132.84 152.9 51.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.291 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.81 ' HB3' HD12 ' A' ' 610' ' ' LEU . 52.6 m95 -131.62 131.86 43.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -122.07 157.96 56.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.92 128.91 9.5 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.787 2.325 . . . . 0.0 112.394 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.55 144.17 26.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.348 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -81.65 -8.48 59.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.566 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.76 17.71 0.09 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 128.36 21.56 1.45 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.98 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 18.6 t0 69.55 72.72 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.537 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -126.04 167.63 15.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.528 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 601' ' ' TRP . 2.1 mm? -115.73 114.37 24.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.888 0.375 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 10.7 mm -110.34 139.42 33.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.775 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.873 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.79 162.69 25.56 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.734 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.704 ' HA ' HD12 ' A' ' 702' ' ' ILE . 2.4 ttp180 -109.61 120.26 41.93 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 126.88 72.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.05 0.452 . . . . 0.0 111.93 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 5.2 mm -110.46 122.32 64.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.747 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 630' ' ' LEU . 5.6 mt -121.53 133.93 55.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.865 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.539 ' O ' HD22 ' A' ' 657' ' ' LEU . 12.3 m120 -110.9 138.42 47.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.577 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.78 ' HG2' HD23 ' A' ' 630' ' ' LEU . 0.4 OUTLIER -97.29 -29.89 13.28 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.414 ' NE ' ' HB ' ' A' ' 620' ' ' THR . 0.7 OUTLIER -98.95 -31.03 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.591 -179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.589 ' O ' ' HB ' ' A' ' 621' ' ' THR . 7.1 t -112.24 172.07 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.169 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 620' ' ' THR . 17.5 m 74.75 -7.45 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.057 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 625' ' ' GLU . 47.9 tpp -104.65 122.69 42.7 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.708 0.29 . . . . 0.0 111.255 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.36 -45.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.695 2.263 . . . . 0.0 112.729 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -86.21 -56.66 3.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.945 -179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 622' ' ' MET . 6.0 mt-10 73.9 100.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.828 0.346 . . . . 0.0 110.878 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 1.2 m -68.72 -47.04 67.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 123.66 37.54 0.58 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.573 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.836 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -136.91 -103.61 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.929 -0.16 . . . . 0.0 110.789 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.836 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -126.79 -146.84 0.34 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.78 HD23 ' HG2' ' A' ' 618' ' ' LYS . 0.0 OUTLIER -61.7 -71.9 0.14 Allowed 'General case' 0 N--CA 1.462 0.168 0 O-C-N 122.058 -0.401 . . . . 0.0 110.394 -179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 656' ' ' SER . . . 164.16 28.21 0.02 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.024 -1.084 . . . . 0.0 113.765 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.543 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.0 OUTLIER -146.49 154.15 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.916 0.389 . . . . 0.0 110.821 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.426 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -119.33 124.78 47.46 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.82 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.1 t -117.03 156.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.542 0.687 . . . . 0.0 112.473 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 647' ' ' ALA . 0.9 OUTLIER -128.39 125.46 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.764 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -105.77 170.41 17.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.648 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 76.15 40.77 28.57 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.416 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -112.06 97.76 6.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.513 ' HA ' HD23 ' A' ' 645' ' ' LEU . 2.0 ttm -59.03 107.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 1.1 p -74.54 -177.53 3.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -19.14 62.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.0 mm? -75.15 -29.07 60.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.889 0.376 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 111.28 15.18 10.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.736 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -125.13 160.59 28.74 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.674 HD13 ' HA ' ' A' ' 682' ' ' THR . 68.4 mt -91.39 149.26 21.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.38 -165.99 13.44 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.556 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.638 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -118.94 144.0 46.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.509 0.195 . . . . 0.0 111.245 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 635' ' ' VAL . 55.6 m-85 -135.38 133.56 38.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 0.0 110.949 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 668' ' ' ASP . 46.8 mt -73.84 119.34 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 3.8 p -83.3 -31.35 26.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.149 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 17.9 ptmt -166.5 153.28 9.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.088 0.47 . . . . 0.0 111.581 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -126.91 133.86 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.766 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -78.73 107.73 11.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.802 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 102.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.01 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 130.4 -27.05 4.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.868 ' O ' HG22 ' A' ' 660' ' ' VAL . 70.9 m -69.79 -178.19 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.68 0.276 . . . . 0.0 110.466 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.777 ' O ' HG12 ' A' ' 661' ' ' VAL . 0.0 OUTLIER -69.64 -46.12 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.928 0.394 . . . . 0.0 110.458 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.735 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.06 -32.96 4.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 -51.64 6.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.714 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 656' ' ' SER . 1.8 m -73.48 -55.59 12.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.777 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.5 p -80.82 -31.76 12.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.72 0.295 . . . . 0.0 111.297 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.49 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.98 -55.4 2.65 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.803 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 2.2 t-160 67.32 59.6 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.58 177.72 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.649 ' HA ' HG21 ' A' ' 652' ' ' VAL . 0.0 OUTLIER -141.16 162.2 36.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.036 0.446 . . . . 0.0 111.393 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -59.7 121.41 11.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.608 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.43 -24.06 5.33 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.519 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.63 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -61.4 143.63 55.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.72 0.295 . . . . 0.0 110.354 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -100.99 108.37 20.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.208 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.665 HG22 ' CG1' ' A' ' 703' ' ' VAL . 56.1 t -91.03 99.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.514 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . . . . . . . . . 5.4 mt -81.32 0.33 37.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.288 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.453 ' HB2' HG12 ' A' ' 702' ' ' ILE . 47.4 mt-10 -144.36 126.45 15.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 111.649 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.82 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 13.5 t-105 -130.89 112.3 12.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.298 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 67.93 37.88 2.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.042 0.448 . . . . 0.0 110.841 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.73 19.52 73.29 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.268 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -114.71 146.4 35.93 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.901 0.351 . . . . 0.0 110.886 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.0 Cg_endo -80.93 118.99 3.48 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.409 1.406 . . . . 0.0 111.066 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 673' ' ' TRP . 29.9 mt -89.27 -37.92 0.43 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.21 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 69.8 Cg_exo -41.23 118.93 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.257 1.972 . . . . 0.0 112.661 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.63 -17.85 45.39 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.522 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.889 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.55 141.73 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.839 0.352 . . . . 0.0 111.001 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.674 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -90.27 -179.05 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 8.0 p-10 -50.03 -43.02 50.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.363 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.654 ' CG ' HG23 ' A' ' 682' ' ' THR . 7.0 pt-20 -64.67 -40.62 95.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.061 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.889 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -61.57 -59.38 5.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.642 HG12 HD11 ' B' ' 946' ' ' ILE . 98.9 t -47.63 -44.03 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.738 ' O ' HD22 ' A' ' 691' ' ' LEU . 20.9 m-30 -48.26 -44.51 33.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -69.6 -35.4 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.0 mp -67.54 -66.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.952 ' CD1' HD12 ' B' ' 946' ' ' ILE . 5.0 mt -52.25 -54.49 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.625 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.78 -49.99 27.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.74 -25.09 66.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.964 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.95 -14.14 21.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.723 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.97 -25.32 64.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 0.0 110.991 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 8.9 m -83.7 -23.45 31.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.093 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 697' ' ' PRO . 0.5 OUTLIER -69.33 136.73 88.81 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.754 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 696' ' ' GLU . 32.2 Cg_exo -58.34 -16.78 30.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.522 2.148 . . . . 0.0 112.61 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -138.72 158.06 44.93 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.02 0.438 . . . . 0.0 111.399 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 616' ' ' LEU . 44.5 t -136.61 143.14 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.766 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.1 108.9 12.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.993 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.595 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -122.38 140.48 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 111.97 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.873 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.0 mm -119.47 146.67 23.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.36 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.665 ' CG1' HG22 ' A' ' 670' ' ' VAL . 7.5 m -130.32 179.31 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 111.653 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 10.5 t -147.77 126.61 12.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.912 0.387 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.71 178.82 7.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.862 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -127.97 -62.16 0.13 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.633 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.952 HD12 ' CD1' ' A' ' 690' ' ' ILE . 1.5 mt -147.29 157.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.259 0.552 . . . . 0.0 111.714 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.426 ' CZ3' ' HG3' ' A' ' 633' ' ' LYS . 0.5 OUTLIER -98.04 115.01 27.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.43 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.787 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.628 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 598' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 597' ' ' HIS . 77.0 Cg_endo -79.16 170.49 17.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.403 2.069 . . . . 0.0 112.275 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.4 t -109.18 146.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.6 p -135.8 155.66 50.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.691 ' HB3' HD12 ' A' ' 610' ' ' LEU . 47.8 m95 -129.49 123.64 32.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.59 ' O ' HD13 ' A' ' 610' ' ' LEU . 9.6 pt20 -122.57 159.32 53.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.73 138.19 41.35 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.821 2.347 . . . . 0.0 112.338 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 611' ' ' ILE . 9.0 p -81.12 -177.45 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.081 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 -9.44 59.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.395 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 -25.09 29.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.733 0.302 . . . . 0.0 110.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 95.1 -25.29 24.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.738 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.89 16.06 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.598 0.237 . . . . 0.0 111.456 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -128.19 157.23 41.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.878 0.37 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -119.15 126.75 52.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 703' ' ' VAL . 12.6 mm -110.37 146.65 15.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.768 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.23 159.14 24.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.408 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.624 ' HA ' HD12 ' A' ' 702' ' ' ILE . 18.0 mtm180 -111.19 119.57 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.739 HG13 ' HA2' ' A' ' 662' ' ' GLY . 53.6 t -110.71 122.08 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.42 . . . . 0.0 111.241 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.2 mm -107.41 115.63 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.871 HD13 HD12 ' A' ' 630' ' ' LEU . 6.7 mt -115.32 151.23 34.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.987 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 657' ' ' LEU . 17.5 m-80 -131.71 117.2 18.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.37 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.497 ' HE2' HD23 ' A' ' 630' ' ' LEU . 2.5 ptpt -112.23 39.73 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.766 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.447 ' H ' ' CD ' ' A' ' 619' ' ' ARG . 0.0 OUTLIER -73.71 -35.39 65.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.521 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.445 HG22 HH11 ' A' ' 619' ' ' ARG . 11.4 t -138.64 -170.65 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.947 0.403 . . . . 0.0 111.258 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m -58.3 151.59 19.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.049 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 624' ' ' LYS . 0.0 OUTLIER -104.87 158.68 31.51 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.025 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.49 -17.93 43.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.61 2.207 . . . . 0.0 112.483 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 622' ' ' MET . 0.0 OUTLIER -80.4 3.28 21.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.421 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.06 -176.96 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.818 0.342 . . . . 0.0 110.993 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.69 -64.46 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.838 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.32 42.7 3.64 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.388 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.847 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -55.69 -92.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.454 0.168 . . . . 0.0 110.92 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -130.44 -78.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.641 0.258 . . . . 0.0 110.986 179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.871 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -133.09 -46.64 0.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.981 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.38 3.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.212 -1.471 . . . . 0.0 115.902 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 147.35 15.51 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.051 1.425 . . . . 0.0 112.916 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.465 ' HE2' ' CD2' ' B' ' 947' ' ' TRP . 37.2 tttm -99.53 132.18 45.04 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.74 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.9 t -119.28 157.05 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.338 0.59 . . . . 0.0 112.248 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.52 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -112.67 161.91 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.369 179.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.42 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.25 154.28 23.35 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.567 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.467 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 80.29 42.92 9.96 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.639 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -103.54 88.14 3.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.481 ' N ' HD23 ' A' ' 645' ' ' LEU . 0.3 OUTLIER -58.37 116.23 3.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.966 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 25.3 p -97.22 -177.61 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -73.97 -7.89 54.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.424 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.618 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.3 mm? -90.5 11.51 21.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.627 0.251 . . . . 0.0 111.45 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.83 29.62 70.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.658 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 145.09 38.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.838 0.351 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.8 mt -90.73 154.25 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -154.82 -157.18 8.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.756 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.569 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -132.29 147.34 52.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.425 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 68.1 m-85 -134.54 139.92 45.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.647 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 668' ' ' ASP . 26.2 mt -76.97 115.75 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 110.813 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.573 HG21 ' HG3' ' B' ' 944' ' ' GLU . 0.0 OUTLIER -77.0 -30.79 56.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.511 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.6 OUTLIER -166.55 161.0 15.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.793 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.1 OUTLIER -137.37 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.881 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.92 106.35 16.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.855 0.36 . . . . 0.0 110.357 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 111.68 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.352 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.55 -32.38 3.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.344 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.781 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.4 m -64.42 175.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.798 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.3 mp -58.93 -51.11 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.045 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -48.06 -28.74 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.858 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -87.32 -49.75 7.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.784 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 656' ' ' SER . 0.5 OUTLIER -72.58 -45.4 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 657' ' ' LEU . 12.3 p -96.13 -29.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.636 0.255 . . . . 0.0 111.675 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.739 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -86.86 -55.51 2.39 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.15 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.456 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER 65.69 65.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 111.846 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.719 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.42 174.47 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' A' ' 652' ' ' VAL . 4.6 mtt180 -136.42 155.65 49.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.91 0.386 . . . . 0.0 111.292 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.39 122.81 12.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.785 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.05 -20.55 5.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.94 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.553 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.1 143.44 56.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.829 0.347 . . . . 0.0 110.468 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.5 tt0 -99.4 112.49 24.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.056 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.68 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.7 t -94.01 101.25 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.615 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -82.19 0.35 41.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.248 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.43 ' HB2' HG12 ' A' ' 702' ' ' ILE . 5.4 mm-40 -143.79 126.61 16.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.427 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.74 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 18.2 t-105 -130.73 115.51 16.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.24 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 65.12 42.17 4.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.935 0.398 . . . . 0.0 110.552 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 63.46 16.74 58.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.299 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.423 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -108.4 146.81 34.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.029 0.414 . . . . 0.0 110.883 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.421 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 92.4 Cg_endo -82.1 118.96 3.08 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.548 1.498 . . . . 0.0 110.935 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 673' ' ' TRP . 61.0 mt -88.84 -35.18 0.42 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.483 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.34 109.51 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.234 1.956 . . . . 0.0 112.779 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.67 -9.05 34.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.503 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 1.001 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -95.79 130.25 42.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.879 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -84.98 -179.04 6.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.424 ' O ' ' CD1' ' A' ' 687' ' ' TYR . 2.6 p-10 -47.09 -53.63 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.849 ' HG3' HG23 ' A' ' 682' ' ' THR . 0.0 OUTLIER -59.0 -34.27 71.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.29 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 1.001 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -63.91 -61.62 2.17 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 87.1 t -50.69 -42.61 22.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.673 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.703 ' O ' HD22 ' A' ' 691' ' ' LEU . 5.4 m-30 -45.93 -46.63 16.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.853 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -70.37 -43.63 69.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.825 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.6 mp -57.35 -63.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.962 HD12 HG13 ' B' ' 946' ' ' ILE . 5.1 mt -56.21 -58.24 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.126 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.7 OUTLIER -47.65 -50.84 23.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.048 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -57.95 -28.68 64.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.834 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 1.4 p -92.75 -12.22 31.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.427 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -58.51 -21.56 52.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.667 0.27 . . . . 0.0 110.94 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.99 3.52 51.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.589 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -88.71 125.5 62.75 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.592 0.234 . . . . 0.0 110.649 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.88 -17.14 22.65 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.64 150.52 43.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 66.0 t -138.45 148.75 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.945 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.4 OUTLIER -129.34 109.06 10.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.538 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -116.98 136.17 55.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.131 0.491 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.0 mm -115.88 145.54 21.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.68 ' CG1' HG22 ' A' ' 670' ' ' VAL . 11.0 m -130.26 179.77 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.851 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.48 ' OG ' HD21 ' A' ' 671' ' ' LEU . 83.5 p -146.28 117.27 7.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.827 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.855 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 635' ' ' VAL . 22.4 tt0 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.573 ' HG3' HG21 ' A' ' 650' ' ' THR . 1.4 mt-10 -88.71 -175.02 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.412 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -145.2 -47.76 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.487 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.962 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.56 150.63 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.071 0.463 . . . . 0.0 111.523 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.497 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.0 OUTLIER -96.31 120.78 37.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.673 178.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.821 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.351 -0.833 . . . . 0.0 110.651 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.714 0.292 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.4 171.58 17.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 613' ' ' ARG . 2.8 t -103.93 152.09 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.032 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.2 152.78 42.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.634 ' HB3' HD12 ' A' ' 610' ' ' LEU . 24.6 m95 -131.3 131.9 44.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -119.83 142.06 32.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.782 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 610' ' ' LEU . 21.0 Cg_endo -60.68 139.58 86.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.654 2.236 . . . . 0.0 112.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.6 t -60.65 176.06 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.758 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.5 -54.49 42.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.92 -27.66 69.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.318 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.0 10.2 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.159 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.38 -22.41 3.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.585 0.231 . . . . 0.0 111.217 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.09 152.78 30.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.854 0.359 . . . . 0.0 110.917 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -115.52 114.47 25.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.589 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 12.5 mm -105.63 143.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.265 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.822 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.69 159.06 24.83 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.468 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 3.1 ttt180 -108.37 119.13 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.564 HG13 ' HA2' ' A' ' 662' ' ' GLY . 51.1 t -112.85 123.14 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 121.009 0.433 . . . . 0.0 111.889 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.9 mm -107.74 115.55 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.763 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.86 HD21 ' N ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -121.19 151.5 39.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 111.275 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.841 ' O ' HD13 ' A' ' 657' ' ' LEU . 6.3 m120 -130.52 144.95 51.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.025 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.438 ' HE2' ' CD2' ' A' ' 630' ' ' LEU . 0.0 OUTLIER -106.27 -28.53 10.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -46.28 70.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.655 HG23 HD11 ' A' ' 657' ' ' LEU . 9.0 t -59.54 135.49 57.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.711 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 3.6 m -67.59 148.75 51.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 111.256 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.534 ' HG2' ' H ' ' A' ' 625' ' ' GLU . 0.0 OUTLIER -104.98 167.53 9.71 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.898 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 -46.93 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.815 2.344 . . . . 0.0 112.686 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.41 62.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.514 . . . . 0.0 110.596 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.534 ' H ' ' HG2' ' A' ' 622' ' ' MET . 0.7 OUTLIER 62.34 126.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.533 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -46.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.483 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 97.19 73.48 1.14 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.702 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.862 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -155.9 -97.96 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.572 0.186 . . . . 0.0 111.325 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.862 HD13 ' C ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -117.81 -132.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.431 -0.107 . . . . 0.0 110.816 -179.384 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -91.57 -72.24 0.6 Allowed 'General case' 0 C--N 1.341 0.199 0 O-C-N 122.132 -0.355 . . . . 0.0 110.736 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -178.8 21.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 C-N-CA 119.659 -1.258 . . . . 0.0 115.003 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.871 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.59 144.02 13.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.174 0.987 . . . . 0.0 111.935 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.467 ' HG3' ' CZ3' ' B' ' 947' ' ' TRP . 0.0 OUTLIER -97.81 132.22 43.61 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -116.27 154.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.276 0.56 . . . . 0.0 111.72 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -117.07 161.3 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.64 179.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.415 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -139.88 148.58 20.16 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 82.94 54.64 3.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 645' ' ' LEU . 22.2 mmtt -121.26 95.2 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.392 . . . . 0.0 110.998 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.464 ' HE3' ' HG ' ' A' ' 645' ' ' LEU . 0.0 OUTLIER -59.12 111.59 1.39 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.697 179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.44 179.65 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.284 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.28 -20.58 66.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . . . . . . . . . 5.9 mt -83.25 -41.62 18.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.057 0.456 . . . . 0.0 110.947 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 123.25 17.12 3.35 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.804 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -113.71 141.87 46.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 110.77 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.781 HD13 ' HA ' ' A' ' 682' ' ' THR . 13.5 mt -86.78 146.0 26.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.092 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -155.55 -159.95 9.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.495 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 635' ' ' VAL . . . -127.94 145.26 51.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 111.291 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 669' ' ' GLU . 78.8 m-85 -135.99 143.35 44.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.487 HG12 HD23 ' A' ' 632' ' ' LEU . 13.6 mt -79.9 116.99 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.721 HG21 ' HA ' ' B' ' 944' ' ' GLU . 3.5 p -73.86 -30.66 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.468 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.738 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 16.3 ptmt -171.45 158.17 5.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.206 0.527 . . . . 0.0 111.698 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -128.38 134.53 64.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.909 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.76 106.46 14.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.615 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.42 104.24 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 125.98 -27.79 5.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.25 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 660' ' ' VAL . 7.3 m -67.73 174.8 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.83 0.347 . . . . 0.0 110.808 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.841 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.3 mt -58.1 -51.21 70.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.14 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.871 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -46.5 -29.04 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.048 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.8 -46.2 10.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.867 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 656' ' ' SER . 0.2 OUTLIER -78.94 -47.12 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 657' ' ' LEU . 7.2 p -92.37 -31.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.608 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.92 -56.0 2.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.998 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.441 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.6 t-160 68.69 58.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -132.94 174.17 10.63 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.669 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.9 ptm180 -137.47 157.39 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.039 0.447 . . . . 0.0 111.466 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -54.21 121.49 8.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.79 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.47 -22.49 6.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.813 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.461 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.7 OUTLIER -62.51 140.2 58.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.379 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 43.5 tt0 -100.16 111.75 24.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.263 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 678' ' ' LEU . 55.3 t -93.17 102.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.681 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 704' ' ' SER . 0.4 OUTLIER -83.54 1.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.415 ' HB2' HG12 ' A' ' 702' ' ' ILE . 8.1 mt-10 -145.68 126.49 14.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.866 0.365 . . . . 0.0 111.449 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.0 t-105 -130.94 114.76 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.262 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 66.55 37.87 4.35 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.967 0.413 . . . . 0.0 110.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.29 17.56 72.4 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.219 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.454 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.98 146.11 33.81 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 117.025 0.412 . . . . 0.0 110.816 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.441 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 95.0 Cg_endo -80.78 118.96 3.53 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.467 1.444 . . . . 0.0 110.835 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 670' ' ' VAL . 73.1 mt -86.41 -38.95 0.55 Allowed Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.103 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 60.5 Cg_exo -40.18 113.58 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.392 2.061 . . . . 0.0 112.715 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.8 -14.85 31.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -96.23 137.16 35.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.781 ' HA ' HD13 ' A' ' 645' ' ' LEU . 4.5 t -89.63 -170.09 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.801 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.429 ' N ' ' OG1' ' A' ' 682' ' ' THR . 32.4 t30 -53.03 -52.49 58.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.507 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.73 ' HG2' HG23 ' A' ' 682' ' ' THR . 5.8 pt-20 -60.8 -32.42 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.25 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.903 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 18.0 mm-40 -65.77 -61.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 68.2 t -50.82 -39.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.556 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.39 -53.19 18.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.783 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -65.2 -36.24 83.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 685' ' ' GLU . 2.0 mp -65.69 -66.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.084 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.02 HD12 HG13 ' B' ' 946' ' ' ILE . 5.7 mt -54.14 -58.46 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.659 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.5 mp -45.64 -51.24 12.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.069 0.462 . . . . 0.0 111.321 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -56.57 -26.12 54.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.792 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 14.8 t -94.62 -13.09 26.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.51 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.415 ' HE3' HD12 ' A' ' 691' ' ' LEU . 10.8 mttt -63.24 -21.6 66.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.655 0.264 . . . . 0.0 111.013 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.4 t -81.5 -26.3 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -71.47 142.12 86.22 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.902 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.98 -4.93 16.14 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.533 2.156 . . . . 0.0 112.602 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -143.21 154.9 44.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 616' ' ' LEU . 54.2 t -144.61 152.14 15.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 111.361 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -129.39 110.16 11.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.704 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.2 pt -120.67 140.6 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.52 . . . . 0.0 111.857 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.1 mm -117.61 145.95 22.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.404 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.637 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.3 m -128.6 178.97 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.104 0.478 . . . . 0.0 111.751 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.629 ' HB3' HD21 ' A' ' 671' ' ' LEU . 4.5 t -144.1 119.87 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.776 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.885 0.374 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.721 ' HA ' HG21 ' A' ' 650' ' ' THR . 0.3 OUTLIER -154.1 177.77 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.616 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -150.16 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.674 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.02 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -141.48 144.97 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.035 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.575 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -94.1 122.19 36.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.963 178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.856 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.452 -0.785 . . . . 0.0 110.863 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.422 ' N ' ' CD ' ' A' ' 598' ' ' PRO . 2.6 t60 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 93.9 Cg_endo -80.64 168.52 17.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.456 2.104 . . . . 0.0 112.404 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.657 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -92.94 151.92 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 151.22 41.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.772 ' HB3' HD12 ' A' ' 610' ' ' LEU . 38.4 m95 -129.96 126.69 38.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -119.3 155.66 53.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -50.45 132.27 34.58 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.784 2.323 . . . . 0.0 112.257 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 8.2 t -60.79 -175.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.085 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.27 -9.31 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.425 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.17 -10.16 15.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.271 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 75.11 13.45 82.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.817 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.64 -0.14 8.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.566 0.222 . . . . 0.0 111.459 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -133.05 167.54 20.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.773 0.321 . . . . 0.0 110.841 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.5 OUTLIER -121.71 114.48 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.749 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.82 141.03 18.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.223 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.8 162.66 25.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.586 ' HA ' HD12 ' A' ' 702' ' ' ILE . 0.0 OUTLIER -116.32 128.03 55.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 0.0 110.334 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 599' ' ' VAL . 48.2 t -115.92 128.56 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.994 0.426 . . . . 0.0 111.763 -178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.847 HD12 ' HG3' ' A' ' 700' ' ' GLU . 1.2 mm -110.84 118.91 58.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.163 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.915 HD13 HD12 ' A' ' 630' ' ' LEU . 6.1 mt -123.51 151.3 42.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.818 ' O ' HD13 ' A' ' 657' ' ' LEU . 22.4 m-80 -131.05 132.83 45.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.122 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.744 ' HZ3' HG21 ' A' ' 699' ' ' VAL . 1.6 mttp -94.35 -29.23 15.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -81.22 -28.03 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.537 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 617' ' ' ASN . 10.9 t -57.85 -22.66 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 111.092 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 626' ' ' SER . 0.6 OUTLIER 69.44 170.99 0.3 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.173 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' A' ' 626' ' ' SER . 0.0 OUTLIER -104.58 165.63 12.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 -20.4 14.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -84.51 -56.03 3.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.151 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -173.01 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 621' ' ' THR . 0.3 OUTLIER 75.44 163.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.911 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 167.22 -29.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.696 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.908 ' O ' HD13 ' A' ' 629' ' ' LEU . . . -84.18 -105.53 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.626 0.213 . . . . 0.0 111.133 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.908 HD13 ' O ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -137.14 -83.46 0.34 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.377 -0.202 . . . . 0.0 111.03 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.915 HD12 HD13 ' A' ' 616' ' ' LEU . 0.1 OUTLIER -121.57 -45.9 2.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.895 -0.139 . . . . 0.0 110.897 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.507 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 157.74 11.55 0.05 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 119.433 -1.365 . . . . 0.0 115.745 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 658' ' ' ALA . 0.0 OUTLIER -160.84 154.05 21.62 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.705 1.253 . . . . 0.0 112.067 179.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -105.58 134.06 49.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.728 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.8 t -125.48 154.66 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.367 0.603 . . . . 0.0 111.837 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.494 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -105.68 159.35 5.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.145 178.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -137.44 131.39 5.5 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.034 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 683' ' ' ASN . . . 78.9 61.73 2.35 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.295 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 638' ' ' LYS . 13.5 ptpt -123.49 117.53 25.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.205 0.526 . . . . 0.0 110.356 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -63.97 104.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.246 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.462 HG21 ' HZ ' ' A' ' 648' ' ' PHE . 0.5 OUTLIER -84.09 -173.89 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.39 -22.15 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.284 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 642' ' ' LEU . 3.3 mm? -69.99 -26.92 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 102.99 11.26 34.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.696 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -128.86 170.3 13.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.776 0.322 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 682' ' ' THR . 29.3 mt -96.43 149.17 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -153.34 -157.14 7.92 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.415 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.449 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.15 125.24 25.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.437 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.462 ' HZ ' HG21 ' A' ' 640' ' ' THR . 49.5 m-85 -120.39 148.3 43.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.495 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.723 HD12 ' HB2' ' A' ' 668' ' ' ASP . 14.5 mt -83.1 116.32 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.907 HG21 ' HA ' ' B' ' 944' ' ' GLU . 7.4 p -75.45 -29.5 59.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.635 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.729 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.0 OUTLIER -174.25 153.91 2.09 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.116 0.484 . . . . 0.0 111.796 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.659 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -122.58 137.03 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.864 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.7 106.47 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.505 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 106.35 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 126.44 -22.64 5.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.463 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.803 ' O ' HG22 ' A' ' 660' ' ' VAL . 31.2 m -74.6 178.46 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.4 mt -62.11 -53.19 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.828 ' CB ' HD12 ' A' ' 632' ' ' LEU . . . -47.99 -27.59 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.658 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 -49.01 8.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.599 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 656' ' ' SER . 0.9 OUTLIER -77.64 -46.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.249 -179.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 657' ' ' LEU . 11.6 p -93.92 -31.84 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.631 0.253 . . . . 0.0 111.482 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.615 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -78.42 -57.18 3.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.017 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.423 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 70.58 55.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -134.63 172.18 13.3 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.659 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.1 mmp_? -138.34 158.7 43.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.729 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -53.56 123.07 11.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.877 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.6 -22.5 6.15 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.781 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.723 ' HB2' HD12 ' A' ' 649' ' ' ILE . 3.2 m-20 -65.22 146.24 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.745 0.307 . . . . 0.0 110.565 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 648' ' ' PHE . 30.7 tt0 -106.52 107.7 18.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.167 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.661 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.3 t -86.48 106.46 15.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.535 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 704' ' ' SER . 1.7 mt -84.85 1.0 48.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -147.31 127.53 13.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.378 . . . . 0.0 111.683 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.876 ' HB2' HD11 ' A' ' 678' ' ' LEU . 13.3 t-105 -130.69 115.45 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.201 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . 0.593 HD22 HG22 ' A' ' 699' ' ' VAL . 5.2 t-20 65.73 37.1 5.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 110.692 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.57 12.76 70.54 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.308 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.442 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.82 149.0 39.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.085 0.443 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.415 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 83.6 Cg_endo -83.45 119.1 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.617 1.545 . . . . 0.0 110.991 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.876 HD11 ' HB2' ' A' ' 673' ' ' TRP . 9.6 mt -88.65 -36.69 0.44 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.363 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.9 Cg_exo -41.93 113.65 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.267 1.978 . . . . 0.0 112.693 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 108.31 -12.9 36.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.627 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 685' ' ' GLU . . . -95.08 139.48 31.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.914 0.388 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.6 t -89.11 -174.13 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.478 ' N ' ' OG1' ' A' ' 682' ' ' THR . 4.7 p30 -50.78 -50.29 56.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.396 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -37.47 78.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.164 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.936 ' CB ' ' HB1' ' A' ' 681' ' ' ALA . 4.7 mm-40 -64.34 -61.8 2.01 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 71.5 t -55.4 -40.92 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.574 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.672 ' O ' HD22 ' A' ' 691' ' ' LEU . 3.1 m-30 -49.73 -47.99 50.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.691 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -70.14 -40.51 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.694 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.86 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.3 mp -59.52 -63.84 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.998 HD12 HG13 ' B' ' 946' ' ' ILE . 5.2 mt -56.95 -56.46 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.258 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.672 HD22 ' O ' ' A' ' 687' ' ' TYR . 0.8 OUTLIER -47.17 -49.51 22.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.134 0.492 . . . . 0.0 110.944 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.29 -26.06 38.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.633 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 3.5 m -90.23 -14.32 33.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.656 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.504 ' HD3' HD12 ' A' ' 629' ' ' LEU . 1.8 mtmt -60.14 -20.47 58.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.6 t -102.62 -0.01 32.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.504 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -83.52 144.99 46.92 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-O 120.665 0.269 . . . . 0.0 110.859 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.34 -11.59 24.84 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.491 2.127 . . . . 0.0 112.667 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -157.38 157.69 34.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.102 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.744 HG21 ' HZ3' ' A' ' 618' ' ' LYS . 17.1 t -144.27 150.7 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.075 0.464 . . . . 0.0 111.297 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.847 ' HG3' HD12 ' A' ' 615' ' ' ILE . 3.6 tt0 -127.89 111.29 13.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.151 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.625 HD11 HD12 ' A' ' 616' ' ' LEU . 0.9 OUTLIER -117.37 136.55 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.656 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.5 mm -114.84 144.78 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.565 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.661 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.6 m -129.17 176.87 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.1 0.476 . . . . 0.0 111.811 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.421 ' HB3' HD11 ' A' ' 671' ' ' LEU . 80.9 p -141.52 122.49 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.721 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.86 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.815 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.907 ' HA ' HG21 ' A' ' 650' ' ' THR . 1.9 pt-20 -158.54 177.32 11.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.538 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -162.45 -43.67 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.508 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 0.998 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -144.13 147.78 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.077 0.465 . . . . 0.0 111.572 -179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 1.2 m95 -94.32 125.77 39.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.317 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.805 ' OXT' HD13 ' A' ' 632' ' ' LEU . . . . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.526 -0.75 . . . . 0.0 110.938 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.57 0.224 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.06 171.59 13.42 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.537 2.158 . . . . 0.0 112.315 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.732 HG21 HG22 ' A' ' 614' ' ' VAL . 2.7 t -111.52 152.14 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.028 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.39 158.28 23.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.038 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.638 ' CB ' HD12 ' A' ' 610' ' ' LEU . 14.7 m95 -132.2 121.82 24.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 611' ' ' ILE . 3.4 pm0 -109.66 156.18 40.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.9 127.24 22.45 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.679 2.253 . . . . 0.0 112.222 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 16.0 t -60.83 -175.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -80.87 -9.36 59.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -96.68 -14.26 22.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 78.54 0.15 78.27 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.14 8.26 8.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.798 0.299 . . . . 0.0 111.349 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.76 164.76 26.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.796 0.332 . . . . 0.0 110.84 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.638 HD12 ' CB ' ' A' ' 601' ' ' TRP . 0.5 OUTLIER -120.97 114.45 21.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.975 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 602' ' ' GLN . 31.9 mm -102.49 141.14 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.761 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -132.68 160.0 23.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.567 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.615 ' HA ' HD12 ' A' ' 702' ' ' ILE . 5.7 ptp180 -111.48 121.73 45.97 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.732 HG22 HG21 ' A' ' 599' ' ' VAL . 45.3 t -116.89 127.84 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 111.659 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . 0.578 HG21 HE21 ' A' ' 698' ' ' GLN . 4.6 mp -113.52 122.83 68.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.316 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.777 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -118.4 147.84 43.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.758 ' O ' HD13 ' A' ' 657' ' ' LEU . 44.1 t-20 -126.55 119.53 27.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.734 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 694' ' ' LYS . 0.0 OUTLIER -88.92 -31.1 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -32.41 72.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.53 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 75.6 p -94.82 96.93 9.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.774 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.404 ' OG1' ' HA ' ' A' ' 626' ' ' SER . 6.3 t -56.92 177.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.501 ' HE1' ' HA3' ' A' ' 627' ' ' GLY . 0.0 OUTLIER -98.81 165.52 14.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.982 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.76 -45.63 6.18 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 123.119 2.546 . . . . 0.0 113.468 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.492 ' HG2' ' HG3' ' A' ' 622' ' ' MET . 0.0 OUTLIER -53.39 -40.25 64.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 6.0 pt-20 178.02 -154.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.566 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.404 ' HA ' ' OG1' ' A' ' 621' ' ' THR . 3.6 m -94.9 134.26 37.74 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.711 0.291 . . . . 0.0 110.626 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . 0.501 ' HA3' ' HE1' ' A' ' 622' ' ' MET . . . -99.14 177.23 29.89 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.66 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.667 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -86.79 -63.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.86 0.362 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.955 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.64 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.813 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.1 OUTLIER -131.79 -41.93 1.03 Allowed 'General case' 0 N--CA 1.463 0.21 0 O-C-N 122.305 -0.247 . . . . 0.0 111.224 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 153.77 7.17 0.09 OUTLIER Glycine 0 CA--C 1.524 0.626 0 C-N-CA 119.61 -1.281 . . . . 0.0 115.168 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.941 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -160.47 148.23 16.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.3 1.05 . . . . 0.0 112.1 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' B' ' 947' ' ' TRP . 2.8 ttmt -101.89 129.15 48.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.848 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.782 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 3.3 t -113.76 155.93 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.338 0.59 . . . . 0.0 111.903 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.572 HG22 ' C ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -115.02 160.6 14.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.575 179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -137.55 147.66 19.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.621 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 83.0 49.27 5.11 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -112.1 90.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.474 ' HA ' HD23 ' A' ' 645' ' ' LEU . 1.3 ttm -58.58 113.42 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.3 p -84.68 178.57 7.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.79 -13.6 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.298 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.9 mm? -78.31 -32.28 49.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 112.0 16.39 9.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.653 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.14 155.76 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.758 0.313 . . . . 0.0 110.952 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 682' ' ' THR . 62.8 mt -90.41 150.12 21.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -151.71 -160.19 9.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.71 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -125.48 156.84 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.328 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 72.6 m-85 -148.96 137.63 21.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 632' ' ' LEU . 22.7 mt -79.8 119.13 28.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.866 0.365 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.555 HG21 ' HA ' ' B' ' 944' ' ' GLU . 2.8 p -77.65 -32.08 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.257 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.1 OUTLIER -169.3 155.46 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.135 0.493 . . . . 0.0 111.66 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -124.43 133.78 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.897 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.83 106.45 12.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -59.03 102.56 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 128.63 -24.52 4.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.312 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.6 m -74.79 168.23 20.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.926 0.394 . . . . 0.0 110.899 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.1 mt -51.19 -50.87 58.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.621 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.777 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.22 -27.69 1.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.699 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -89.93 -50.55 5.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 656' ' ' SER . 1.5 m -74.55 -44.18 47.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 657' ' ' LEU . 13.5 p -98.55 -29.91 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.673 0.273 . . . . 0.0 111.522 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.517 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -80.09 -58.61 2.75 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.251 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.463 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.2 OUTLIER 71.89 60.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.716 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -140.4 173.32 11.62 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.665 ' HA ' HG21 ' A' ' 652' ' ' VAL . 3.0 mtp-105 -142.22 163.72 32.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.967 0.413 . . . . 0.0 111.319 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -57.03 124.01 17.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.46 -23.05 6.47 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.985 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 649' ' ' ILE . 2.0 m-20 -66.8 141.54 57.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 110.457 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.567 ' CD ' HD11 ' A' ' 671' ' ' LEU . 20.9 tt0 -101.52 115.54 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.046 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.655 HG22 ' CG1' ' A' ' 703' ' ' VAL . 54.4 t -95.31 102.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -83.44 1.06 43.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.444 ' HB2' HG12 ' A' ' 702' ' ' ILE . 15.6 mt-10 -145.17 126.61 14.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 111.512 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.782 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 22.8 t-105 -130.71 116.02 17.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.161 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 64.95 37.23 7.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.049 0.452 . . . . 0.0 110.614 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.66 18.38 72.02 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.363 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.416 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -109.03 147.07 35.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 117.123 0.461 . . . . 0.0 110.896 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.406 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 94.4 Cg_endo -81.06 118.84 3.42 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.428 1.419 . . . . 0.0 110.64 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 673' ' ' TRP . 73.1 mt -90.75 -29.69 0.33 Allowed Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 70.9 Cg_exo -41.36 109.31 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.107 1.871 . . . . 0.0 112.554 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 105.09 -1.71 40.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.347 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -91.46 130.33 37.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.793 0.33 . . . . 0.0 111.177 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.2 t -88.64 179.13 6.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -50.09 -46.56 53.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.523 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -69.67 -30.13 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.175 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 689' ' ' ILE . 0.8 OUTLIER -66.59 -61.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 67.8 t -51.86 -39.26 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.583 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.529 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 2.3 m-30 -48.03 -51.85 22.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.745 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.5 -38.91 85.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.79 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 685' ' ' GLU . 1.7 mp -61.58 -63.09 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.101 HD12 HG13 ' B' ' 946' ' ' ILE . 4.6 mt -56.62 -57.2 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.288 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 687' ' ' TYR . 1.1 mp -46.96 -50.53 18.85 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.15 0.5 . . . . 0.0 111.052 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -24.96 66.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.658 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 23.4 m -96.28 -10.51 27.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.689 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 618' ' ' LYS . 0.1 OUTLIER -72.85 -7.79 52.5 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.639 0.257 . . . . 0.0 111.185 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.75 3.5 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.232 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.76 147.02 35.18 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 0.0 111.05 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.18 -23.24 76.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.579 2.186 . . . . 0.0 112.606 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . 0.578 HE21 HG21 ' A' ' 615' ' ' ILE . 3.3 tt0 -146.67 162.69 37.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.18 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . . . . . . . . . 50.7 t -140.7 139.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -114.99 107.96 16.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.025 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 673' ' ' TRP . 1.1 pt -116.39 137.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.068 0.461 . . . . 0.0 111.706 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.4 mm -117.38 146.74 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.655 ' CG1' HG22 ' A' ' 670' ' ' VAL . 9.7 m -130.53 177.77 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 22.8 t -151.84 144.67 24.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.853 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 121.015 0.436 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.572 ' C ' HG22 ' A' ' 635' ' ' VAL . 4.8 mp0 60.72 177.49 0.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.767 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -155.68 -58.1 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.089 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.101 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -138.92 147.17 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.958 0.409 . . . . 0.0 111.218 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.528 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.3 OUTLIER -89.73 122.56 32.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.488 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.955 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.622 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.705 ' HA ' HG23 ' A' ' 661' ' ' VAL . 41.8 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 597' ' ' HIS . 85.5 Cg_endo -82.88 128.03 5.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.344 2.03 . . . . 0.0 112.322 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.502 HG21 HG22 ' A' ' 614' ' ' VAL . 2.7 t -92.46 151.96 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.1 p -123.19 151.69 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.117 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.69 ' HB3' HD12 ' A' ' 610' ' ' LEU . 29.5 m95 -130.01 131.28 45.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 603' ' ' PRO . 0.0 OUTLIER -123.4 161.55 44.89 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.998 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 602' ' ' GLN . 80.5 Cg_exo -45.4 125.71 7.66 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.729 2.286 . . . . 0.0 112.569 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.418 ' HA ' HG12 ' A' ' 611' ' ' ILE . 46.6 t -66.33 175.67 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -20.52 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.269 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -88.42 -16.9 31.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 93.38 -43.32 2.52 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -95.03 14.68 21.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.585 0.231 . . . . 0.0 111.465 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 604' ' ' SER . 4.0 mpt_? -122.6 158.65 29.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.753 0.311 . . . . 0.0 110.597 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 601' ' ' TRP . 0.3 OUTLIER -121.08 116.36 24.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.078 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 604' ' ' SER . 26.4 mm -105.85 146.32 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.75 162.35 25.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.691 ' HA ' HD12 ' A' ' 702' ' ' ILE . 12.4 mtt180 -112.11 121.55 45.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.502 HG22 HG21 ' A' ' 599' ' ' VAL . 39.9 t -115.13 126.29 72.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 111.723 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 4.8 mm -108.97 119.33 58.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.921 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.773 HD11 ' HA ' ' A' ' 658' ' ' ALA . 2.9 mt -120.99 147.78 45.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.959 0.409 . . . . 0.0 111.447 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.796 ' O ' HD13 ' A' ' 657' ' ' LEU . 7.8 m120 -129.06 133.1 47.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.502 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -101.29 -31.05 11.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.536 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.13 12.13 37.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 621' ' ' THR . 9.6 t -167.16 -177.2 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.924 0.392 . . . . 0.0 111.539 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 621' ' ' THR . 0.5 OUTLIER 54.08 22.21 3.38 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.515 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.843 ' CE ' HD11 ' A' ' 657' ' ' LEU . 0.6 OUTLIER -83.93 123.34 75.9 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.476 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.95 -45.69 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.475 2.117 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 625' ' ' GLU . 13.9 ptmt -89.47 -55.87 3.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 624' ' ' LYS . 2.5 pt-20 175.75 -171.52 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.72 0.295 . . . . 0.0 110.712 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 4.2 p -90.73 77.1 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.843 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -58.64 -76.87 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.753 ' C ' HD13 ' A' ' 629' ' ' LEU . . . -139.7 -75.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.847 HD23 ' OXT' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -119.17 -127.68 0.28 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.57 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -88.23 -42.92 11.97 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.081 0.401 . . . . 0.0 110.773 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . 149.04 6.02 0.22 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.054 -1.07 . . . . 0.0 114.363 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.922 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.3 OUTLIER -149.08 144.62 26.78 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.026 0.913 . . . . 0.0 112.316 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.457 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 7.8 tttt -96.53 131.05 43.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.758 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.746 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 4.0 t -120.73 156.12 24.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.547 0.689 . . . . 0.0 112.179 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.515 HG23 ' HA ' ' B' ' 944' ' ' GLU . 0.9 OUTLIER -114.88 161.87 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.691 179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -131.97 149.4 19.36 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 73.09 72.71 0.94 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.649 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -130.11 95.8 4.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 0.0 111.014 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.412 ' HE1' ' O ' ' A' ' 643' ' ' GLY . 0.6 OUTLIER -58.47 109.01 0.7 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.68 HG21 ' OE2' ' A' ' 669' ' ' GLU . 1.9 p -85.5 -178.04 6.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.077 0.465 . . . . 0.0 111.408 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -62.96 -21.25 65.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.457 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 644' ' ' ARG . 3.3 mt -76.12 -49.72 16.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.166 0.508 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.412 ' O ' ' HE1' ' A' ' 639' ' ' MET . . . 127.19 15.58 2.5 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.441 -0.8 . . . . 0.0 113.003 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . 0.419 ' CZ ' HD13 ' A' ' 642' ' ' LEU . 28.2 ptt180 -122.67 155.94 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.597 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.678 HD13 ' HA ' ' A' ' 682' ' ' THR . 47.9 mt -89.66 147.06 24.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.4 -160.49 9.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.602 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -123.6 143.29 50.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.235 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 669' ' ' GLU . 36.8 m-85 -135.33 137.22 42.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.664 HD13 HD12 ' A' ' 632' ' ' LEU . 31.7 mt -77.51 115.98 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.906 0.384 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -31.08 57.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.617 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 20.7 ptmt -169.89 149.6 3.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.148 0.499 . . . . 0.0 112.016 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -121.19 132.51 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.491 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.05 122.77 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.834 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -59.05 154.86 14.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.02 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 65.15 13.88 58.41 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.829 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.717 ' O ' HG22 ' A' ' 660' ' ' VAL . 50.7 m -105.6 163.28 12.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.809 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.843 HD11 ' CE ' ' A' ' 622' ' ' MET . 0.9 OUTLIER -53.09 -55.71 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.169 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.773 ' HA ' HD11 ' A' ' 616' ' ' LEU . . . -48.13 -28.32 2.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.01 -50.58 6.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.683 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 656' ' ' SER . 0.0 OUTLIER -77.17 -55.59 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.062 -179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.705 HG23 ' HA ' ' A' ' 597' ' ' HIS . 11.0 p -83.98 -30.41 7.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.544 0.211 . . . . 0.0 111.449 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.508 ' C ' HD13 ' A' ' 664' ' ' LEU . . . -84.29 -53.85 3.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.156 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 66.91 60.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.603 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -136.65 175.22 9.81 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 1.5 mmt85 -140.73 160.56 39.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.957 0.408 . . . . 0.0 111.33 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.85 122.51 11.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.53 -20.29 6.95 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.051 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.456 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.5 OUTLIER -64.35 143.2 58.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.762 0.315 . . . . 0.0 110.527 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.68 ' OE2' HG21 ' A' ' 640' ' ' THR . 32.2 tt0 -102.27 104.32 14.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.129 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.652 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.0 t -87.39 100.84 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.55 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 679' ' ' PRO . 3.9 mt -80.63 -0.65 38.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.254 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.424 ' HB2' HG12 ' A' ' 702' ' ' ILE . 13.9 mm-40 -144.81 126.35 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 111.565 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.746 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 20.9 t-105 -130.78 115.8 17.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.131 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 68.5 37.17 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.963 0.411 . . . . 0.0 110.622 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.06 21.54 71.78 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.382 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.43 ' HD3' ' HD2' ' A' ' 677' ' ' PRO . 0.0 OUTLIER -115.6 150.25 44.4 Favored Pre-proline 0 CA--C 1.519 -0.243 0 CA-C-N 117.029 0.414 . . . . 0.0 110.953 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' HD3' ' A' ' 676' ' ' LYS . 87.0 Cg_endo -81.89 118.96 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.611 1.541 . . . . 0.0 110.798 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 673' ' ' TRP . 56.9 mt -88.97 -35.99 0.42 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.606 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 61.5 Cg_exo -40.13 112.32 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.312 2.008 . . . . 0.0 112.918 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 106.55 -10.87 42.46 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.7 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.995 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -92.07 135.79 33.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.678 ' HA ' HD13 ' A' ' 645' ' ' LEU . 3.7 t -88.95 -178.08 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 p30 -50.0 -47.58 52.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.376 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.69 -35.56 80.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.975 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.995 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.1 OUTLIER -64.04 -61.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 69.9 t -49.65 -40.97 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.542 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.53 ' CE1' HD13 ' B' ' 946' ' ' ILE . 2.5 m-30 -48.1 -50.87 26.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.73 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -64.83 -46.89 80.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.983 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 685' ' ' GLU . 3.2 mp -55.83 -63.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.023 HD12 HG13 ' B' ' 946' ' ' ILE . 3.1 mt -56.79 -57.67 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.404 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 687' ' ' TYR . 1.4 mp -47.83 -50.61 25.61 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.045 0.45 . . . . 0.0 110.979 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -57.95 -25.52 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 699' ' ' VAL . 38.6 t -92.21 -14.62 28.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 691' ' ' LEU . 3.7 mttt -62.62 -23.1 66.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.313 . . . . 0.0 110.682 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.7 t -85.08 -24.95 27.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.954 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 143.73 94.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.746 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.3 -2.29 12.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.785 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 54.9 tt0 -154.16 156.19 36.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.954 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 693' ' ' SER . 62.4 t -144.67 154.79 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 111.384 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 699' ' ' VAL . 35.1 tt0 -129.27 109.24 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 616' ' ' LEU . 1.1 pt -116.24 138.36 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.892 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 612' ' ' GLY . 7.8 mm -117.63 145.88 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.389 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.652 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.2 m -129.68 177.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.689 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 671' ' ' LEU . 15.5 p -141.64 108.21 5.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.9 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.881 0.372 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.515 ' HA ' HG23 ' A' ' 635' ' ' VAL . 0.9 OUTLIER -59.01 -172.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.654 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -151.66 -44.16 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.988 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.023 HG13 HD12 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -142.42 147.73 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.961 0.41 . . . . 0.0 111.257 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.512 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -94.27 118.8 32.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.847 ' OXT' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.549 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.53 0.205 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.92 171.65 17.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.244 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 614' ' ' VAL . 2.8 t -101.8 151.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.66 150.99 50.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.198 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.655 ' HB3' HD12 ' A' ' 610' ' ' LEU . 56.7 m95 -129.32 123.05 30.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . 0.542 ' O ' HD13 ' A' ' 610' ' ' LEU . 0.0 OUTLIER -118.9 159.65 43.78 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.022 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.6 123.48 13.94 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.668 2.245 . . . . 0.0 112.137 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . . . . . . . . . 78.1 p -60.76 178.4 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -9.11 58.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.443 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.34 -24.29 14.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.956 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 86.34 11.41 72.21 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.803 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -128.52 -4.68 5.34 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.76 157.07 42.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.89 0.376 . . . . 0.0 110.915 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 601' ' ' TRP . 1.2 mm? -114.56 114.43 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . . . . . . . . . 24.0 mm -96.34 141.76 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.767 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -137.88 162.58 25.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.601 ' HA ' HD12 ' A' ' 702' ' ' ILE . 15.0 mtt-85 -118.04 125.33 50.12 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.731 HG22 HG21 ' A' ' 599' ' ' VAL . 26.1 t -117.68 130.78 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.107 0.48 . . . . 0.0 111.94 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 3.0 mm -111.73 119.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.779 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.851 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.4 mt -118.99 151.29 38.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.085 0.469 . . . . 0.0 111.648 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.517 ' O ' HD13 ' A' ' 657' ' ' LEU . 29.8 m-80 -131.56 113.78 14.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.424 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.501 ' HE2' HD23 ' A' ' 630' ' ' LEU . 1.5 ptpt -100.79 -35.28 9.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 111.23 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 697' ' ' PRO . 0.0 OUTLIER -75.21 -5.03 42.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.7 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . . . . . . . . . 32.6 p -93.78 20.11 7.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.585 0.231 . . . . 0.0 111.285 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.9 m 61.0 153.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 110.98 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.53 ' HG3' HD11 ' A' ' 657' ' ' LEU . 2.2 mpp? -102.01 160.04 27.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.838 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.41 -36.67 93.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.501 2.134 . . . . 0.0 112.134 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -26.28 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.934 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 68.49 158.32 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 71.09 9.37 6.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.501 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -60.11 -86.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.314 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.904 ' O ' HD13 ' A' ' 629' ' ' LEU . . . -168.8 -74.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.201 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.904 HD13 ' O ' ' A' ' 628' ' ' ALA . 0.0 OUTLIER -135.53 -77.74 0.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.755 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -131.06 -45.1 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.938 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 658' ' ' ALA . . . 164.0 1.38 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 C-N-CA 119.16 -1.495 . . . . 0.0 116.12 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.735 HD22 ' O ' ' A' ' 632' ' ' LEU . 0.0 OUTLIER -160.77 154.09 21.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.163 1.482 . . . . 0.0 112.794 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.425 ' HB2' ' CZ3' ' B' ' 947' ' ' TRP . 18.2 ttpt -105.01 131.44 52.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.757 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 6.5 t -119.74 155.29 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 0.0 112.577 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.511 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -108.57 159.84 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.3 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 635' ' ' VAL . . . -129.58 154.12 20.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.549 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.423 ' C ' HD22 ' A' ' 645' ' ' LEU . . . 67.5 62.5 4.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.74 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -119.81 92.97 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.727 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.523 ' N ' HD23 ' A' ' 645' ' ' LEU . 0.0 OUTLIER -58.31 110.22 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 43.8 p -80.55 -177.81 6.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.984 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.38 -13.48 61.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.346 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.551 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.9 mm? -79.19 -33.69 43.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 114.44 18.65 6.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.753 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -129.48 158.29 39.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.856 HD13 ' HA ' ' A' ' 682' ' ' THR . 80.9 mt -93.2 152.43 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -156.01 -152.24 6.17 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.624 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.601 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -135.53 142.74 45.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.908 0.385 . . . . 0.0 111.48 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . 0.414 ' CE1' ' HG3' ' A' ' 669' ' ' GLU . 49.9 m-85 -130.3 144.81 51.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.609 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 668' ' ' ASP . 33.3 mt -82.35 118.68 30.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.977 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . 0.827 HG21 ' HA ' ' B' ' 944' ' ' GLU . 13.1 p -77.88 -33.24 52.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.556 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 0.3 OUTLIER -169.74 156.56 6.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.072 0.463 . . . . 0.0 111.706 -179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -125.21 135.04 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.199 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.97 106.32 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.429 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.33 109.4 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.298 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 129.89 -25.18 4.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.42 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 660' ' ' VAL . 1.2 m -74.33 176.97 6.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.847 0.356 . . . . 0.0 110.951 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.84 ' O ' HG12 ' A' ' 661' ' ' VAL . 1.8 mp -63.41 -49.76 72.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.382 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.851 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -46.55 -35.53 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.958 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.37 -49.34 11.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.902 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 656' ' ' SER . 1.2 m -73.1 -46.44 51.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 657' ' ' LEU . 14.3 p -92.36 -29.43 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.587 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -91.0 -49.58 3.06 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.216 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 664' ' ' LEU . 1.0 OUTLIER 62.3 65.08 0.9 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 0.0 111.694 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -133.38 173.01 11.93 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.657 ' HA ' HG21 ' A' ' 652' ' ' VAL . 17.5 mmm-85 -139.92 160.62 39.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.476 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -55.5 123.76 15.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.892 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 126.39 -23.07 5.8 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.921 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 649' ' ' ILE . 1.4 m-20 -67.06 143.11 56.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 110.377 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.532 ' CD ' HD11 ' A' ' 671' ' ' LEU . 17.5 tt0 -102.21 113.7 27.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.134 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.666 HG22 ' CG1' ' A' ' 703' ' ' VAL . 53.9 t -93.72 102.31 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.591 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.7 OUTLIER -82.15 2.01 33.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.294 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.418 ' HB2' HG12 ' A' ' 702' ' ' ILE . 10.3 mt-10 -146.67 126.37 13.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.55 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.757 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.5 t-105 -130.85 115.9 17.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 66.91 36.11 4.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.096 0.474 . . . . 0.0 110.548 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.13 18.11 74.49 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.511 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.424 ' CD ' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.17 154.13 42.95 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.347 0.574 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -87.31 119.1 1.4 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.833 1.688 . . . . 0.0 111.09 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 670' ' ' VAL . 60.3 mt -90.04 -35.96 0.4 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.482 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 73.4 Cg_exo -41.68 110.05 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.202 1.935 . . . . 0.0 112.552 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 109.15 -11.16 34.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.658 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.987 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -90.4 133.7 34.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.831 0.348 . . . . 0.0 110.989 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.856 ' HA ' HD13 ' A' ' 645' ' ' LEU . 1.9 t -87.7 -176.39 5.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.905 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.451 ' N ' ' OG1' ' A' ' 682' ' ' THR . 14.0 m-80 -44.54 -58.79 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.989 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.61 ' HG2' HG23 ' A' ' 682' ' ' THR . 12.9 pt-20 -56.84 -37.05 70.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.987 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 0.0 OUTLIER -61.51 -61.87 2.22 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 689' ' ' ILE . 79.3 t -46.1 -47.42 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.604 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.527 ' CD1' ' CD1' ' B' ' 946' ' ' ILE . 8.1 m-85 -53.61 -38.43 63.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.052 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.85 -36.86 84.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 685' ' ' GLU . 4.8 mp -68.15 -64.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.127 HD13 HG13 ' B' ' 946' ' ' ILE . 1.8 mp -50.48 -58.59 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 694' ' ' LYS . 1.4 mp -47.9 -48.18 31.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.04 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.19 -24.11 66.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.73 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 13.0 m -94.24 -16.57 23.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.896 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -68.22 -13.57 62.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.708 0.29 . . . . 0.0 111.128 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 27.2 t -102.42 -15.62 16.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.329 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -68.8 150.94 97.49 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 619' ' ' ARG . 62.9 Cg_endo -73.19 -11.67 25.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.553 2.169 . . . . 0.0 112.736 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 699' ' ' VAL . 20.6 tt0 -157.63 151.14 23.76 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.42 ' N ' ' HG2' ' A' ' 698' ' ' GLN . 60.3 t -130.33 148.34 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.348 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -129.08 109.9 11.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -118.43 136.75 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 112.204 -178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 612' ' ' GLY . 10.1 mm -115.48 144.13 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.666 ' CG1' HG22 ' A' ' 670' ' ' VAL . 6.3 m -128.62 178.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.003 0.43 . . . . 0.0 111.66 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 23.1 p -151.64 122.42 7.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.753 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.884 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.841 0.353 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . 0.827 ' HA ' HG21 ' A' ' 650' ' ' THR . 0.3 OUTLIER -150.64 175.12 12.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.77 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.755 ' C ' HD13 ' B' ' 946' ' ' ILE . . . -138.28 -59.36 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.126 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.127 HG13 HD13 ' A' ' 690' ' ' ILE . 0.0 OUTLIER -137.12 144.18 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.389 . . . . 0.0 111.662 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.477 ' O ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -83.56 122.12 28.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.634 178.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.843 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.973 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' HIS . . . . . 0.833 ' HA ' HG23 ' A' ' 661' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 597' ' ' HIS . 92.3 Cg_endo -83.46 129.07 4.94 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.62 2.213 . . . . 0.0 112.548 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.03 151.89 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.52 150.3 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.147 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' TRP . . . . . 0.604 ' HZ3' HG23 ' A' ' 703' ' ' VAL . 62.7 m95 -133.61 141.23 47.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.86 118.45 30.5 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.639 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.39 140.72 24.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.47 2.114 . . . . 0.0 112.155 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 609' ' ' ARG . 0.1 OUTLIER -91.22 161.92 14.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.022 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -9.19 58.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.376 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.56 -13.94 55.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.458 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLY . . . . . . . . . . . . . . . 94.76 -42.37 2.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.569 -0.825 . . . . 0.0 111.961 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.2 62.73 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.685 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' ARG . . . . . 0.4 ' CB ' ' HB2' ' A' ' 604' ' ' SER . 1.0 OUTLIER -146.83 122.17 10.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.788 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' LEU . . . . . 0.67 ' C ' HD13 ' A' ' 611' ' ' ILE . 0.4 OUTLIER -132.17 114.37 14.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 610' ' ' LEU . 2.1 mm -114.09 133.63 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.03 0.443 . . . . 0.0 111.353 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' GLY . . . . . 0.652 ' O ' HG23 ' A' ' 702' ' ' ILE . . . -138.03 161.89 25.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.534 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ARG . . . . . 0.599 ' HA ' HD12 ' A' ' 702' ' ' ILE . 48.6 ttt85 -109.85 119.09 38.26 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.698 HG13 ' HA2' ' A' ' 662' ' ' GLY . 54.0 t -114.97 124.81 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.951 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.1 118.34 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.842 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' LEU . . . . . 0.826 HD21 ' N ' ' A' ' 658' ' ' ALA . 6.5 mt -116.14 148.03 40.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.962 0.41 . . . . 0.0 111.303 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ASN . . . . . 0.845 ' O ' HD13 ' A' ' 657' ' ' LEU . 5.1 m120 -125.08 131.43 53.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.145 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LYS . . . . . 0.65 ' HG2' HD23 ' A' ' 630' ' ' LEU . 1.5 mtpp -97.98 -33.29 11.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.088 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' ARG . . . . . 0.875 ' HD2' HG23 ' A' ' 620' ' ' THR . 0.0 OUTLIER -67.59 -15.06 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.457 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' THR . . . . . 0.875 HG23 ' HD2' ' A' ' 619' ' ' ARG . 3.2 p -104.97 121.58 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.808 0.337 . . . . 0.0 110.974 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.8 t -61.5 170.26 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.609 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' MET . . . . . 0.44 ' HG3' ' HG ' ' A' ' 657' ' ' LEU . 0.8 OUTLIER -99.12 161.51 24.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.292 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.06 -13.8 39.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.853 2.369 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 625' ' ' GLU . 0.0 OUTLIER -98.64 -42.24 7.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.001 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.421 ' N ' ' HD3' ' A' ' 624' ' ' LYS . 7.3 pt-20 175.62 -179.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.84 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 47.9 m -66.7 131.65 46.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . -100.66 -173.39 29.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.522 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.643 ' HB3' HD22 ' A' ' 629' ' ' LEU . . . -92.59 -60.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' LEU . . . . . 0.867 HD23 ' O ' ' B' ' 948' ' ' ALA . 0.0 OUTLIER -118.56 -77.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.779 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' LEU . . . . . 0.81 HD12 HD13 ' A' ' 616' ' ' LEU . 0.0 OUTLIER -138.14 -52.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.659 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.535 ' C ' ' HB3' ' A' ' 658' ' ' ALA . . . 162.08 13.23 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 119.514 -1.327 . . . . 0.0 115.537 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 632' ' ' LEU . 0.2 OUTLIER -161.01 154.18 21.46 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.773 1.287 . . . . 0.0 112.495 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' LYS . . . . . 0.432 ' HD2' ' CE2' ' B' ' 947' ' ' TRP . 1.9 tttt -105.52 132.16 52.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' VAL . . . . . 0.764 HG21 ' HZ3' ' A' ' 673' ' ' TRP . 2.6 t -125.88 154.16 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.383 0.611 . . . . 0.0 111.944 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . 0.47 ' N ' ' CG1' ' A' ' 634' ' ' VAL . 0.9 OUTLIER -114.23 160.04 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.448 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -134.67 154.55 21.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.478 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 82.25 39.85 10.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.54 91.11 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' MET . . . . . 0.623 ' HA ' HD23 ' A' ' 645' ' ' LEU . 0.8 OUTLIER -58.55 113.6 2.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.0 p -82.23 176.94 9.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -73.34 -11.17 60.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.303 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 642' ' ' LEU . 2.7 mm? -80.45 -28.4 37.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 110.08 23.08 6.25 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.01 151.47 49.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.829 0.347 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' LEU . . . . . 0.72 HD13 ' HA ' ' A' ' 682' ' ' THR . 58.2 mt -86.54 148.63 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -149.61 -161.33 9.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.653 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . 0.474 ' HB1' ' CG1' ' A' ' 634' ' ' VAL . . . -133.11 147.35 52.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.878 0.371 . . . . 0.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.82 144.99 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.416 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' ILE . . . . . 0.578 HD13 HD12 ' A' ' 632' ' ' LEU . 43.1 mt -82.44 119.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.401 . . . . 0.0 111.201 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.27 -34.47 55.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.52 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . 0.619 ' HA ' ' HB2' ' A' ' 666' ' ' ALA . 3.3 ptpp? -167.62 158.73 11.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.164 0.506 . . . . 0.0 111.841 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' VAL . . . . . 0.681 HG21 ' HA ' ' A' ' 665' ' ' ARG . 0.0 OUTLIER -129.02 131.16 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.672 179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -77.99 106.38 9.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.5 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.12 103.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . 124.22 -21.56 6.86 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' SER . . . . . 0.776 ' O ' HG22 ' A' ' 660' ' ' VAL . 11.8 m -70.72 173.98 6.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 617' ' ' ASN . 1.0 OUTLIER -58.76 -52.42 65.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 111.063 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.826 ' N ' HD21 ' A' ' 616' ' ' LEU . . . -47.97 -29.9 3.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.497 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -84.34 -49.54 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.703 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 656' ' ' SER . 0.3 OUTLIER -76.09 -52.0 18.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 597' ' ' HIS . 12.2 p -87.55 -29.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.52 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' GLY . . . . . 0.698 ' HA2' HG13 ' A' ' 614' ' ' VAL . . . -84.07 -54.96 2.88 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.22 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' HIS . . . . . 0.414 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.4 OUTLIER 68.83 58.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -135.33 174.6 10.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' ARG . . . . . 0.681 ' HA ' HG21 ' A' ' 652' ' ' VAL . 9.3 mtp-105 -141.01 161.53 37.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 111.253 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 651' ' ' LYS . . . -56.36 124.47 18.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 125.2 -23.83 6.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.832 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' ASP . . . . . 0.491 ' HB2' HD12 ' A' ' 649' ' ' ILE . 0.6 OUTLIER -66.54 140.56 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.494 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -99.92 116.02 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.055 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.696 HG22 ' CG1' ' A' ' 703' ' ' VAL . 60.3 t -95.28 105.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.669 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.604 ' H ' HD22 ' A' ' 671' ' ' LEU . 0.5 OUTLIER -85.78 -0.24 54.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 701' ' ' ILE . 11.2 mt-10 -143.6 126.43 16.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.381 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' TRP . . . . . 0.764 ' HZ3' HG21 ' A' ' 634' ' ' VAL . 10.6 t-105 -130.96 113.58 14.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.168 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 66.92 42.32 2.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.749 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 700' ' ' GLU . . . 64.17 16.39 59.99 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.478 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' LYS . . . . . 0.517 ' HD3' HG12 ' A' ' 689' ' ' ILE . 0.0 OUTLIER -110.67 144.31 30.0 Favored Pre-proline 0 CA--C 1.519 -0.221 0 CA-C-N 117.162 0.481 . . . . 0.0 110.915 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 676' ' ' LYS . 91.9 Cg_endo -79.68 119.01 3.93 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.397 1.398 . . . . 0.0 110.575 177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 673' ' ' TRP . 60.9 mt -86.88 -33.29 0.44 Allowed Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.535 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 678' ' ' LEU . 72.9 Cg_exo -41.94 115.43 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.222 1.948 . . . . 0.0 112.61 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' GLY . . . . . . . . . . . . . . . 104.17 -11.56 51.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.494 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' A' ' 685' ' ' GLU . . . -93.7 134.26 36.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.85 0.357 . . . . 0.0 110.988 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.72 ' HA ' HD13 ' A' ' 645' ' ' LEU . 2.5 t -87.97 -179.72 6.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 687' ' ' TYR . 4.1 p-10 -49.41 -47.29 48.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.349 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.509 ' CG ' HG23 ' A' ' 682' ' ' THR . 6.1 pt-20 -64.31 -37.14 86.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' GLU . . . . . 0.922 ' HB3' ' HB1' ' A' ' 681' ' ' ALA . 1.6 tt0 -62.65 -61.5 2.38 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.446 HG12 HD11 ' B' ' 946' ' ' ILE . 85.8 t -48.73 -42.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 684' ' ' GLU . 19.1 m-30 -47.0 -45.78 21.26 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.515 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -69.04 -36.19 77.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' ILE . . . . . 0.517 HG12 ' HD3' ' A' ' 676' ' ' LYS . 2.2 mp -63.07 -66.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.033 0.444 . . . . 0.0 110.989 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.0 HD12 HD12 ' B' ' 946' ' ' ILE . 7.4 mt -52.54 -53.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.68 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 694' ' ' LYS . 1.3 mp -51.54 -49.25 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.014 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.81 -25.02 68.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 91.3 p -96.69 -12.66 23.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.904 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 691' ' ' LEU . 0.1 OUTLIER -69.43 -16.22 63.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.709 0.29 . . . . 0.0 111.194 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 38.7 m -92.11 -15.82 27.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.233 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -72.15 141.08 83.36 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.5 -17.73 42.84 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.734 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -146.35 162.22 38.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.009 0.433 . . . . 0.0 111.254 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 616' ' ' LEU . 55.4 t -137.69 147.97 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.978 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' GLU . . . . . 0.453 ' CG ' ' N ' ' A' ' 675' ' ' GLY . 0.6 OUTLIER -128.98 109.63 11.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.142 179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' ILE . . . . . 0.594 HD11 HD12 ' A' ' 616' ' ' LEU . 1.0 OUTLIER -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.496 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 612' ' ' GLY . 9.9 mm -118.57 145.75 24.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.545 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.696 ' CG1' HG22 ' A' ' 670' ' ' VAL . 8.1 m -130.36 178.94 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.941 0.401 . . . . 0.0 111.58 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' SER . . . . . . . . . . . . . 74.8 m -151.2 128.35 11.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.79 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.837 0.351 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 944' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -100.03 178.63 4.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 945' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 635' ' ' VAL . . . -134.56 -53.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.674 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 946' ' ' ILE . . . . . 1.0 HD12 HD12 ' A' ' 690' ' ' ILE . 1.8 mt -147.26 158.11 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.141 0.496 . . . . 0.0 111.187 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 947' ' ' TRP . . . . . 0.464 ' C ' ' HG ' ' A' ' 629' ' ' LEU . 0.1 OUTLIER -97.18 118.13 32.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.962 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 948' ' ' ALA . . . . . 0.867 ' O ' HD23 ' A' ' 629' ' ' LEU . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.839 -179.581 . . . . . . . . 1 1 . 1 stop_ save_